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9Scope of this thesis
Chromatin is hierarchically folded and wrapped in order to compact DNA. It is 
accessible to specific proteins to allow regulation of various cellular processes. Although 
chromatin is organized into higher-order structures it is highly dynamic and it can influence 
genome configuration and transcription via interactions with various subnuclear compartments. 
CTCF is the most important factor involved in chromatin structure regulation, in particular the 
spatial organization of higher-order chromatin configurations. CTCF-like (CTCFL) is a testis 
specific paralogue of CTCF, whose function has been characterized to a lesser extent. 
The aim of this thesis is to obtain more insight in the biological roles of CTCF and 
CTCFL. 
A general introduction to the field of nuclear organization and transcription regulation is 
provided in chapter 1. This chapter also provides an overview of the process of spermatogenesis 
during which both CTCF and CTCFL are thought to perform important functions. Finally 
this chapter also summarizes already known aspects of CTCF, CTCFL and their functional 
interaction partners. 
The role of CTCF and CTCFL in the regulation of ribosomal repeat DNA is the main 
focus of chapter 2. CTCF and CTCFL interact with the key regulator of RNA polymerase 
I, UBF. Furthermore, CTCF regulates the spacer promoter by recruiting RNA polymerase I, 
H2A.Z and UBF to rDNA. 
In chapter 3 the focus shifts towards the study of CTCF binding motifs and the binding 
of CTCF zinc fingers to DNA. Using a genome-wide binding analysis on CTCF zinc finger 
mutants we propose a model for DNA binding by CTCF. 
Chapter 4 and 5 examine the functional relationship between CTCF and CTCFL 
extensively in mouse embryonic stem cells and testis by examining genome-wide binding and 
transcription profiles. 
Finally, chapter 6 provides a general discussion elaborating on the findings in this 
thesis. Furthermore, the findings are positioned in perspective with current literature and 
provide recommendations for further experiments on this topic. 

Chapter 1
General Introduction
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§ 1-1 Chromatin organization and transcription regulation
DNA compaction in the nucleus
The hereditary information needed for the functioning of an organism is stored in DNA. 
DNA is a two-stranded helix in which each strand consists of four different nucleotides called 
adenine (A), guanine (G), cytosine (C) and thymine (T). Like letters in a very long phrase, the 
nucleotides are placed in a non-random order so as to convey a message: the genetic code. 
A small part of that code contains the information for our ~25,000 genes. Humans have 46 
chromosomes that concatenated together would stretch up to 2 meters. DNA is stored in the 
nucleus, which on average has a diameter of 10 µm. This obviously requires an enormous 
compaction of the DNA, which is achieved by folding and wrapping the DNA in a hierarchical 
manner, using specific associated proteins. DNA together with its associated proteins is called 
chromatin. DNA folding requires many proteins, including the histones, which provide the first 
level of folding of the double helix and can be considered the core chromatin proteins.
DNA folding is hierarchically organized into several levels (Figure 1). First, 147 base 
pairs (bp) of DNA is tightly wrapped in almost two helical turns around a histone octamer 
consisting of two dimers of H2A-H2B and H3-H4. This protein-DNA complex is called the 
nucleosome (Luger et al., 1997; Noll and Kornberg, 1977; Richmond and Davey, 2003). Nucleosomes are 
separated by ~20-50 bp of linker DNA, which is associated with histone H1 (Oudet et al., 1975). In 
electron microscopic (EM) images nucleosomes appear to be arrayed as “beads on a string”, 
forming a 10 nm chromatin fiber (Oudet et al., 1975). This fiber has been shown in vitro to be 
organized into a secondary structure, the 30 nm chromatin fiber (Finch and Klug, 1976). However, 
the in vivo existence of the 30 nm fiber remains controversial (Tremethick, 2007). Chromatin is 
further compacted into higher order structures in interphase, and even further into very tightly 
folded structures, called chromonema, in mitotic chromosomes (Belmont and Bruce, 1994; Rattner and 
Lin, 1985; Widom and Klug, 1985).
Based on EM images, chromatin was originally divided into 2 types, heterochromatin and 
euchromatin. Heterochromatin shows up as dark and condensed matter with often a granular 
composition. By contrast, euchromatin appears more lightly colored and less condensed 
(Oudet et al., 1975). This division also has structural and functional relevance. Heterochromatin is 
indeed highly condensed, generally gene poor and transcriptionally inactive. It comes in two 
varieties: permanently silenced chromatin or constitutive heterochromatin, which is often found 
at centromeres, telomeres and inactive repetitive elements, and facultative heterochromatin, 
2 nm
DNA double helix
Nucleosome
Histone H1
30 nm fiber
Chromosomes
Higher-order structures
10 nm
Figure 1: Chromatin organization
DNA is a double-stranded helical structure 
with a diameter of 2 nm. DNA and its 
associated proteins are called chromatin. 
The DNA is tightly wrapped around a 
histone octamer consisting of two dimers 
of H2A-H2B and H3-H4. This protein-
DNA structure is called the nucleosome. 
These nucleosomes are separated by 
20-50 bp of linker DNA bound by histone 
H1 and are further compacted in a 30 
nm chromatin fiber. Chromatin is further 
compacted into higher-order structures 
in interphase and even further folded in 
mitotic chromosomes. 
Image adapted from W. H. Freeman Pierce, Benjamin. 
Genetics: A Conceptual Approach, 2nd ed. 
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which is mostly inactive but which can be activated, e.g. during development or differentiation 
(Dillon and Festenstein, 2002; Le et al., 2004). Euchromatin is less condensed, generally gene rich, 
trancriptionally active, and evenly distributed along the genome (Dillon and Festenstein, 2002). 
Despite this general classification, euchromatic regions may also contain inactive genes 
whereas active genes can also be located in heterochromatic regions (Gilbert et al., 2004). In 
addition, although DNA is highly compacted, it has to be accessible to all kinds of proteins 
in order to allow processes like transcription, replication, recombination and repair to occur 
efficiently and in a regulated manner.
Epigenetic modifications
The genetic four-letter code of DNA is quite reliably passed on to the next generation, 
although mutations can occur. Depending on their position these changes may lead to altered 
gene function and/or expression. There are also other phenomena that can lead to changes 
in gene expression. These cannot be explained by alterations in DNA sequence, but they can 
nevertheless be stable, at least for one generation. Such changes are due to an “epigenetic” 
code, which is laid down “on top” of the genetic one. The epigenetic code does not meddle with 
the nucleotide sequence but instead it acts on the proteins that wrap and protect the DNA, or it 
modifies the DNA itself. The epigenetic code represents the chromatin state, i.e. the properties 
of DNA and its associated proteins, and this in turn can affect gene expression.
Epigenetic modifications on the four core histones, H2A, H2B, H3 and H4, occur post-
translationally. Many epigenetic modifications have been described, including acetylation, 
methylation, ubiquitination and phosphorylation (Kouzarides, 2007; Rivera and Ren, 2013). Together 
they are important to facilitate proper chromatin organization and to allow the efficient execution 
of biological tasks in the nucleus, e.g. gene expression or silencing, cell cycle progression and 
DNA repair (Dillon and Festenstein, 2002; Kouzarides, 2007; Rivera and Ren, 2013). Epigenetic modifications 
are mainly restricted to the histone tails and are carried out by chromatin remodeling complexes, 
e.g. histone acetyl transferases (HATs) and histone deacetylases (HDACs). These chromatin 
remodeling complexes modify the histones and affect the local chromatin state (Brownell and 
Allis, 1996; Brownell et al., 1996; Mizzen et al., 1996). Besides the canonical histones, there are many 
histone variants, that differ in a small subset of amino acids from the canonical proteins, and 
that change the chromatin state upon replacement of the core histones. These replacements 
can be stable too and are therefore also considered to be “epigenetic events”.
In addition to histone modifications and replacements, DNA methylation is the third 
major epigenetic modification. DNA methylation occurs on cytosines of CpG dinucleotides, 
and can be divided into de novo and maintenance events. De novo DNA methylation occurs 
on non-methylated CpGs and is established by DNA methyltransferases 3A and 3B (DNMT3A 
and DNMT3B) (Bestor, 1992). Maintenance of DNA methylation is carried out by DNMT1 and 
occurs after DNA replication on the non-methylated cytosine of the new CpG (Holliday and Pugh, 
1975; Pradhan et al., 1999).
Epigenetic modifications can mark specific regions of the DNA (Table 1). For example, 
H2A.Z and H3.3, which replace canonical H3, are often found on actively transcribed regions 
(Barski et al., 2007; Jin and Felsenfeld, 2007; Jin et al., 2009). Histone 3 lysine 4 mono-, di- and tri-
methylation (H3K4me1/2/3), histone 3 lysine 36 mono- and tri-methylation (H3K36me1/3), 
H2A.Z, H3.3, histone 3 lysine 27 acetylation (H3K27ac) and histone 3 lysine 9 acetylation 
(H3K9ac) are located in actively transcribed regions and promoters and the levels of these 
modifications correlate with gene activation (Barski et al., 2007; Ernst et al., 2011; Heintzman et al., 
2009; Heintzman et al., 2007). Heterochromatic regions on the other hand are often marked by 
histone 3 lysine 9 (H3K9), histone 3 lysine 27 (H3K27) and histone 4 lysine 20 methylation 
(H4K20me) and hardly show histone acetylation. Differential modification of the same amino 
acid residue can be associated with different chromatin domains; for example histone 3 lysine 
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27 mono-methylation (H3K27me1) associates with active promoters, whereas histone 3 lysine 
27 di- and tri-methylation (H3K27me2/3) are more associated with silent promoters (Barski et al., 
2007). Furthermore H3K27me3 is present together with H3K4me1/2/3 in “poised” promoters in 
embryonic stem cells (ES cells), i.e. promoters that may become expressed (and lose these 
marks) depending on the differentiation path of the ES cell (Ernst et al., 2011).
DNA methylation marks chromatin domains during differentiation and in general 
differentiated cells have more DNA methylation than pluripotent cells (Gifford et al., 2013; Xie et al., 
2013). Genes that are active during early stages of differentiation are often CpG rich and are 
silenced due to DNA methylation in later stages. Genes active at later stages during differentiation 
are often CpG poor and therefore unmethylated (Xie et al., 2013). In fact, the genome can be 
segmented into three categories regarding methylation: fully methylated regions containing 
most of the genome, unmethylated regions encompassing promoters and unmethylated CpG 
islands and low-methylated regions often identified at distal regulatory regions (Stadler et al., 
2011). 
Transcription and regulatory elements 
 Mammalian genomes have ~ 25,000 genes whose transcription is tightly regulated 
in order to carry out the spatio-temporally controlled, lineage-specific gene expression 
program that is required for the development of an organism. Transcription is a dynamic and 
complicated process that involves multiple proteins and consists of three phases: initiation, 
elongation and termination (Roeder, 2005; Venters and Pugh, 2009; Weake and Workman, 2010). The mega 
dalton, multisubunit proteins, RNA polymerase I, and III, are responsible for transcription of 
ribosomal RNA (rRNA), occurring in the nucleolus, and of transfer RNA (tRNA), respectively. 
RNA polymerase II is responsible for the transcription of protein coding genes and of non-
coding RNAs (ncRNAs) other than rRNA and tRNA.
Histone Modification Residues Modified Functions Regulated
Acetylation K-ac Transcription, Repair, Replication, Condensation
Methylation (lysines) K-me1 Kme2 Kme3 Transcription, Repair
Methylation (arginines) Rme1 Rme2a Rme2sTranscription
Phosphorylation S-ph T-ph Transcription, Repair, Condensation
Ubiquitylation K-ub Transcription, Repair
Sumoylation K-su Transcription
ADP ribosylation E-ar Transcription
Deimination R > Cit Transcription
Proline Isomerization P-cis > P-trans Transcription
Histone modification Transcriptional role
H3K4me1 Activation
H3K4me2 Activation
H3K4me3 Activation
H3K27ac Activation
H3K27me1 Activation
H3K27me3 Repression
H3K36me1/2 Activation
H3K9ac Activation
H3K9me2/3 Repression
H4K20 Repression
Histone variant Transcriptional role
H3.3 Activation
H2A.Z Activation
Table 1: Histone modifications and their 
functions
(A) Possible modifications on histones and their 
associated functions. Modifications on specific 
amino acids are depicted in the center column. 
(B) Functional role on transcription of histone 
modifications and (C) histone variants. Tables based on 
Kouzarides et al, 2007 and Rivera and Ren, 2013.
A
B C
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In order to start transcription a gene needs to be(come) accessible to the basic 
transcription machinery, which involves chromatin remodeling (Muller et al., 2001; Tumbar et al., 
1999). Epigenetic modifications, that change local chromatin structure to increase or decrease 
accessibility, can obviously impact on transcription. Like initiation, transcription elongation and 
termination, which are linked to RNA splicing, are also highly regulated, by factors acting on the 
processes themselves as well as by epigenetic modifications.
At the DNA level relatively small domains called regulatory elements regulate 
transcription. These regulatory elements include promoters, enhancers (or silencers), locus 
control regions, and insulator sequences (Figure 2). The promoter is a small DNA sequence 
upstream of the transcription start site on to which the basal transcription machinery 
assembles and from where transcription is initiated (Butler and Kadonaga, 2002; Roeder, 2005). 
Enhancers, silencers, and locus control regions are distal regulatory elements that can be 
located inside or outside the transcription unit regulating transcription in cis, often over a long 
distance. Transcription requires contact between promoters and regulatory elements, bringing 
together the pre-initiation complex (basal transcription factors and the RNA polymerase) and 
transcription regulators (e.g. activators) and/or co-regulators (e.g. chromatin remodelers). 
This requires folding of the chromatin into loops. This type of looping, which one could call 
“regulatory looping”, differs from the type of looping (or folding) described above, that is required 
to compact chromatin and that one might call “architectural looping”.
Enhancer
Silencer
Insulator
Locus Control Region
Insulator 
binding 
protein
Enhancer
Silencer
InsulatorActive promoter
Inactive promoter
Figure 2. Distal transcriptional regulatory elements
Enhancers and silencers are elements that can activate or repress transcription, respectively. Insulators can act as 
enhancer-blocker by preventing interactions between promoter and enhancer when placed in between these two 
elements. Locus control regions are cis-regulatory elements that regulate transcription of clusters of genes. Image adapted 
from Maston et al 2006
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Enhancers are operationally defined as DNA sequences that can activate transcription 
when brought in the vicinity to the promoter (Banerji et al., 1981; Nolis et al., 2009; Vilar and Saiz, 2005). 
These elements are marked by specific histone modifications e.g. H3K4me1, and chromatin 
remodelers (e.g. p300) and are bound by cell type specific transcription factors (Visel et al., 
2009). Silencing/repressor elements function to repress transcription of a gene, and are also 
regulated by different histone modifications, chromatin remodelers and cell type specific 
factors (Maston et al., 2006). Insulators (also termed boundary elements), which are often bound 
by the protein CTCF (see below), are elements that prevent the spreading of modified histones 
from one chromatin domain into another, thereby for example blocking the expansion of 
heterochromatin. Insulators can also act as enhancer-blockers, preventing enhancer-promoter 
interactions when placed between these two elements (Maston et al., 2006). While some insulators 
exert both functions, others only act as a boundary element or as enhancer-blocker (Maston et 
al., 2006; Parkhurst et al., 1988; Recillas-Targa et al., 2002; Scott et al., 1999; Spana et al., 1988). Locus control 
regions (LCRs) were defined as cis-regulatory elements that regulate transcription of an entire 
gene locus or cluster. Like enhancers they act over a distance and require DNA looping to exert 
their effect (Dean, 2011; Grosveld et al., 1987; Maston et al., 2006). The best studied LCR, which will be 
described later in this introduction, is the one regulating the β-globin locus.
Links between the spatial organization of chromatin and transcription
Microscopic experiments using fluorescent in situ hybridization (FISH) to detect 
chromosomes, loci, and genes, and genome-wide experiments examining intra- and 
interchromosomal interactions, have revealed that chromatin is organized in more intricate 
manners and into smaller domains or sub-compartments than the folding and compaction, 
and heterochromatic and euchromatic divisions mentioned earlier. The chromosomes during 
interphase each occupy a distinct part of the nuclear space, called chromosome territory (CT). 
Epigenetic modifications have a big impact on this refined spatial organization (Cremer and Cremer, 
2010; Lichter et al., 1988; Lieberman-Aiden et al., 2009; Pinkel et al., 1988; Zhang et al., 2012).
 Consistent with the CT view, interactions between DNA elements within a locus or 
between loci on the same chromosome occur much more often than interactions between 
chromosomes (Dixon et al., 2012; Lieberman-Aiden et al., 2009). The interaction frequency of 
intrachromosomal loci revealed that CTs consist of smaller chromosomal areas, topologically 
associated domains (TADs). Frequent long-range interactions occur within loci in a TAD and 
much less frequent between loci in different TADs (Dixon et al., 2012; Nora et al., 2012). 
 Several other sub-compartments have been detected within nuclei, for example, 
areas combining gene-rich regions within a CT, or in multiple CTs, and excluding gene-poor 
regions (Dixon et al., 2012; Lieberman-Aiden et al., 2009). Actively transcribed genes have also been 
show to come together in so-called transcription factories, which suggest that these genes 
might be coordinately regulated (Ghamari et al., 2013; Iborra et al., 1996; Osborne et al., 2004). Inactive 
regions often associate with the nuclear lamina, and are called lamina associated domains 
(LADs), while active regions often localize to the inner part of the nucleus and the nuclear pore 
complexes (Brown et al., 2008; Capelson et al., 2010; Guelen et al., 2008). These regions are dynamic 
and change during differentiation or upon reception of environmental signals, e.g. nucleolus 
associated domains (NADs) can switch to LADs and vice versa (Nemeth et al., 2010; Peric-Hupkes et 
al., 2010; van Koningsbruggen et al., 2010).
Long-range interactions between DNA elements cause DNA looping, which include 
both “regulatory looping” and “architectural looping”. Interactions are mediated by protein-
protein interactions and create a complex three-dimensional structure. Long-range interactions 
involve the structural proteins CTCF and cohesin. These proteins are described in more 
detail later in this introductory chapter. Long-range interactions also involve other proteins, 
such as transcription factors and chromatin remodelers. Together these proteins establish cell 
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type specific TADs and other domains, which are thought to regulate gene expression and 
epigenetic events (Gibcus and Dekker, 2013).
In 2002 a paralogue of CTCF, called CTCFL or BORIS (Brother of the Regulator 
of Imprinted Sites) was discovered (Loukinov et al., 2002). A short overview of the published 
literature regarding CTCFL will be given at the end of this chapter. Since CTCFL is specifically 
expressed in the male germ line, the following paragraph will provide a description of mouse 
spermatogenesis and an overview on what is known about chromatin organization during this 
process.
  
§ 1-2 Chromatin organization during mouse spermatogenesis
Mammalian spermatogenesis
Spermatogenesis in mammals is a complex process in which male haploid cells are 
generated from diploid precursors. Spermatogenesis involves multiple rounds of cell division 
(mitotic phase) but without cytokinesis in order to form a syncytium, a group of nuclei sharing 
a common cytoplasm and without the usual complete plasma membrane division. This 
syncytium is maintained throughout spermatogensis. The mitotic phase is followed by the 
generation of haploid spermatocytes (meiotic phase). The final stage is the differentiation into 
spermatids and spermatozoa. The latter process, which is called spermiogenesis, involves the 
compaction of the nucleus that requires replacement of histones with, first, transition proteins 
and then protamines. During spermiogenesis the cytoplasm is extruded and a flagellum is built 
for sperm motility. Spermatogenesis takes place in the seminiferous tubules of the testis in 
an outside-in fashion, i.e. diploid cells are located towards the outside of the tubule whereas 
more differentiated cells (e.g. spermatids and spermatozoa) are located more and more on the 
inside. Within the seminiferous tubules basal and luminal compartments are present, which 
form a blood-testis barrier, and which are maintained by Sertoli cells, that connect to each other 
via junctional complexes (Griswold, 1998; Yoshida et al., 2007; Zhou and Griswold, 2008). Shortly after cells 
have entered meiotic prophase, they move from the basal to the luminal compartment through 
an intricate regulatory system that allows the blood-testis barrier to remain intact during the 
passage of these cells. It is interesting to realize that luminal testicular cells are separated from 
the immune system by the blood-testis barrier for proper development and maturation of the 
testis (Mital et al., 2011). Germ cell specific genes that are aberrantly expressed in cancer cells are 
termed cancer germ cell genes (CG genes) (Cheng et al., 2011). The proteins of these genes can 
be used for immunotherapy to treat cancer.
 In mice diploid primordial germ cells (PGC) give rise to prospermatogonia, the 
spermatogonial stem cell, which is located at the basal side of the seminiferous tubule and 
which undergoes both self-renewal and differentiation (Figure 3) (Eddy, 2002; Zhou and Griswold, 
2008). Three types of spermatogonia are observed: A, B and intermediate. Type A spermatogonia 
consist of seven sub-types, A (single) A (pair), A (aligned), which are the spermatogonial stem 
cells, and A1-A4 spermatogonia, which are committed to differentiation and which expand via 
a couple of mitotic divisions. A1-A4 spermatogonia also start to migrate laterally along the 
tubule until they differentiate further, first to intermediate spermatogonia and then to type B 
spermatogonia (Chiarini-Garcia et al., 2001; de Rooij, 1998; Dettin et al., 2003; Yoshida et al., 2007). It has 
been proposed that retinoic acid plays an important role in spermatogonial differentiation. 
Retinoic acid can induce differentiation in vitro (Haneji et al., 1983), and positively regulates stem 
cell factor KIT, STRA8 (stimulated by retinoic acid), and DAZL (deleted in azoospermia-like) 
(Schrans-Stassen et al., 1999; Zhou and Griswold, 2008), proteins that are essential for spermatogonial 
differentiation. Mutation or knock out experiments of these genes result in a pre-meiotic block, 
increased apoptosis and infertility (Baltus et al., 2006; Brannan et al., 1992; de Kretser, 1997; Koubova et al., 
2006; Mark et al., 2008; Schrans-Stassen et al., 2001).
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Type B spermatogonia give rise to primary spermatocytes that enter meiosis starting 
with the pre-leptotene phase. In these spermatocytes DNA is replicated in a prolonged S-phase 
and the sister chromatids are tightly bound by cohesin complexes, a multi-subunit protein 
complex, which function will be further discussed in section 1-3. Subsequently to S-phase a 
prolonged G2 phase is initiated, meiotic prophase I, in which DAZL and STRA8 are required 
(Anderson et al., 2008; Jan et al., 2012; Lin et al., 2008). 
There are four stages during meiotic prophase I: leptonema, zygonema, pachynema 
and diplonema (Handel and Schimenti, 2010; Jan et al., 2012). First, during the beginning of leptonema 
chromosomes begin to align but are not yet paired. Chromatin condensation occurs and DNA 
double-strand breaks (DSB) are induced by the enzyme SPO11. DSB repair and checkpoint 
proteins like e.g. the checkpoint kinases ATM and ATR, the recombinases RAD51 and its 
meiosis-specific paralogue DMC1 are recruited to the chromosomes (Handel and Schimenti, 2010). 
In addition, the assembly of the axial elements composed of synaptonemal complex (SC)-
specific proteins, SYCP2 and SYCP3, and cohesin is initiated (Handel and Schimenti, 2010; Jan et 
al., 2012; Page and Hawley, 2004). The SC with its axial elements is required for the synapsis of the 
chromosomes (Handel and Schimenti, 2010; Jan et al., 2012; Page and Hawley, 2004). 
By zygonema, the homologous chromosomes have paired and synapsis is initiated. 
Prior to synapsis, the axial elements become the lateral elements of the SC and interact with 
the central element formed of e.g. SYCP1 (Handel and Schimenti, 2010; Jan et al., 2012; Page and Hawley, 
2004). In the third stage, pachynema, the synapses are established and chromosome crossover 
occurs. In this process non-sister chromatids of the homologous chromosomes exchange 
segments over homologous regions and chiasmatas are formed were this exchange happens 
I II-III IV V VI VII VIII IX X XI XII
In In B B PI PI L L Z Z
P P P P P P P P P D SS
1 2-3 4 5 6 7 8 9 10 11 12
13 14 15 15 16 16 16
Figure 3. Schematic overview of the seminiferous tubule of mouse during spermatogenesis.
In mouse there are 12 stages for the production of spermatozoa in the seminiferous epithelium. During differentiation 
certain cell types are always aligned from the basal to luminal compartment. In each diagram, the lower and upper rows 
of cells are located closer to basal and luminal compartments, respectively. Undifferentiated and type A spermatogonia 
are not depicted. In: intermediate-type spermatogonia; B: B-type spermatogonia; PI: primary spermatocytes of the 
preleptotene stages; L: leptotene stage; Z: zygotene stage; P: pachytene stage; SS: secondary spermatocytes. Arabic 
numbers represent the step of spermiogenesis. Modified from Russel et al 1990.
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(Page and Hawley, 2004). Crossover formation is established in late pachynema (Handel and Schimenti, 
2010; Jan et al., 2012; Page and Hawley, 2004). During the fourth and last stage, diplonema, the SC is 
disassembled, but the homologous chromosomes are still tightly bound to each other at the 
region of the chiasmata (Handel and Schimenti, 2010; Page and Hawley, 2004). Prophase I ends with 
diakinesis, the stage of transition to metaphase I. During metaphase I the microtubles are 
attached to the kinetochore and cohesin complexes are dissociated along the sister chromatid 
arms, which resolves the crossovers and allows the duplicated homologs to separate at 
anaphase I (Handel and Schimenti, 2010; Jan et al., 2012). The sister chromatids are still together by 
the residual cohesin. During anaphase II the remaining cohesin complex is dissociated, which 
allows the sister chromatids to separate resulting in four haploid round spermatids (Handel and 
Schimenti, 2010; Jan et al., 2012).
During spermiogenesis the round spermatids undergo morphological changes and 
develop a flagellum, which is composed of a microtubular structure, the axoneme (Jan et al., 2012; 
Kierszenbaum and Tres, 2004). Nuclear elongation is established by another microtubular structure, 
the manchette, which is transient in contrast to the axoneme. During nuclear elongation chromatin 
remodeling takes place. A major event is the replacement of histones, first by transition proteins 
and then by protamines (Jan et al., 2012; Meistrich et al., 2003). This results in an enormous chromatin 
compaction and is accompanied by a general silencing of transcription (Gaucher et al., 2010). Prior 
to global histone replacement open chromatin domains are created by incorporation of histone 
variants and global H4 hyperacetylation, which results in unstable nucleosomes (Boussouar 
et al., 2008; Jin et al., 2009). It has been proposed that these chromatin domains with unstable 
nucleosome are targets for nucleosome disassembly and histone displacement (Gaucher et al., 
2010). Histone hyperacetylation gradually disappear with the appearance of transition proteins, 
TNP1 and TNP1. Transition proteins are not essential for histone removal and protamines 
loading as these processes still occur in Tnp1 and Tnp2 knock out mice (Yu et al., 2000; Zhao et al., 
2001). However, they are important for the proper regulation of chromatin structure, since the 
lack of both TNP1 and TNP1 results in irregular chromatin condensation. Transition proteins 
are subsequently replaced by protamines, PRM1 and PRM2 (Gaucher et al., 2010). These proteins 
are essential for male fertility and the incorporation of protamines in the DNA results in further 
compaction of chromatin.
During spermiogenesis the cytoplasm is extruded from cells, the acrosome and the 
mitochondrial sheet around the midpiece of the sperm cells are established (Kierszenbaum and 
Tres, 2004). The acrosome is a granular vesicle that is required for the penetration of the zona 
pellucida during fertilization. The zona pellucida is a layer of fibrous glycoproteins secreted by 
the oocyte, which surrounds the plasma membrane of the oocyte. It acts as physical barrier 
and is required for the initiation of the acrosome reaction, the release of enzymes contained in 
the acrosome that breaks down the zona pellucida. Before this is possible, spermatogenesis 
has to be completed by the release of spermatozoa into the lumen of the seminiferous tubule 
(Jan et al., 2012).
Regulation of DNA imprints during spermatogenesis
In addition to histone modifications in spermatids, major epigenetic reprogramming 
events need to take place during spermatogenesis, in particular to erase somatic imprints and 
establish sex-specific (i.e. paternal) ones. In mice the genomes of PGCs of both females and 
males become demethylated during early development (Mayer et al., 2000; Monk et al., 1987; Reik 
et al., 2001). After embryonic day (E) 13-14 imprinted genes and single-copy genes become 
demethylated (Reik et al., 2001; Tada et al., 1998). PGCs in males and females enter mitosis or arrest 
in meiosis, respectively, after complete erasure of DNA methylation. Gain of methylation in the 
female germ line is initiated after birth during oocyte growth. In the male germ line remethylation 
of the genome is initiated at the prospermatogonia stage (E15-16 in mice) (Reik et al., 2001).
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 Reprogramming takes place once more after fertilization, in the early embryo. 
Reprogramming occurs on both maternal and paternal genomes (Kafri et al., 1992; Reik et al., 
2001). However, not all marks are erased, and most sex-specific imprinted genes are actually 
protected from global DNA methylation erasure (Brandeis et al., 1993; Kafri et al., 1992; Tada et al., 1998). 
DNA methylation is again established during blastocyst formation in the inner cell mass (Reik et 
al., 2001). Both CTCF and its paralogue CTCFL, which will be discussed in the following section, 
have been suggested to play a role in reprogramming of imprinted genes.
  
§ 1-3 Key players in chromatin organization: CTCF, cohesin and CTCFL
 Maintenance of genetic and epigenetic integrity of the genome is essential to 
control various cellular processes. Several studies on chromatin organization have shown 
that CTCF and cohesin play an important role in the regulation of chromatin structure and 
spatial organization in order to regulate transcription and epigenetic events. The function of 
testis specific CTCF paralogue CTCFL in relation to transcriptional regulation and chromatin 
organization is less clear. 
CTCF - Identification and basal function
CTCF (CCCTC-binding factor) was first identified as a transcriptional repressor 
that binds a highly divergent 50-60 bp DNA sequence on human/mouse and chicken c-myc 
promoters (Filippova et al., 1996; Klenova et al., 1993; Lobanenkov et al., 1990). Additionally, CTCF was 
discovered in an independent study as negative protein 1 (NeP1) that binds a silencer element 
and negatively regulates the chicken lysozyme gene (Baniahmad et al., 1990; Burcin et al., 1997). 
Subsequently, two other independent studies identified factors that bound to the APPβ promoter 
of the human amyloid precursor protein (APP) (Quitschke et al., 1996; Vostrov and Quitschke, 1997), or to 
the HS4 insulator sequence upstream of the chicken beta globin locus (Walters et al., 1999). These 
factors were also identified as CTCF.
CTCF is a ubiquitously expressed nuclear protein that consists of a centrally located 
eleven zinc finger (ZF) domain, which is surrounded by the N- and C-terminal domains. The first 
ten ZFs of CTCF are composed of approximately 30 amino acids and belong to the C2H2 ZF 
class while the eleventh ZF belongs to the C2HC class (Ohlsson et al., 2001). The ZF region binds 
DNA, RNA and other proteins. An AT-hook domain in the C-terminus might also have a role in 
DNA binding and/or protein interactions, although additional research is needed to confirm this 
(Ohlsson et al., 2001). The C-terminal domain is subjected to posttranslational modifications (e.g. 
phosphorylation of four serine residues), which was proposed to influence CTCF binding to its 
target sites on DNA (Klenova et al., 2001).
CTCF is an essential protein, as Ctcf knock out mice die early during embryogenesis 
(Heath et al., 2008). Furthermore, transgenic females with RNAi constructs against CTCF 
produce less offspring than wild type and show increased zygotic lethality and defects in pre-
implantation development (Fedoriw et al., 2004). Ctcf knock down mice develop normally until 16-
31 cell stage. Hereafter, increased apoptosis occurs and development of the inner cell mass 
and trophoectoderm are inhibited (Moore et al., 2012).  
The importance of CTCF is further emphasized by studies focusing on the conservation 
of the protein. CTCF is highly conserved in higher order eukaryotes as it has been identified 
in basal nematodes (e.g. T. spiralis), zebrafish, drosophila, frogs, birds, rodents and humans 
(Burke et al., 2002; Heger et al., 2009; Moon et al., 2005; Ohlsson et al., 2001; Pugacheva et al., 2006). CTCF has 
~90% amino acid identity in the mammals and its eleven zinc finger shows an almost 100% 
conservation between mouse, human and chicken (Ohlsson et al., 2001). Zebrafish CTCF shows 
an overall 70% amino acid identity and the zinc finger region shows 98% amino acid identity 
compared to aves (birds) and mammals (Pugacheva et al., 2006).
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CTCF - DNA binding specificity 
Early in vitro approaches suggested that CTCF uses different combinations of ZFs to 
recognize its binding sites, ZF 2-7 being able to bind the chicken c-myc site while ZF 3-11 were 
required for binding to the human site (Filippova et al., 1996). By contrast, CTCF ZF 6-11 were 
required for the F1 lysozyme silencer element (Burcin et al., 1997), whereas ZF 5-7 facilitated 
binding to the APP promoter and deletion of the flanking ZFs or N-terminus decreased but did 
not abolish CTCF binding to this site (Quitschke et al., 2000; Vostrov et al., 2002). Together, these data 
suggested that the peripheral ZFs are needed to stabilize CTCF binding.
A more precise in vitro study demonstrated, by deleting individual ZFs, that ZF 4-7 
were absolutely required for DNA binding (Renda et al., 2007). Interestingly, ZF 8 becomes 
essential when ZF 4 is deleted and vice versa, suggesting that at least four ZFs are required for 
CTCF binding. Deletion of the peripheral ZFs reduced CTCF affinity for DNA (Renda et al., 2007), 
supporting the hypothesis that the flanking ZFs stabilize protein binding and increase binding 
affinity but are not involved in specific DNA recognition. Furthermore, four ZFs were able to 
bind at least 23 base pairs (bp), and the N-terminal ZFs were able to bind the 3’end of the 
CTCF target site while the C-terminal ZFs were bound to the 5’end. DNA methylation inhibited 
the binding of ZF 7 indicating that this finger acts as a methylation sensor that prevents binding 
to methylated sites (Renda et al., 2007).
The first attempt to map CTCF binding sites on a genome-wide level used chromatin 
immunoprecipitation (ChIP) followed by detection of the precipitated DNA on chip arrays (ChIP-
on-chip). Using this technique in primary human fibroblasts (IMR90) ~14000 CTCF binding sites 
were found dispersed throughout the genome (Kim et al., 2007). Subsequent ChIP experiments 
followed by high throughput sequencing (ChIP-Seq) using CD4+ T cells identified ~20,000 
CTCF sites (Barski et al., 2007). Other studies in mouse embryonic stem cells then revealed 
~40,000 binding sites (Chen et al., 2008). A recently developed method, ChIP-exo, in which ChIP 
is first followed by lambda exonuclease treatment, which trims the DNA sequence up until the 
formaldehyde crosslink, and then by high throughput sequencing, redefined CTCF binding 
sites with a near single base pare resolution. This method detected ~35,000 CTCF sites in 
HeLa cells (Rhee and Pugh, 2011). A very recent report discovered ~48,000 binding sites in primary 
B cells (Nakahashi et al., 2013), whereas a bio-informatics approach in which all CTCF binding sites 
derived from 56 human cell lines were compared identified ~450,000 unique CTCF binding 
sites from which ~24,000 sites are conserved in >90 % of the cell lines (Li et al., 2013). This shows 
how detection method and bioinformatic analysis can influence the estimation of the amount of 
CTCF sites throughout the genome.
Initial genome-wide study in IMR90 human fibroblasts using ChIP-on-chip revealed 
that 46% of the CTCF binding sites are located in intergenic regions, 20% within 2.5 kb of 
transcription start sites, 22% in introns and 12% in exons (Kim et al., 2007). An independent 
study in human CD4+ T cells using ChIP-Seq which has been reanalyzed identified a similar 
distribution in which CTCF binds in 45% in intergenic region, 7% in 5’ UTR, 3% in exons, 29% 
in introns, 2% in 3’UTR, and 13% within 5 kb of the transcription start site (Barski et al., 2007; Xie et 
al., 2007). 10% of all CTCF binding sites identified by ChIP-exo are located in annotated genes 
from which 6% of these CTCF sites are located at core promoters that are located ~85 bp 
upstream of the transcription start site (Rhee and Pugh, 2011). 
The distribution of CTCF binding sites seemed to be correlated with gene density 
(Barski et al., 2007; Kim et al., 2007; Xie et al., 2007), although many CTCF sites are also detected in 
intergenic regions. While there is a high correlation between CTCF binding and gene density 
there are regions in the genome that deviate from this trend. Two areas can be distinguished 
1) regions that contain clusters of related gene families that are CTCF depleted (less than 2 
CTCF sites within 2 Mb) 2) regions that contain high CTCF binding density within clusters of 
related genes. Here, ~81% of these genes have two or more alternative promoters (Kim et al., 
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2007). Euchromatic regions are marked by DNase I hypersensitivity sites and CTCF (Wen et al., 
2012). Furthermore, CTCF was located at boundaries of different chromatin domains where 
it acts as a barrier to prevent spreading of heterochromatic regions to euchromatic regions 
(Barski et al., 2007; Cuddapah et al., 2009). It has been proposed that the amount of CTCF binding 
sites expanded during evolution and are also located in retrotransposon elements, where they 
function as chromatin and transcription insulators in a cell-specific fashion (Bourque et al., 2008; 
Kunarso et al., 2010; Schmidt et al., 2012). Approximately 5000 highly stable CTCF sites are conserved 
in eutherian mammals (Schmidt et al., 2012). It has also been proposed that cell-specific CTCF 
sites flank developmental genes associated with disease (Martin et al., 2011). Tissue-specific 
CTCF sites are preferentially associated with enhancers while ubiquitous CTCF sites are more 
frequently linked to promoters (Shen et al., 2012).
Next to the attempts to determine the amount and distribution of CTCF binding sites 
a search for the CTCF consensus sequence has also been performed. This revealed that 
~75% of the CTCF binding sites harbor a 20 bp consensus sequence, termed the “core” motif 
(C), which is highly conserved in all eutherian mammals, opossum, chicken and pufferfish 
Tetraodon (Figure 4A and B) (Chen et al., 2008; Jothi et al., 2008; Kim et al., 2007; Xie et al., 2007). In 
addition a similar CTCF motif was discovered in drosophila (Figure 4C) (Holohan et al., 2007; Smith 
et al., 2009b). Interestingly, a computational analysis discovered 233 motifs in 60019 conserved 
noncoding elements (CNE) in the human genome, of which one fourth was determined to be 
a CTCF motif (Xie et al., 2007). An additional 10 bp motif, found ~21-22 bp upstream of the core 
motif, was discovered using DNase I hypersensitivity assays combined with CTCF ChIP-Seq 
(Boyle et al., 2011), ChIP-exo (Rhee and Pugh, 2011) and regular ChIP-Seq experiments (Schmidt et al., 
2012) (Figure 4D). Fifteen percent of all CTCF sites harbor this upstream sequence, which was 
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Figure 4. CTCF consensus sequence
(A) CTCF 20 bp core consensus sequence identified in human, (B) mouse and (C) drosophila. (D) CTCF’s upstream 
motif in human is located ~10 bp from the core motif and is identified by DNase I hypersensitivity assays combined 
with ChIP-Seq. (E) This upstream motif and position relative to the core motif is conserved in eutherian mammals. The 
sequence in this panel is inverted compared to the sequences in the other panels. (F) An additional downstream motif 
6-8 bp from the core motif was recently identified in mouse. Nucleotide position is shown underneath each sequence. 
The height of each letter represents the relative frequency of each nucleotide. Images adapted from Kim et al 2007, Chen et al 2008, 
Holohan 2007, Boyle 2011, Schmidt et al 2012 and Nakahashi et al 2013.
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termed the “M2” or upstream (U) motif, and which is highly conserved in mammals (Figure 4E) 
(Schmidt et al., 2012). In addition a downstream motif (D) was discovered, which is located 6-8 bp 
3’ to the core (Figure 4F) (Nakahashi et al., 2013). This motif was proposed to bind a competitor 
of CTCF. However, the proportion of CTCF sites containing this downstream motif is low, also 
compared to the prevalence of two other downstream motifs (Li et al., 2013). 
In line with in vitro studies (Renda et al., 2007), recent genome-wide in vivo studies in 
primary B lymphocytes, using CTCF ZF mutants to determine how individual ZFs contribute 
to CTCF binding, showed that ZFs 4-7 are essential for recognition of its core sequence motif 
(Nakahashi et al., 2013). In this approach histidine residues in the zinc binding domain of each ZF 
were mutated. The orientation of CTCF binding to its target sites in vivo was also consistent 
with in vitro results (Nakahashi et al., 2013; Renda et al., 2007). It was proposed that CTCF binding is 
modular, i.e. groups of adjacent zinc fingers are involved in binding certain sequences, with 
ZFs 1-2, 3-7, 4-7, 8-11 and 9-11 each comprising a specific module. It was shown that ZFs 8-11 
bind to an upstream (5’end) domain and ZFs 4-7 bind the core part of the CTCF motif. ZFs 1-3 
would not recognize a specific sequence but stabilize binding. It was hypothesized that ZFs 3 
and 8 act as ‘spacer ZFs’ that are required for binding simultaneously to the individual CTCF 
modules in the consensus (Nakahashi et al., 2013).
CTCF - Transcription regulation
A wealth of studies has tried to link the binding of CTCF to the transcriptional activation 
or repression of specific genes. However, although the CTCF binding pattern follows gene 
distribution none of the genome-wide studies in which global transcription was investigated 
has revealed a specific or overlapping set of genes activated or repressed by CTCF, despite 
the fact that many CTCF sites are located near a TSS (Barski et al., 2007; Kim et al., 2007; Phillips and 
Corces, 2009; Ribeiro de Almeida et al., 2011; Soshnikova et al., 2010; Xie et al., 2007). Consistently, in mouse 
embryonic stem cells CTCF does not exhibit a high overlap with transcriptional regulatory 
networks at the genome-wide level (Chen et al., 2008). Nonetheless, being a chromatin organizer, 
or DNA looper, CTCF does affect transcription. Two specific examples, which have lead to 
different concepts, are described below.
The mouse beta-globin-locus contains four functional genes, εy, βh1, βmaj and βmin 
whereas the human locus has five functional genes, ε, Gγ, Aγ, δ, and β (Figure 5A). They 
are expressed in sequential order during different stages of erythroid development and their 
expression is regulated by the LCR (Epner et al., 1998; Grosveld et al., 1987). In mouse and man the 
LCR contains DNAse hypersensitive sites, termed HS. CTCF binds the LCR (5’HS5), as well 
as the 3’end (3’HS1) of the locus, and sites upstream of the LCR (HS-62.5 and HS-85) (Bulger 
et al., 2003; Farrell et al., 2002; Saitoh et al., 2000). Chromatin conformation capture (3C) experiments 
revealed higher order structure in the active and inactive beta-globin locus. These structures 
were established by CTCF binding and CTCF-mediated interactions which places actively 
transcribed genes in a so-called active chromatin hub (ACH) (Hou et al., 2008; Splinter et al., 2006; 
Tolhuis et al., 2002). The ACH is a dynamic structure in which active genes enter the ACH before 
RNA polymerase II-mediated transcription (Palstra et al., 2008; Palstra et al., 2003). Surprisingly, 
CTCF binding to 5’HS and 3’HS sites is not essential for proper beta-globin gene expression 
but influences the local chromatin state (Bender et al., 2006; Splinter et al., 2006). This result can be 
explained by assuming that in the absence of 5’HS or 3’HS CTCF binding sites neighboring 
sites could take part in the organization of the ACH. Indeed, genome-wide analysis confirmed 
that both CTCF and cohesin facilitate long-range interactions throughout the beta-globin locus 
and influence beta-globin gene transcription and chromatin state (Chien et al., 2011; Hou et al., 2010). 
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Figure 5. Long-range interactions in beta-globin and Igf2-H19 locus.
(A) Schematic representation of the mouse beta globin locus. DNase I hypersensitivity sites (HS) are depicted with 
arrows. The beta globin locus are looped out from the CTCF-mediated chromatin hub in erythroid progenitor cells. (B) 
Schematic representation of the Igf2-H19 locus on the maternal and paternal alleles. On the maternal allele CTCF 
mediated loops are established via CTCF interactions with the unmethylated ICR, DMR and MAR resulting into the 
expression of H19. On the paternal allele DNA methylation prevents CTCF binding, which leads to Igf2 expression. 
OR: olfactory genes; LCR: locus control region; DMR: differentially methylated region; MAR: matrix attachment region; 
ICR: imprinting control region. Modified from Ribeiro de Almeida et al 2012.
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The second case in which the role of CTCF in transcription was intensively studied is 
the imprinted Igf2-H19 locus (Figure 5B). Transcription of the Igf2 and H19 genes is regulated 
via genomic imprinting of the parental alleles. The Insulin-like growth factor 2 (Igf2) gene is 
located 100 kb from the H19 gene (Zemel et al., 1992). In between these genes a 2 kb imprinting 
control region (ICR) is located, which is 2kb upstream of the H19 promoter/enhancer (Tremblay 
et al., 1997). On the paternal allele the ICR is fully methylated and only Igf2 is expressed. By 
contrast, the maternal ICR is unmethylated allowing H19 expression (Tremblay et al., 1997). CTCF 
binds the ICR in a methylation-sensitive fashion: it only binds to the maternal unmethylated 
ICR and not to the fully methylated paternal ICR (Bell and Felsenfeld, 2000; Hark et al., 2000). The 
parental-specific regulation of Igf2-H19 expression by selective binding of CTCF to the ICR has 
underscored to the notion of CTCF acting as an enhancer blocker by preventing the formation 
of specific loops. On the maternal allele, when CTCF is bound to the ICR, the enhancer located 
distally of H19 cannot contact the Igf2 promoter and hence Igf2 is not transcribed. By contrast, 
on the paternal allele, which carries a fully methylated ICR, CTCF does not bind. Consequently, 
the H19 downstream enhancer and Igf2 promoter now can contact each other and the Igf2 
gene is transcribed.
Chromatin conformation capture techniques revealed the higher-order structure of the 
Igf2/H19 locus and provided evidence for the model described above. It was shown that on 
the paternal allele enhancers interacted with the Igf2 promoter. This interaction was prevented 
on the maternal allele, where CTCF was bound to the ICR and regulated interactions with 
matrix attachment region (MAR) and differentially methylated region 1 (DMR1) at the Igf2 gene. 
Igf2 was thereby trapped in a separate loop, and remained inactive and its promoter was not 
available for the enhancer. All interactions were shown to be CTCF-dependent (Kurukuti et al., 
2006; Murrell et al., 2004). Later studies revealed that cohesin was also bound to CTCF sites and 
facilitated higher order chromatin conformation (Nativio et al., 2009).
It has been proposed that CTCF protects the ICR against de novo methylation and 
maintains it in a methylation-free state (Pant et al., 2003). However, other studies suggested that 
CTCF is not necessary to keep the maternal allele unmethylated (Schoenherr et al., 2003; Szabo et 
al., 2004). A more recent study reported that CTCF binding to the maternal ICR is essential to 
maintain monoallelic Igf2 expression (Engel et al., 2006).
Although many studies have been performed regarding the regulatory mechanism of 
Igf2/H19 imprinting not a lot is known about the chromatin landscape of this locus. The ICR 
is occupied by nucleosomes but the four CTCF sites are in an open chromatin conformation. 
Disruption of the nucleosomes interfered with CTCF binding and its insulator function. 
Interestingly, it has been suggested that CTCF is not a nucleosome positioning factor (Kanduri et 
al., 2002). H3K9ac, H3K4me were enriched to H19 while H3K27me3 marked the maternal ICR, 
DMR’s, promoter and gene of Igf2. On the other hand the paternal allele exhibited H3K27me3 
and macroH2A1 at the H19 promoter and H3K9ac and H3K4me on the Igf2 DMR. These 
marks were established by the allelic specific binding of CTCF supporting the role of CTCF in 
establishing chromatin composition (Guibert et al., 2012; Han et al., 2008).
CTCF - Chromatin organization and higher order structure
As described above, CTCF mediates the special organization of chromatin via long-
range interactions, thereby regulating transcriptional activity (Phillips and Corces, 2009). CTCF 
not only regulates the Igf2/H19 (Kurukuti et al., 2006; Murrell et al., 2004; Nativio et al., 2009) and beta-
globin loci (Hou et al., 2010; Palstra et al., 2003; Splinter et al., 2006; Tolhuis et al., 2002), but CTCF-mediated 
chromatin looping also occurs in the Hox cluster (Ferraiuolo et al., 2010), the interferon-γ locus 
(Sekimata et al., 2009), the Myb locus (Stadhouders et al., 2012), the major histocompatibility complex 
class II (MHC-II) (Majumder et al., 2006; Majumder et al., 2008) and Immunoglobin locus (Ig) (Ribeiro de 
Almeida et al., 2011). However, CTCF also regulates chromatin beyond specific loci.
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Within the human genome LADs are present. These LADs are 0.1-10 Mb in size and 
are specifically associated with the nuclear lamina at one point during the cell cycle. They are 
marked by H3K9me2 and H3K27me3 and generally encompass genes that are expressed at 
a low level (Guelen et al., 2008). CTCF mediated loops are enriched at the boundaries of LADs, 
suggesting that CTCF acts as a boundary element that maintains the LAD borders and prevents 
silencing of neighboring regions (Handoko et al., 2011).
A “CTCF chromatin interactome” was established using the novel paired-end 
tag (ChIA-PET) technique followed by deep next generation sequencing. This approach 
revealed that CTCF mediates both inter- and intra-chromosomal interactions (Handoko et al., 
2011). CTCF-mediated interactions could be categorized into five clusters: 1) CTCF-mediated 
loops with active chromatin marks (H3K4me1, H3K4me2 and H3K36me3), RNA polymerase 
II and p300 binding, and depleted of repressive chromatin marks; 2) chromatin interactions 
encompassing repressive marks (H3K9, H3K20 and H3K27me) and lacking active marks; 3) 
hubs containing enhancers and promoters with H3K4me1, H3K4me2 within the loop, H3K4me3 
at the boundaries, whereas other repressive or active marks are outside the hub; 4) areas 
demarcating active and repressive chromatin outside the loop and 5) loops with no particular 
chromatin marks present inside (Handoko et al., 2011). Interestingly, genome-wide studies suggest 
that classical CTCF insulator function is rare and context-dependent (Handoko et al., 2011; Phillips-
Cremins and Corces, 2013; Phillips-Cremins et al., 2013; Sanyal et al., 2012).
CTCF is also enriched at the borders of conserved topologically associated domains 
(TADs) together with histone modifications H3K4me3, H3K36me3 but depleted for H3K9me3, 
chromatin binding proteins and transcription factors (Dixon et al., 2012). These TADs contain 
subdomains, which can be distinguished in constitutive and cell type specific domains. 
Hundred kb - 1 Mb interactions within and between constitutive subdomains are anchored 
by CTCF and cohesin, whereas cohesin and mediator has been suggested to mediate small 
interactions (<100 kb) in cell type specific subdomains (Phillips-Cremins et al., 2013). Knock down 
of CTCF shows that the number of interactions genome-wide decrease, but that the number of 
interactions between TADs increases, probably caused by the delocalization of cohesin (Zuin et 
al., Submitted). 
CTCF - Interaction partners
 Besides mediating its function via interaction with DNA, CTCF also regulates certain 
processes interacting protein partners (Table 2). Interaction partners linked to transcription 
regulation are, for example, the largest subunit of RNA polymerase II (Chernukhin et al., 2007), 
and YB-1 (as a repressor of c-myc transcription) (Chernukhin et al., 2000). Partners linked to the 
insulator function of CTCF are the methylation insensitive transcription factor KAISO (Defossez 
and Gilson, 2002). CTCF also interacts with the class II transactivator (CIITA) protein, to mediate 
long-range interactions in the MHC-II locus (Majumder et al., 2008).
Interaction partners related to chromatin modification were also discovered. CTCF 
interacts for example with SNF2-like chromodomain helicase CHD8 to regulate epigenetic 
changes (Ishihara et al., 2006). CTCF-SIN3A complexes repress transcription via recruitment 
of histone deacetylase (HDAC) activity (Lutz et al., 2000). The Polycomb repressive complex 2 
(PRC2) is recruited via CTCF-SUZ12 interactions at CTCF target sites resulting in H3K27me 
and suppression of transcription (Li et al., 2008). DNMT1 and PARP1 form a complex with CTCF 
to maintain the unmethylated status of CTCF binding sites (Guastafierro et al., 2008; Zampieri et al., 
2012). The loss of PARP and CTCF binding result in de novo methylation of CpG. Next to CTCF-
DNA interactions CTCF-protein interactions are also highly important to mediate its function in 
chromatin and spatial organization.
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Cohesin and CTCF
 Cohesin is a highly conserved multisubunit protein complex. It consists of four subunits: 
two coiled-coil ATPases, SMC1 and SMC3, that are rod-shaped subunits forming a 45 nm long 
ring-like structure with RAD21, that connects SMC1 and SMC3, and SA1 (or SA2), that binds to 
RAD21 (Anderson et al., 2002; Haering et al., 2002). Cohesin is classically known as an essential factor 
for the establishment of sister chromatid cohesion, prior to chromosome segregation. Cohesin 
is loaded on the DNA in G1 via loading factors NIPBL and MAU-2 (Ciosk et al., 2000; Misulovin et 
al., 2008). During S-phase cohesion is established and maintained by SORORIN (Lafont et al., 
2010; Schmitz et al., 2007). During prophase AURORA B, PLK1, and WAPL remove the majority 
of cohesin, except centromeric-bound cohesin, which is protected by SGO1 (Kitajima et al., 2006; 
Lipp et al., 2007; Salic et al., 2004; Sumara et al., 2002). Sister chromatid cohesion at the centromere 
persists until the chromatids are properly attached to the opposite poles of the mitotic spindle. 
At this point SEPARASE cleaves RAD21 subunit, which results in removal of the remaining 
cohesin. Removal of cohesin allows chromosomes to segregate (Salic et al., 2004; Uhlmann et al., 
2000; Waizenegger et al., 2000).
 In addition to this classical function cohesin was more recently shown to also be 
involved in gene regulation and chromatin organization. In fact, genome-wide studies showed 
that the vast majority of cohesin-bound sites co-localize with CTCF sites (Parelho et al., 2008; Wendt 
et al., 2008). A bio-informatics approach in which all CTCF binding sites derived from 56 human 
cell lines and all cohesin binding sites derived from 8 human cell lines were compared identified 
~12,000 CTCF-cohesin sites (Li et al., 2013). It has been proposed that the direct interaction of 
CTCF and cohesin is established between the cohesin subunit SA2 and the C-terminal tail of 
CTCF (Xiao et al., 2011). Regardless of whether a direct interaction exists, CTCF is responsible for 
cohesin localization along the genome and therefore mediates long-range interactions together 
with cohesin (Hadjur et al., 2009; Mishiro et al., 2009; Nativio et al., 2009). 
Besides shared cohesin-CTCF sites, cohesin-specific binding sites (not bound by 
CTCF) have also been described; they coincide with enhancer marker p300, and tissue specific 
transcription factors. Moreover, these sites tend to be more tissue-specific when compared 
to CTCF-cohesin sites (Faure et al., 2012; Nitzsche et al., 2011; Schmidt et al., 2010). Cohesin-specific 
binding sites are able to mediate long-range interactions in a tissue specific fashion (Demare 
et al., 2013; Phillips-Cremins et al., 2013; Schmidt et al., 2010). Cohesin mediates together with CTCF 
long-range interactions e.g. in the apolipoprotein locus, interferon gamma locus and Igf2/H19 
Table 2. CTCF interacting partners
Known CTCF interacting partners, their main function and CTCF interaction domain. 
CTCF Interaction partner Function CTCF interaction domain References
Large subunit Pol II Transcription factor C-terminus Chernukhin et al 2007
YBI Transcription factor Zinc finger domain Chernukhin et al 2000
KAISO Transcription factor C-terminus Defossez and Gilson 2002
YYI Transcription factor N-terminus Donohoe et al 2007
CIITA Transcriptional co-activator Unknown Majumder et al 2008
CHD8 Chromatin modification Zinc finger domain Ishihara et al 2006
SIN3A Chromatin modification Zinc finger domain Lutz et al 2000
PRC2 Chromatin remodeler Zinc finger domain Li et al 2008
SUZ12 Transcription factor Unknown Li et al 2008
DNMT1 DNA methylation Unknown
Guastafierro et al 2008, Zampieri 
et al 2012
PARP1 Protein modification Unknown
Guastafierro et al 2008, Zampieri 
et al 2012
Cohesin Chromatin organization C-terminus Xiao et al 2011
Nucleophosmin Nucleolar protein Unknown Yusufzai et al 2004
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locus. Both proteins control proper expression of these genes, since depletion of either cohesin 
or CTCF results in aberrant gene expression and disruption of chromatin architecture (Hadjur 
et al., 2009; Mishiro et al., 2009; Nativio et al., 2009). Thus, CTCF mediates long-range interactions in 
collaboration with cohesin and other factors.
CTCFL - Identification and gene conservation
In 2002 a CTCF paralogue, termed CTCFL or BORIS (Brother Of the Regulator of 
Imprinted Sites), was identified that is specifically expressed in testis (Loukinov et al., 2002). Just 
like CTCF, CTCFL has N- and C-terminal domains flanking an eleven ZF domain that shows 
71% identity to the DNA binding domain of CTCF. In contrast, CTCFL’s N- and C-termini are 
distinct compared to CTCF (Loukinov et al., 2002). It has been hypothesized that a Ctcf gene 
duplication event during vertebrate evolution gave rise to Ctcfl since the gene is present in 
mammals, amphibians, reptiles, and monotremes, but not in avians (birds) (Hore et al., 2008; 
Loukinov et al., 2002). CTCFL expression gradually constricted during evolution to the gonads in 
marsupials and cattle and eventually to the testis in mice and man (Hore et al., 2008). This tissue-
specific pattern of expression is in stark contrast to that of CTCF. No cell so far has been 
detected lacking CTCF. 
The CTCFL gene is located on chromosome 20q13.2 in humans and on chromosome 
2 in mice. In humans this region is frequently amplified in human cancer (Klenova et al., 2002). The 
human CTCFL gene has 16 (10 coding) exons and 3 alternative promoters (A, B and C) and 
encodes at least 23 CTCFL isoforms, only 7 contain the full-length 11 ZF domain (Pugacheva 
et al., 2010; Renaud et al., 2007). All three CTCFL promoters in human have multiple CTCF sites 
and, at least in cell culture, their activities appear to be partly controlled by CTCF (Renaud et 
al., 2007). Remarkably, as shown in chapter 4, murine Ctcfl is much simpler in terms of isoform 
expression. 
CTCFL - Intracellular distribution and function
As mentioned above CTCFL is mainly expressed in the testis. The exact cellular 
localization of CTCFL is under debate. The first immunostainings of adult mouse testis showed 
a mutually exclusive expression of CTCFL and CTCF (Loukinov et al., 2002). Here, CTCFL was 
restricted to primary spermatocytes in meiotic prophase. Remarkably, CTCFL localization was 
cytoplasmic rather than nuclear. In contrast, CTCF showed a completely nuclear localization 
pattern and could only be detected during later stages of spermatogenesis, in round spermatids. 
It was proposed that although both CTCF and CTCFL could bind to the same target site they 
could not compete with each other due to the mutually exclusive expression pattern during 
male germ cell differentiation. This also led to the hypothesis that CTCFL substitutes for the 
absence of CTCF and that this switch is associated with reprogramming of DNA methylation 
during spermatogenesis (Loukinov et al., 2002).
Another report described CTCFL in gonocytes during embryonic development, at 
14.5 d.p.c. and revealed a nuclear localization of the protein in spermatogonia after birth 
(Jelinic et al., 2006). This finding was linked to ongoing methylation and appearance of de novo 
DNA methyltransferases. In addition, CTCFL interaction with PRMT7, a protein arginine 
methyltransferase, was associated with the establishment of DNA methylation of imprinted 
genes by marking histones H2A and H4 with methylated arginine residues at sites for de novo 
DNA methylation by DNMT3A (Jelinic et al., 2006). These data suggested an active role for CTCFL 
in DNA methylation reprogramming. However, Ctcfl knock out mice did not show any embryonic 
phenotype that could be associated with imprinting defects (Suzuki et al., 2010). Instead, male 
knock out mice displayed a subfertility phenotype accompanied by small testis and increased 
apoptosis (Suzuki et al., 2010). Intriguingly, in this study CTCFL was localized in round spermatids 
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and not in spermatocytes.
To gain further insights into the function of CTCFL, knock out mice were generated 
(Suzuki et al., 2010). In the Ctcfl knock out mice, two testis-related genes, Prss50 (Protease serine 
50, also known as testis-specific protease 50 (Tsp50)) and the testis specific isoform of Gal3st1 
(Cst), were shown to be aberrantly expressed (Suzuki et al., 2010) and to be activated by CTCFL 
(Kosaka-Suzuki et al., 2011; Suzuki et al., 2010). CTCFL positively regulated Gal3st1 and Prss50, 
suggesting a role for CTCFL in the regulation of these genes during spermatogenesis. CTCF 
also binds the testis-specific promoter of Gal3st1, tested in vitro, but does not appear to affect 
transcription of this gene (Suzuki et al., 2010). 
 Several groups have found CTCFL to be expressed outside the testis. An interesting 
observation is the detection of CTCFL in human embryonic ovary (Monk et al., 2008; Pugacheva 
et al., 2010). Besides the reproductive organs, CTCFL was also detected in human embryonic 
stem cells (Pugacheva et al., 2010) and in human skin (Rosa-Garrido et al., 2012). In human skin CTCFL 
expression is restricted to keratinocytes in the differentiating layers of the epidermis. CTCFL 
accumulates in nuclear and peri-nuclear spots identified as centrosomes in keratinocytes. 
Within the nucleus CTCFL localizes to the nucleolus. CTCFL overexpression resulted in the 
accumulation of S and G2/M phased cells and in polyploidy, suggesting a function for CTCFL 
during the keratinocyte cell cycle and in the maintenance of genomic stability (Rosa-Garrido et 
al., 2012). Furthermore, CTCFL was also localized to DNA sites with high histone occupancy 
indicating that the protein localizes to less condensed and euchromatic regions (Rosa-Garrido et 
al., 2012).
In vitro analysis revealed that CTCF and CTCFL bind similar DNA sequences in vitro 
(Loukinov et al., 2002). A number of cell culture experiments have subsequently been carried out 
to further investigate the DNA binding specificity of CTCFL. In one study, the unmethylated 
promoter of the telomerase reverse transcriptase (hTERT) gene was found to be bound by 
CTCFL in testicular (NCCIT) and ovarian (OVCAR-3) tumor cell lines (Renaud et al., 2011). In 
addition, both CTCFL and CTCF were shown to bind a site within the first exon, here CTCFL 
competes with CTCF to initiate hTERT expression (Renaud et al., 2011; Renaud et al., 2005). In 
contrast, while CTCF binds DNA in a methylation-sensitive manner, a methylation-independent 
binding of CTCFL to the human Igf2/H19 ICR has been reported (Nguyen et al., 2008; Pugacheva et 
al., 2010). Together these and other studies raise a confusing picture about the mode of binding, 
intracellular localization and function of CTCFL. 
 
CTCFL - A role in human cancer?
 During germ cell development many germ cell specific factors are essential to establish 
proper spermatogenesis and oogenesis. However, a subset of these genes, most of them 
part of multigene families, are also expressed in various cancers and are called cancer germ 
line genes (CG genes). These CG genes are usually activated in cancer due to promoter 
demethylation (Cheng et al., 2011). Approximately 50% of CG genes can be mapped to the 
X-chromosome and, as explained above, the majority shows immunogenicity of their protein 
products (giving rise to the term cancer testis antigen (CTA)), which makes them an interesting 
target for cancer immunotherapy (Cheng et al., 2011; Simpson et al., 2005). So far 70 gene families and 
more than 140 proteins have been identified as CTA, including CTCFL itself (Cheng et al., 2011). In 
addition, CTCFL is also expressed in cancer cell lines derived from melanoma, neuroblastoma, 
breast cancer, prostate cancer and colon cancer, and in primary tumors including breast 
cancer, prostate cancer and colon cancer (Vatolin et al., 2005). The fact that CTCFL is normally 
only found in testis but is upregulated in cancer was the basis to suggest that CTCFL could 
act as tumor-promoting protein. Higher frequency of Ctcfl expression and other CG genes in 
metastatic tumors could be due to selection of these genes in this phase of tumorigenesis. 
It has been proposed that aberrant activation of CG genes in somatic cells could result in 
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abnormal re-programming events that would lead to fully transformed cancer cells (Wang et al., 
2011). In addition, the expression of a subset of CG genes in cancer could lead to the activation 
of a significant number of germline genes that can initiate the germ cell genetic program (Wang 
et al., 2011). This occurs often in malignant cells, which suggests that the activation of the CG 
genes results in a selective advantage in the process of oncogenic transformation (Rousseaux et 
al., 2013; Wang et al., 2011).
 A role for CTCFL during carcinogenesis has been investigated in cultured cell lines and 
in cancer tissues but has not yet been clearly demonstrated. In one of the first genome-wide 
expression studies it was shown that in spermatocytic seminomas, tumors originating from 
primary spermatocytes, CTCFL, PRSS50 and SYCO1 expression was elevated (Looijenga et al., 
2006). In addition, in vitro transient CTCFL expression in fibroblasts leads to the reactivation 
of several X-linked cancer testis genes, MAGE genes, NY-ESO-1 and pluripotency factor 
POU5F1 (Bhan et al., 2011). Here, CTCFL expression coincides with partial demethylation of 
the MAGE-A1 promoter suggesting that CTCFL disrupts the regulation of these cancer-testis 
genes in somatic cells. Remarkably, CTCF binds in a methylation-independent manner to the 
MAGE-A1 promoter in NHDF cells and is competed from its binding site by CTCFL (Vatolin et al., 
2005). Other members of the MAGE-A family were also positively regulated by CTCFL in NHDF 
cells (Bhan et al., 2011), and were expressed in primary head and neck squamous cell carcinoma 
(Smith et al., 2009a). CTCFL binding correlated with an active chromatin state, containing H3K8ac, 
H3K14ac and H3K4me3, on MAGEA promoters (Bhan et al., 2011). Interestingly, expression of 
these genes and CTCFL promote cell growth (Smith et al., 2009a). In general, in cultured cells CG 
expression coincides with CTCFL expression and DNA demethylation. 
In breast cancer patients, elevated CTCFL expression levels were detected in 
neutrophil polymorphonuclear granulocytes (PMNs) and in all types of breast cancer (non-
malignant and malignant) but not in primary breast cells (D’Arcy et al., 2006). CTCFL expression 
in PMNs could therefore be used as a diagnostic tool to detect breast cancer (D’Arcy et al., 2006). 
Taxane docetaxel is a cytotoxic antitumor agent used in patients with breast cancer and has 
an anti-proliferative effect. Histone deacetylase inhibitors, such as apicidin, are another type 
of anticancer agents used in breast cancer patients, which suppress growth of human breast 
cancer cells by modulating the cell cycle and inducing apoptosis. Treatment with a combination 
of apicidin and docetaxel in breast cancer cell lines induced CTCFL expression in highly 
metastatic breast cancer cells (Buoncervello et al., 2012). Together with CTCFL the expression of 
presumed target genes, NY-ESO-1 ad MAGE-A1, were up-regulated in MDA-MB-435 cells 
(Buoncervello et al., 2012). This data suggests that treatment with these antitumor agents enhances 
expression of these particular CG (onco)genes. How the expression of CG genes affects the 
efficacy of antitumor drugs has to be determined.  
In ovarian cancer CTCFL is expressed due to promoter hypomethylation (Link et al., 2013; 
Woloszynska-Read et al., 2007). CTCFL expression can be induced via DAC (DNMT inhibitor 5-aza-
2’-deoxycytidine) that demethylates the CTCFL promoter (Woloszynska-Read et al., 2007). However, 
CTCFL over-expression in ovarian cells did not induce expression of CG genes (MAGEA-1, 
NY-ESO-1 and XAGE-1) and global DNA hypomethylation (Woloszynska-Read et al., 2010). Another 
report by the same group showed DNA hypomethylation in epithelial ovarian cancer and on CG 
promoters (Woloszynska-Read et al., 2011).
As shown in the examples above, virtually all studies relating CTCFL to cancer, 
either examine CTCFL expression and function in cell culture focusing on a restricted set of 
CTCFL binding sites and presumed target genes, or document (lack of) correlation of CTCFL 
expression with that of other genes, in particular the CTAs. In a very recent study, it was found 
that 50% of the esophageal squamous cell cancers (ESCCs) stage pT1N+ express CTCFL 
(Okabayashi et al., 2012). Importantly, it was shown that patients with CTCFL-positive ESCC show 
a poor 5-year survival rate. Furthermore, a CTCFL knock down resulted in decreased cell 
proliferation and invasion ability of ESCC cell lines (Okabayashi et al., 2012). This is the first time 
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that CTCFL expression was linked to the survival of cancer patients. Together, studies on 
CTCFL (and CTCF) in cancer suggest that CTCFL plays a role during carcinogenesis, however 
no mechanistic pathway has been revealed so far. 
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Abstract
Background: CCCTC binding factor (CTCF) is a highly conserved zinc finger protein, which is involved in
chromatin organization, local histone modifications, and RNA polymerase II-mediated gene transcription. CTCF may
act by binding tightly to DNA and recruiting other proteins to mediate its various functions in the nucleus. To
further explore the role of this essential factor, we used a mass spectrometry-based approach to screen for novel
CTCF-interacting partners.
Results: Using biotinylated CTCF as bait, we identified upstream binding factor (UBF) and multiple other
components of the RNA polymerase I complex as potential CTCF-interacting partners. Interestingly, CTCFL, the
testis-specific paralog of CTCF, also binds UBF. The interaction between CTCF(L) and UBF is direct, and requires the
zinc finger domain of CTCF(L) and the high mobility group (HMG)-box 1 and dimerization domain of UBF. Because
UBF is involved in RNA polymerase I-mediated ribosomal (r)RNA transcription, we analyzed CTCF binding to the
rDNA repeat. We found that CTCF bound to a site upstream of the rDNA spacer promoter and preferred non-
methylated over methylated rDNA. DNA binding by CTCF in turn stimulated binding of UBF. Absence of CTCF in
cultured cells resulted in decreased association of UBF with rDNA and in nucleolar fusion. Furthermore, lack of
CTCF led to reduced binding of RNA polymerase I and variant histone H2A.Z near the rDNA spacer promoter, a
loss of specific histone modifications, and diminished transcription of non-coding RNA from the spacer promoter.
Conclusions: UBF is the first common interaction partner of CTCF and CTCFL, suggesting a role for these proteins
in chromatin organization of the rDNA repeats. We propose that CTCF affects RNA polymerase I-mediated events
globally by controlling nucleolar number, and locally by regulating chromatin at the rDNA spacer promoter, similar
to RNA polymerase II promoters. CTCF may load UBF onto rDNA, thereby forming part of a network that maintains
rDNA genes poised for transcription.
Background
CTCF is a conserved and ubiquitously expressed pro-
tein, which binds DNA through an 11-zinc finger (ZF)
domain and organizes chromatin into loops [1]. CTCF
may act as an insulator, mainly by inhibiting inappropri-
ate interactions between regulatory elements on adjacent
or distal chromatin domains. In many instances, CTCF
binds cognate sites in a methylation-sensitive manner,
allowing the regulation of imprinted loci, such as the
H19/Igf2 locus. A testis-specific paralog of CTCF has
been characterized, called CTCFL or BORIS (brother of
the regulator of imprinted sites), which has strong simi-
larity to CTCF in the ZF domain and has overlapping
DNA-binding specificity [2]. CTCF and CTCFL share
little similarity outside their ZF region. To date, no
common interaction partners of CTCF and CTCFL have
been reported.
Genomewide studies have revealed a multitude of
CTCF binding sites, whose distribution over chromo-
somes correlates with gene density [3]. The cohesin
complex, which mediates sister chromatid cohesion in
dividing cells, was shown to colocalize with CTCF on
CTCF binding sites [4-6]. Recent data suggest that
CTCF/cohesin are together involved in the organization
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of chromatin loops, with CTCF recruiting cohesin to spe-
cific sites, and cohesin in turn mediating chromosomal
interactions [7]. CTCF may also colocalize with the variant
histone H2A.Z [8]. When CTCF is bound near an RNA
polymerase II-regulated transcription start site (TSS), it is
mostly located upstream of a DNAse I hypersensitive site
(HS) which in turn precedes the TSS [9]. These data sug-
gest a global role played by CTCF as an organizer of RNA
polymerase II-mediated transcription. By contrast, we
have shown that loss of a CTCF-binding site affects chro-
matin looping and local histone modifications in the
mouse b-globin locus, without significantly perturbing
transcription [10]. Collectively, these data indicate that
CTCF is able to regulate the balance between active and
repressive chromatin modifications near its binding sites,
with different outcomes in terms of transcription. CTCF
may control epigenetic modifications by binding to the
chromatin remodeling factor CHD8 [11].
The nucleolus is a nuclear subcompartment in which
the 18S, 5.8S and 28S ribosomal (r)RNAs are synthe-
sized by RNA polymerase I, processed and, together
with 5S rRNA, assembled into ribosomes [12]. Ribosome
biogenesis is tightly coordinated with cellular metabo-
lism and cell proliferation. In all organisms, ribosomal
genes are repeated many times, so that enough rRNA
can be produced when demand for ribosomes is high.
However, even in metabolically active cells, a significant
number of repeats are not transcribed. In human and
mouse, there are approximately 200 rDNA repeats per
haploid genome (that is, ~400 per interphase nucleus).
These are clustered in five nucleolar organizer regions
(NORs), located on different chromosomes. Two pro-
moters have been identified within the mouse rDNA
repeat: the spacer promoter and the gene promoter. The
spacer promoter is located upstream of the gene promo-
ter within the intergenic spacer (IGS). Transcription
from this promoter is thought to serve a regulatory
function and gives rise to non-coding RNAs (ncRNAs
or nc-rRNAs). Transcription from the gene promoter
yields a ~13 kb (or 47S) ribosomal precursor RNA (pre-
rRNA), which is processed in a complex manner into
the mature 18S, 5.8S and 28S rRNAs.
Efficient transcription from the ribosomal gene pro-
moter requires a multiprotein complex including selec-
tivity factor (SL)1, RNA polymerase I, and upstream
binding factor (UBF) [13]. UBF is an abundant nucleolar
protein that contains several HMG domains involved in
DNA binding [14]. UBF binds dynamically throughout
the rDNA repeat [15], and not only plays a role as a
transcriptional activator of RNA polymerase I, but also
in transcription elongation [16] and in the maintenance
of the specific chromatin structure of NORs [17]. More
recent data suggest that UBF is involved in determining
the number of active rDNA genes [18].
To better understand the function of CTCF, we
performed a screen for CTCF-interacting proteins. We
found that both CTCF and CTCFL interact directly with
UBF. CTCF binds immediately upstream of the riboso-
mal spacer promoter in a methylation-sensitive manner,
and activates spacer promoter transcription. CTCF bind-
ing controls the loading of UBF onto rDNA, and the
binding of RNA polymerase I and H2A.Z near the
spacer promoter. Our data show that CTCF regulates
the local epigenetic state of the rDNA repeat. CTCF
may organize RNA polymerase I and II promoters in a
similar manner. We propose that CTCF binding main-
tains rDNA repeats in a state poised for activation.
Results
Characterization of biotinylated CTCF
To identify CTCF-binding partners, we used a biotinyla-
tion tagging and proteomics approach (Figure 1A) [19].
As CTCF levels are crucial for cell proliferation, we did
not generate cell lines overexpressing biotinylated
CTCF. Instead, we used homologous recombination in
embryonic stem (ES) cells to generate a novel Ctcf
knock-in allele. DNA encoding a small peptide tag of 23
amino acids was inserted in the last exon of the Ctcf
gene, before the stop codon of CTCF (Figure 1B). This
tag is biotinylated upon addition of the bacterial biotin
ligase enzyme, BirA. Southern blot and PCR analysis
identified homologous recombination events (Figure
1C). The resulting allele was termed Ctcf bio-neo, as it
contains both the biotinylation sequence and the neo-
mycin resistance gene.
Ctcf bio-neo/+ ES cells were transfected with a plasmid
expressing Cre recombinase to remove the neomycin
resistance gene and generate the Ctcf bio allele (Figure
1B). Then, using homologous recombination, the BirA
biotin ligase was placed into the Rosa26 locus (data not
shown). Genotyping and verification of these targeting
events was performed by PCR (Figure 1D). This method
yielded an ES cell line expressing normal CTCF (from
the wild type allele) and biotinylated CTCF (from the
Ctcf bio allele). The biotin tag is placed at the C-terminus
of CTCF, hence the fusion protein was called CTCF-bio.
Ctcf bio-neo ES cells were also injected into blastocysts to
generate knock-in mice. These mice were subsequently
crossed with a mouse line expressing BirA from the
Rosa26 locus [20]. From these mice, CTCF-interacting
proteins could be identified in a developmental and tis-
sue specific manner.
CTCF-bio cannot be distinguished from untagged
CTCF with anti-CTCF antibodies because the biotin
tag does not cause a major difference in migration
behavior in SDS-PAGE gels (Figure 1E, upper panel).
However, CTCF-bio is detected using streptavidin-
based methods (Figure 1E, middle panel). Our results
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indicate that CTCF-bio and CTCF are expressed at
similar levels (Figure 1E). Pull-down assays using ES
cell extracts with streptavidin-coupled magnetic beads
results in efficient and specific binding of CTCF-bio to
the beads (Figure 1F). Size fractionation experiments
suggest that CTCF and CTCF-bio are present in high
molecular weight complexes in ES cells (Figure 1G).
Furthermore, CTCF-bio binds known CTCF target
sites such as the c-Myc insulator and the 3” HS1 of
b-globin (Figure 1H). Importantly, mice expressing
CTCF-bio are viable and fertile (data not shown).
Combined, these results indicate that CTCF-bio is a
functional protein.
CTCF and CTCFL interact with UBF
CTCF-bio was purified from ES cell nuclear extracts
under mild conditions using streptavidin-coupled mag-
netic beads (Figure 2A). Known CTCF-interacting part-
ners, including Yin Yang (YY)-1, poly(ADP-ribose)
polymerase (Parp)1 and nucleophosmin, co-precipitated
with CTCF-bio (see Additional file 1, Figure S1A),
further confirming that CTCF-bio is a functional fusion
Figure 1 Characterization of biotinylated CCCTC binding factor (CTCF). (A) Identification of CTCF-binding partners. CTCF (light grey boxes)
was tagged with biotin at its C-terminus (biotinylated lysine indicated by a star) and pulled down, and interacting proteins were identified by
mass spectrometry. Zinc fingers are indicated by dark grey box; proline-rich region with AT hook. (B) Targeting of mouse Ctcf. The Ctcf gene is
shown on the top line. Exons (black boxes are coding, open boxes are non-coding) and probes (1, 2) are indicated. X = XbaI, P = PstI. Targeting
construct is shown in the middle. Bio = biotin-tag, black triangles = loxP sites, Neor = PMC1-neomycin cassette. After targeting, Ctcfbio-neo was
obtained. Cre-mediated excision yielded the Ctcfbio knock-in allele (bottom line). (C) Southern blot analysis. Digested embryonic stem (ES) cell
DNA was analyzed by Southern blotting using probes 1 or 2. Alleles are indicated. (D) PCR analysis of mouse tail DNA. (E) Expression of biotin
tagged CTCF (CTCF-bio). Nuclear thymic extracts were analyzed by western blotting. Coomassie staining shows total protein. (F) CTCF-bio pull-
down assay with streptavidin beads. Nuclear ES cell extracts were incubated with streptavidin-coupled magnetic beads. Input (i) = 5% of nuclear
extract, (u) = 6% of unbound fraction, b = material bound to beads. (G) Size fractionation of CTCF and CTCF-bio. Size fractionated nuclear
extracts were analyzed by western blotting. Molecular mass markers are indicated. V0 = void volume, input = nuclear extract (5%). (H) Chromatin
immunoprecipitations. CTCF-bio precipitated with streptavidin-coupled magnetic beads from formaldehyde fixed nuclei bound known CTCF sites
(b-globin 3” HS1 and c-Myc insulator).
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protein, and suggesting that the conditions used to iso-
late CTCF-bio were sufficiently mild to allow identifica-
tion of novel interaction partners. Proteins co-purifying
with CTCF-bio were detected by mass spectrometry and
classified by BLAST searches; 58 of these co-purified
specifically with CTCF in more than one pull-down
experiment (data not shown). We noted that several
CTCF-interacting proteins are involved in RNA poly-
merase I-mediated transcription (see Additional File 2
Table S1), including UBF and proteins that form a
complex with UBF, such as the large subunit of RNA
polymerase I (RPA194) and its associated factor PAF53
[21]. Moreover, the 40 kDa and 135 kDa subunits of
RNA polymerase I (RPA40, RPA135) and polymerase
associated factor (PAF)49 were pulled down by CTCF-
bio (data not shown). These data suggest that CTCF
interacts with essential components of the machinery
that regulates the synthesis of rRNA. We therefore
decided to further analyze the function of CTCF in
rRNA transcription.
Figure 2 Interaction of CCCTC binding factor (CTCF) and CTCFL with upstream binding factor (UBF). (A) Biotin tagged CTCF (CTCF-bio)
interacted with UBF and RNA polymerase I in embryonic stem (ES) cells. Nuclear extracts from ES cells expressing CTCF-bio and control ES cells
(-) were incubated with streptavidin beads, and CTCF-bio was purified with interacting proteins. Extracts were treated with (+) or without (-)
benzonase for 2 hours at 4°C. Western blots were incubated with the indicated antibodies (CTCF-bio detected with streptavidin-coupled
horseradish peroxidase). UBF was detected as a doublet consisting of UBF1 and UBF2; RPA194 = the large subunit of RNA polymerase I. B =
bound fraction; i = input (5%). (B) Both CTCF and CTCFL interacted with UBF. Cells were transfected with different cDNAs (indicated below the
lanes). CTCFL was not tagged. Immunoprecipitations (IPs) were carried out using anti-Flag antibodies. Western blots were incubated with
antibodies against the indicated proteins. (C) Green fluorescent protein (GFP) tagged CTCF deletion mutants. The regions of CTCF used for
making the different fusion proteins are indicated by lines. (D) UBF interacts with the zinc-finger domain of CTCF. GFP tagged CTCF deletion
mutants (in (C)) were co-expressed with Flag tagged UBF in HEK293T cells. All fusion proteins are expressed at similar levels (input). After a Flag
pull-down (IP), co-precipitating proteins were detected with an antibody against GFP. Lane numbers correspond to mutant numbers in (C).
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Streptavidin pull-down assays followed by western
blot analysis confirmed the CTCF-bio interaction
with UBF and the large subunit of RNA polymerase I
(Figure 2A). We also detected interaction of CTCF-bio
and UBF in lung (see Additional file 1, Figure S1B)
and thymus (not shown), indicating that the associa-
tion between these two proteins is not confined to ES
cells. When ES cell nuclear extracts were treated with
benzonase, the CTCF-bio interaction with UBF
remained detectable, indicating that the interaction is
not mediated by DNA (Figure 2A). Co-immunoprecipi-
tation (co-IP) with anti-CTCF antiserum revealed an
interaction between untagged CTCF and UBF (see
Additional file 1, Figure S1C).
As CTCF and CTCFL are very similar in their ZF
domains, we tested the possibility that CTCFL also
interacts with UBF. We overexpressed a Flag-tagged
form of UBF in 293T cells, either alone or with CTCFL,
and performed a Flag co-IP on extracts from these cells.
Flag-UBF brings down endogenous CTCF and overex-
pressed CTCFL (Figure 2B). Interestingly, diminished
interaction between CTCF and UBF was detected in
cells expressing CTCFL. These results identify UBF as
the first common interaction partner of CTCF and
CTCFL, and also indicate that CTCF and CTCFL com-
pete for binding to UBF.
Experiments with bacterially purified proteins revealed
a direct interaction between the CTCF and CTCFL ZF
domains and the UBF dimerization domain plus HMG-
box 1 (see Additional file 3, Figure S2). Using CTCF
deletion mutants [22], we observed that both the N-
and C-terminal ZFs of CTCF interacted with UBF (Fig-
ure 2C, D). Taken together, our data show that CTCF
and CTCFL bind UBF directly via their ZF domains.
Identification of a CTCF binding site upstream of the
rDNA spacer promoter
To provide a functional explanation for the CTCF-UBF
interaction, we tested binding of both proteins using chro-
matin immunoprecipitation (ChIP) in mouse embryonic
fibroblasts (MEFs). Consistent with published experiments
[15,23], UBF bound throughout the enhancer/promoter
regions and transcribed portion of the mouse rDNA
repeat, with hardly any enrichment in the IGS (Figure 3B,
blue line). By contrast, ChIP of CTCF revealed a highly
specific accumulation immediately upstream of the rDNA
spacer promoter (Figure 3B, black line). We also detected
CTCF binding to the rDNA spacer promoter region in
extracts of adult thymus from wild type and CTCF-bio-
expressing mice (see Additional file 4, Figure S3). The
CTCF binding coincided with (and was adjacent to) RNA
polymerase I enrichment (Figure 3B, red line). Strong
RNA polymerase I association to the spacer promoter
relative to the gene promoter has also been shown by
others [24-26].
The ChIP experiments suggest the presence of a CTCF
binding site near the spacer promoter of the mouse
rDNA locus. An algorithm was devised to search for
potential binding sites within this locus. One site (R30),
which conforms to the CTCF consensus sequence [3], is
present in the spacer promoter area (Figure 3C). A probe
(also called R30) was designed and tested in band-shift
analysis, using nuclear extracts of non-transfected cells
and of cells overexpressing CTCF. The known chicken
lysozyme F1 site was used as control. We detected bind-
ing of endogenous CTCF and bacterially purified glu-
tathione-S-transferase (GST)-CTCF-ZF to the R30 probe
(Figure 3D, lanes 6 to 10 and 11 to 13, respectively).
Competition experiments indicated that CTCF bound
the FI probe less efficiently than it did R30, (Figure 3E,
lanes 3 and 4). These data demonstrate that CTCF binds
R30 through its ZF domain.
Previous studies have shown that mouse, rat and ham-
ster rDNA repeats share significant sequence similarity
in the spacer promoter region of the IGS [27]. Rat and
hamster rDNA also contain the CTCF binding site (Fig-
ure S4, Additional file 5). Based on alignment informa-
tion, we mutated three residues within R30, and
performed band-shifts with normal and mutant R30
probes. As shown in Figure 3E, CTCF bound less effi-
ciently to mutant R30 (lanes 5 and 7). Combined, these
results identify a novel CTCF binding site in the mouse
rDNA repeat that is conserved in rat and hamster.
The IGS of the human rDNA repeat is completely
divergent in sequence from the mouse IGS (see Addi-
tional file 6, Figure S5A to C) and the presence of a
spacer promoter has not been accurately described.
Nevertheless, we identified two potential CTCF binding
sites in the rDNA repeat, which were 0.9 kb and 5.1 kb
upstream of the ribosomal gene promoter (called H42.1
and H37.9, respectively, for their respective positions)
(see Additional file 6, Figure S5B). ChIP analysis
revealed occupancy of CTCF at both sites, although
binding was more prominent in the region near H42.1
than near H37.9 (see Additional file 7, Figure S6A). As
K562 cells express both CTCF and CTCFL, we also
tested whether CTCFL could bind the human rDNA
repeat. Protein-DNA complexes were immunoprecipi-
tated with two different CTCFL antibodies. CTCFL
bound both H37.9 and H42.1, with a preference for site
H42.1 (see Additional file 7, Figure S6A). We also
detected binding of UBF to these rDNA regions (see
Additional file 7, Figure S6A) and using sequential
(ChIP-reChIP) analysis, found that CTCF and UBF
were present on the same rDNA repeats (see Additional
file 7, Figure S6B).
van de Nobelen et al. Epigenetics & Chromatin 2010, 3:19
http://www.epigeneticsandchromatin.com/content/3/1/19
Page 5 of 21
52
12
Figure 3 Identification of a novel CCCTC binding factor (CTCF) binding site near the ribosomal (r)DNA spacer promoter. (A) Outline of
mouse rDNA repeat. Transcription (spacer promoter = ncRNA, gene promoter = pre-rRNA, right-pointing arrows), chromatin
immunoprecipitation (ChIP) primers (downward-pointing arrows), organization of 47S pre-rRNA (external transcribed spacers (ETS), internal
transcribed spacers (ITS), 18S, 5.8S and 28S rRNA, CTCF consensus site (grey box) and enhancer repeats (white boxes)), are indicated. (B) Binding
of CTCF, upstream binding factor (UBF) and RNA polymerase I to mouse rDNA was analyzed by ChIP on formaldehyde-fixed mouse embryonic
fibroblast (MEF) nuclei. (C) CTCF binding site in mouse rDNA. The R30 sequence is shown, with CTCF consensus site (underlined), highly
conserved CTCF site residues (dots), deviation from consensus (asterisk) and CpG dinucleotides (gray). Nucleotides in bold were mutated
(R30mut). (D, E) Band-shift analysis. Increasing amounts of HEK293T extracts (non-transfected (n) or transfected with CTCF), were incubated with
the indicated probes (a known CTCF binding site (F1, chicken lysozyme, R30 and R30mut). Competitor was added in 300-fold excess. Band shifts
were also performed with purified bacterial proteins (glutathione-S-transferase (GST) only (G) and zinc fingers (ZF) of CTCF tagged with GST. (F)
CTCF and UBF bound R30 DNA together. HEK293T extracts (increasing amounts indicated, transfected with GFP-CTCF (+) Flag-UBF (1 to 5×) or
the C-terminal domain of CTCF tagged with GFP (Ct, see Figure 2C) were incubated with R30. aC = addition of anti-CTCF; pr = addition of anti-
UBF and anti-FLAG (preclear). (G) CTCF and UBF bound human rDNA together. HEK293T extracts (increasing amounts indicated, transfected with
GFP-CTCF (+) or Flag-UBF (1 to 7×) were incubated with H42.1. Asterisks indicate UBF binding to H42.1. aC = addition of anti-CTCF. (H) UBF
weakly bound human rDNA. HEK293T extracts (increasing amounts indicated), transfected with Flag-UBF (1 to 5×) were incubated with H42.1.
Asterisks indicate UBF binding to H42.1 Cp = cold probe; UBF = addition of anti-UBF; UBF(p) = addition of anti-UBF and anti-FLAG before
incubation with probe (preclear).
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The CTCF ChIP results were confirmed in vitro by
electrophoretic mobility shift assay (EMSA) analysis (see
Additional file 7, Figure S6C). Nuclear extracts from
cells transfected with CTCF showed stronger binding to
H42.1 and H37.9 rDNA probes compared with extract
from mock-transfected cells. The specificity of the bind-
ing was shown by competition with unlabeled probes
and by supershift assays using anti-CTCF antibody.
Incubation with an anti-actin antibody, used as a nega-
tive control, did not produce supershifts (data not
shown). Together, these results demonstrate that CTCF
associates upstream of the gene promoter in human
rDNA and suggest that CTCF and UBF are bound
together to the rDNA.
We next tested whether the in vitro binding of CTCF
to DNA influences binding of UBF. Extracts of cells
transfected with GFP-CTCF or Flag-UBF were incubated
separately or together with the H42.1 probe, and bind-
ing of CTCF and UBF was examined by EMSA (Figure
3G, H). Binding of UBF alone to the H42.1 probe
resulted in a relatively weak signal (Figure 3G, lane 9;
Figure 3H, lane 1; asterisks), that was specific for UBF
(Figure 3H, lanes 2, 3, 6). Increasing the amount of UBF
in the reaction eventually led to enhanced and coopera-
tive binding of UBF (Figure 3G, lanes 10 to 12; Figure
3H, lanes 4, 5). Interestingly, binding of CTCF to H42.1
resulted in enhanced binding of UBF at much lower
levels of this protein (Figure 3G, compare lanes 4 to 8
with 9 to 12). These data suggest that CTCF helps to
load UBF onto rDNA.
CTCF binds rDNA in a methylation-sensitive manner
The CTCF R30 binding site in the mouse rDNA repeat
includes two CpG residues (Figure 3C), which might be
methylated in vivo. The CpG residues are conserved in
rat and hamster (see Additional file 5, Figure S4). As
CTCF often binds DNA in a methylation-sensitive man-
ner, we tested whether the in vitro methylation of these
two sites in R30 affected CTCF binding. We found that
this was the case to some extent, as CTCF bound the
non-methylated R30 probe slightly more efficiently, and
this probe was a better competitor than methylated R30
(see Additional file 8, Figure S7A).
Human 37.9 and 42.1 CTCF binding sites contain three
CpG residues instead of two (not shown). One of these
overlaps with the highly conserved GG dinucleotide that
is part of the ‘core’ CTCF binding site (Figure 3C). The
second CpG is conserved between human and mouse
rDNA sites (it is the 5"end CpG in R30) (Figure 3C),
whereas the third CpG in the human rDNA sites is not
conserved between mouse and human, nor between 37.9
and 42.1 (not shown). We used SssI methyltransferase to
completely methylate the human H37.9 and H42.1
probes (see Additional file 8, Figure S7B). Interestingly,
CTCF binding to these fully methylated probes was
severely reduced (Figure 4A). These data indicate that
CTCF binds rDNA in a methylation-sensitive manner
in vitro. Both the position and number of methylated
CpG residues appear to influence CTCF binding to
cognate sites.
To test whether DNA methylation might interfere
with CTCF binding to the rDNA in vivo, we performed
ChIP-chop experiments. Before quantitative PCR, the
input and CTCF-enriched DNA samples were subjected
to digestion with the methylation-sensitive enzyme
HpaII or the methylation-insensitive enzyme MspI.
CTCF did not bind HpaII-resistant (that is, methylated)
H42.1 rDNA (Figure 4B). Similar data were obtained for
H37.9 rDNA (not shown). These results indicate that
CTCF prefers non-methylated over methylated riboso-
mal DNA in vivo. A ChIP-chop assay performed on
mouse ES cell DNA also showed CTCF binding to non-
methylated rDNA (data not shown).
Fully methylated rDNA repeats are thought to be
inactive [28]. To investigate an in vivo correlation
between CTCF binding in the spacer promoter and
methylation status of the rDNA repeats, we used 3T3L1
cells. These cells can be differentiated into adipocytes,
which results in the repression of rRNA transcription by
more than 50% [29]. Increased heterochromatin features
at the rDNA promoter accompany this repression
[29,30]. ChIP analysis revealed binding of CTCF, UBF
and RNA polymerase I at the spacer promoter in undif-
ferentiated 3T3L1 cells (Figure 4C, left panel). As
reported previously [29], UBF and RNA polymerase I
binding to the rDNA repeat was reduced in differen-
tiated 3T3L1 cells (Figure 4C, right panel). CTCF bind-
ing was also significantly reduced (Figure 4C, right
panel). These data suggest that increasing heterochro-
matinization in vivo significantly affects binding of
CTCF, UBF and RNA polymerase I. We propose that
in vivo CTCF binds rDNA repeats in a methylation-
sensitive manner.
CTCF regulates nucleolar number, and is required for UBF
and RNA pol I binding near the spacer promoter
To examine the physiological significance of a CTCF-
UBF interaction and of CTCF binding to the rDNA
spacer promoter, we generated a system to efficiently
deplete CTCF in vitro. MEFs were isolated from mice
homozygous for a Ctcf conditional knockout allele [31],
and CTCF was deleted by infecting confluent MEFs
with a replication-deficient lentivirus expressing Cre
recombinase [10]. After 4 days of culture, only very low
levels of CTCF protein were detected on western blot
(Figure 5A). Immunofluorescence analysis revealed that
a small proportion of MEFs still expressed CTCF (data
not shown), suggesting that these were not infected by
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Figure 4 CCCTC binding factor (CTCF) binding to ribosomal (r)DNA is methylation-sensitive. (A) Influence of methylation on the binding
of CTCF to rDNA. Band-shift assays using human H37.9 and H42.1 rDNA probes, either completely methylated with SssI methyltransferase
(methylated probe) or non-methylated (control probe) on HEK293T extracts, transfected or not with CTCF. Competition was assessed by adding
increasing amounts of non-labeled probe. In some cases, extracts were incubated with the indicated antibodies. (B) CTCF prefers non-
methylated rDNA in vivo. Chromatin from K562 cells was immunoprecipitated with anti-CTCF (CTCF ChIP). Purified DNA was left uncut (mock
digestion), or digested with HpaII or MspI. Quantitative PCR was then performed with H42.1 primers, both on non-precipitated K562 DNA (input)
and on DNA enriched for CTCF binding sites (CTCF ChIP). Note the high content of HpaII-resistant H42.1 rDNA in K562 cells (input), which
represents methylated rDNA. In the CTCF-enriched sample, the HpaII-resistant rDNA was not present, suggesting that CTCF does not bind well to
methylated rDNA. (C) ChIP analysis on (left panel) undifferentiated and (right panel) differentiated 3T3L1 cells. Nuclei were fixed with 1%
formaldehyde, and protein-DNA complexes were immunoprecipitated with antibodies against the indicated proteins (the large subunit of RNA
polymerase I (RPA194), CTCF, upstream binding factor (UBF) and acetylated histone H4). The position of the primer sets (upward arrows, see also
ChiP2 in Figure 6A), spacer promoter (right-pointing arrow with ncRNA (part A), enhancer repeats (white rectangles) and gene promoter (right-
pointing arrow with pre-rRNA)) is indicated on the rDNA. The horizontal axis of the panels is co-aligned with the rDNA underneath and shows
distance in base pairs.
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the virus. MEFs lacking CTCF could be maintained as a
confluent layer for several days (data not shown), but
they could not be passaged, because they are severely
impaired in division. These results are in line with
in vivo data showing that CTCF is essential for the pro-
liferation and growth of b-selected T cells [31].
Next, we investigated the intracellular distribution of
UBF in MEFs. Interestingly, deletion of CTCF reduced
the number of UBF-positive spots, and thus the number
of nucleoli, in MEFs (Figure 5B, C). However, the aver-
age size of a UBF-positive area, and thus that of a
nucleolus, was larger in CTCF-deleted MEFs. As a result
the total fluorescence intensity (and hence the level) of
UBF was similar in CTCF-deleted and normal MEFs, a
result supported by western blot analysis (not shown)
and data in T cells [31]. We conclude that deletion of
CTCF in MEFs results in fusion of nucleoli but does not
affect UBF levels.
CTCF binding to the rDNA spacer promoter was
virtually undetectable in MEFs treated with Cre virus
(Figure 6B, right-hand panels, red line) compared with
non-treated MEFs (Figure 6B, left-hand panels, red line).
In the absence of CTCF, binding of UBF and RNA poly-
merase I was severely reduced (Figure 6B, right hand
panels, blue and green line, respectively). Remarkably,
the absence of CTCF did not significantly perturb RNA
polymerase I binding to the gene promoter. Thus,
CTCF exerts a local influence.
In mouse ES cells, distribution of CTCF, UBF and RNA
Pol I over the rDNA repeat, as analyzed by ChIP, was
similar to that in MEFs (see Additional file 9, Figure S8).
We used an RNA interference (RNAi)-based approach to
knock down Ctcf mRNA in ES cells. Real time PCR and
immunofluorescence analysis suggested knock down of
CTCF of > 70% after 4 days of culture. Although the
depletion of CTCF in ES cells was less effective than Cre-
treatment of Ctcff/f MEFs, this reduction did lead to a loss
in UBF and RNA pol I binding (see Additional file 9, Fig-
ure S8B). These results confirm the role of CTCF in UBF
and RNA polymerase I localization.
CTCF maintains specific histone marks at the spacer
promoter
Given the role of CTCF in epigenetic chromatin remo-
deling near its binding sites, we examined the distribu-
tion of specific histone marks across the rDNA
regulatory region in the presence and absence of CTCF.
ChIP analysis in normal MEFs revealed peaks of histone
H3 acetylation, H3K4 dimethylation and H2A.Z just
upstream of the CTCF binding site (Figure 6C, left
panel). In the absence of CTCF H2A.Z, H3K4 dimethy-
lation and H3 acetylation (that is, markers of ‘active’
chromatin and of insulator sites) were clearly downregu-
lated (Figure 6C, right panel). A control ChIP experi-
ment revealed similar amounts of histone H3 in the
presence or absence of CTCF (see Figure S9A, Addi-
tional file 10), showing that the reduction in H2A.Z,
H3K4me2 and H3ac levels is specific. Furthermore,
ChIP analysis in the human rDNA repeat revealed speci-
fic accumulation of H2A.Z, H3K4me2 and H3ac at both
CTCF binding sites in K562 cells (see Figure S9C, Addi-
tional file 10). Combined, our data suggest that CTCF is
required for local histone modifications and the accu-
mulation of a histone variant at the spacer promoter.
Because we found that CTCF is required for H2A.Z
accumulation at the rDNA spacer promoter, we tested
whether this also occurs with H2A.Z sites near RNA
polymerase II-dependent genes. In the absence of
CTCF, H2A.Z was indeed lost from the c-Myc promoter
Figure 5 CCCTC binding factor (CTCF) regulates nucleolar
number. (A) Efficient deletion of CTCF in mouse embryonic
fibroblasts (MEFs). MEFs carrying the conditional Ctcff knockout allele
were infected (+) or not (-) with a lentivirus expressing Cre
recombinase. After 4 days, cell extracts were analyzed for residual
CTCF. Mta2 was used as loading control. In MEFs, Ctcf deletion with
lentiviral Cre was very efficient, with > 90% of cells infected. (B, C)
Distribution of upstream binding factor (UBF) in MEFs. Primary MEFs
carrying the conditional Ctcff knockout allele were either infected
(+CrE) or not (-CrE) with a lentivirus expressing Cre recombinase.
Cells were fixed, and incubated with antibodies against UBF
(because both the CTCF and UBF antibodies used for
immunofluorescence analysis were mouse monoclonals, we could
not perform a combined CTCF/UBF stain. (B) Single image; (C)
immunofluorescence results from several images were quantified.
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(see Additional file 10, Figure S9B), implying that CTCF
can mediate the deposition of this histone variant close
to RNA polymerase I and II promoters. The relatively
constant levels of histone H3 in the rDNA locus in nor-
mal and Cre-treated MEFs (see Additional file 10, Figure
S9A) indicate that the observed loss of histone modifica-
tions and H2A.Z are not caused by a reduction in
nucleosomes in the absence of CTCF. Furthermore, the
changes in DNA binding by specific proteins (for exam-
ple, UBF and RNA polymerase I) seen in the absence of
CTCF, are not the result of changes in the total amount
of these proteins (data not shown).
CTCF activates transcription from the spacer promoter
We next examined the effect of a CTCF deletion on
steady state RNA levels using total RNA isolated from
Figure 6 CCCTC binding factor (CTCF) organizes chromatin on ribosomal (r)DNA. (A) Outline of mouse rDNA repeat. The position of the
primer pairs (1 to 7) used in the second chromatin immunoprecipitation (ChIP2; panel B) is indicated by upward-pointing arrows. For
comparison, the primers used in the first ChIP (ChIP1; Figure 3) are also shown. For other explanations, see Figure 3A. (B) Binding of CTCF,
upstream binding factor (UBF) and RNA polymerase I to the mouse spacer promoter. ChIP analysis was performed on mouse embryonic
fibroblasts (MEFs) homozygous for the conditional Ctcf knockout allele (Ctcff/(F). MEFs were either (right panels) infected or not (left panels) with
a lentivirus expressing Cre recombinase. Nuclei were fixed with 1% formaldehyde, and protein-DNA complexes were immunoprecipitated with
antibodies against the indicated proteins (control = rabbit IgG). The upper and lower panels show the same results, but with a different vertical
axis. Numbers on the horizontal axis refer to primer pairs. (C) Binding of modified and variant histones to the mouse spacer promoter. ChIP
analysis was performed as described above. Protein-DNA complexes were immunoprecipitated with antibodies against the indicated proteins
(control = rabbit IgG). Numbers on the horizontal axis refer to primer pairs.
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Ctcff/f MEFs that were either treated or not treated with
Cre virus. Using northern blot analysis, we found similar
ratios of pre-rRNA (47S) to Gapdh mRNA in CTCF
depleted MEFs (Figure 7B). Furthermore, the ratio of
mature 18S rRNA to Gapdh mRNA was comparable in
normal and CTCF-depleted cells. These results indicate
that a deletion of CTCF does not affect steady state
rRNA amounts in confluent non-dividing fibroblasts.
Using nuclear run-on analysis, we investigated transcrip-
tion from spacer and gene promoters in the presence
and absence of CTCF. Deletion of CTCF significantly
reduced transcription from the spacer promoter but did
not affect transcription from the ribosomal gene promo-
ter (Figure 7C). These results show that CTCF can acti-
vate transcription from the spacer promoter
independently of the gene promoter.
We next examined the influence of CTCF on rRNA
biogenesis in a cell type other than MEF. For these
experiments, we used mouse ES cells, because RNAi-
mediated knockdown of CTCF is effective in these cells.
We investigated spacer and gene-promoter derived tran-
scription in the presence or absence of CTCF using
real-time PCR and fluorescent in situ hybridization
(FISH). For the latter, we used probes against spacer
promoter-derived transcripts (’ncRNA’ probe), together
with a previously described probe (’pre-rRNA’ probe
[32]) that covers the unstable 5” end of the external
transcribed spacer (see Figure 7A for position of the
probes on the rDNA). RNA FISH experiments showed
that both the ncRNA probe (green) and the pre-rRNA
probe (red) were located inside ES cell nucleoli (see
Additional file 11, Figure S10C-E). Whereas the pre-
rRNA signal was detected at a relatively constant level
in each ES cell nucleolus, the ncRNA signal varied with
respect to intensity and number of spots (on average ~4
per cell). These FISH experiments indicate that only a
small subset of the rDNA repeats express ncRNA, con-
sistent with recently published data [26]. Remarkably,
ncRNA spots were often located at the periphery of the
nucleolus, whereas pre-rRNA was detected throughout
(see Figure S10C, D, Additional file 11). Our results sug-
gest that ncRNA and pre-rRNA transcription can be
independently regulated in space and time inside the
nucleoli of ES cells.
Real-time PCR analysis suggests that pre-rRNA levels
are reduced in ES cells lacking CTCF (Figure 7D). We
also quantified pre-rRNA levels by measuring the fluor-
escence intensity in FISH experiments in non-treated,
control RNA-treated, and CTCF RNAi-treated ES cells.
Consistent with the PCR data, the pre-rRNA transcript
was mildly affected in cells knocked down for CTCF
(Figure 7E). Thus, in ES cells, lack of CTCF resulted in
a very mild reduction of pre-rRNA levels, to ~80% of
control. By contrast, both real-time PCR experiments
using two different primers sets (Figure 7D) and RNA
FISH data (see Additional file 11, Figure S10F) showed
that ncRNA levels were significantly decreased in ES
cells lacking CTCF. Combined with the run-on analysis
in MEFs (Figure 7C) these results strongly suggest that
CTCF activates transcription from the spacer promoter,
an activity that is independent of cell type.
Discussion
We have identified UBF as the first common interaction
partner of CTCF and CTCFL, emphasizing a role for
these proteins in the organization of rDNA chromatin.
It will be interesting to determine how CTCFL influ-
ences rRNA transcription in vivo, as in normal tissues
this protein is expressed in a very restricted manner [2],
whereas its expression is upregulated in various types of
cancers [33]. The ZF domain of CTCF and CTCFL
mediates the interaction with UBF. In CTCF, this
domain has also been shown to be responsible for inter-
action with other proteins, including CHD8 [11]. Inter-
estingly, a ZF-dependent, pan-nucleolar localization of
CTCF was described in K562 cells, which correlated
with poly (ADP-ribosyl)ation and growth arrest of cells
[34]. The pan-nucleolar distribution of CTCF indicates
that the protein must be bound to rRNA and/or nucleo-
lar proteins in addition to rDNA. It is therefore not sur-
prising that CTCF function is different in K562 cells
compared with MEFs or ES cells. Post-translational
modifications may alter the function, localization and
interactions of CTCF in a cell type-specific manner. We
conclude that the ZF-domain of CTCF is a versatile
nucleic acid and protein-protein interaction surface,
explaining why it is so conserved.
Previously, the Xenopus laevis rDNA repeat was
reported to contain multiple weak CTCF binding sites
near its spacer promoter [35]. Although the physiological
significance for rDNA transcription was not investigated
in that study, the result is consistent with our data. The
importance of CTCF binding near the spacer promoter is
emphasized by the observation that the mouse binding
site is conserved in rat and hamster. Furthermore, we
identified two CTCF sites in the human rDNA (H37.9
and H42.1, respectively) upstream of the gene promoter.
We found a specific accumulation of H2A.Z, H3K4me2
and H3ac at CTCF binding sites in the human and
mouse rDNA repeats. Interestingly, enrichment of the
acetylated histones H3 and H4 and of TATA binding
protein (TBP) was observed 100 bp upstream of site
H42.1, whereas UBF accumulates 3’ to this site [36].
Thus, despite the fact that the IGS regions of mouse and
human are not conserved (see Additional file 6, Figure
S5A to C), critical factors and chromatin modifications
are similarly organized around CTCF binding sites in
rDNA (see Additional file 6, Figure S5D). In fact, our
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Figure 7 CCCTC binding factor (CTCF) activates spacer promoter transcription. (A) Transcribed portion of mouse ribosomal (r)DNA.
Transcription initiation (spacer promoter = ncRNA, gene promoter = pre-rRNA, right-pointing arrows) and positions of run-on (left-pointing
arrows), northern blot and fluorescent in situ hybridization (lines) probes are indicated. (B) Northern blot analysis. Total RNA from Ctcff/f primary
mouse embryonic fibroblasts (MEFs) (either treated (+) or not (-) with Cre) was analyzed sequentially with probes against the 47S pre-rRNA [32]
and Gapdh (two samples per genotype shown, > 10 independent samples per genotype analyzed. (C) Spacer promoter transcription in the
absence of CTCF. Nuclear run-on of spacer and gene promoter in Ctcff/f MEFs (Cre-treated (+) or not (-)). The suppression effect of a-amanitin on
RNA polymerase II-mediated transcription was measured. Left panel shows Actin and Histone H3 genes; a typical run-on is shown on the right.
The graph shows the relative transcription activity of spacer and gene promoter (three independent experiments; *P = 0.005, Student t-test). (D,
E) CTCF knockdown in embryonic stem (ES) cells. Cells were transfected with a pSUPER plasmid to knock down CTCF (controls were either no
transfection, or transfection with a control vector). After 4 days, cells were harvested for (D) RNA analysis by PCR, or fixed and analyzed by
fluorescent in situ hybridization (E). ncRNA was determined twice with independent primers (1, 2), Ctcf and pre-rRNA were determined four
times (SD indicated). Taking the average of the four ncRNA experiments showed a reduction of spacer transcript in CTCF-depleted cells to 39 ±
22% (mean ± SD). (E) Quantification was performed with > 300 cells per treatment (SEM indicated).
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data suggest that the local organization of chromatin at
CTCF sites near the RNA polymerase I-regulated spacer
promoter and near RNA polymerase II promoters [9] is
also similar. First, CTCF binds ~200 bp upstream of the
TSS in both types of promoters, and an HS is present
between the TSS and CTCF binding site. Furthermore,
H2A.Z and H3K4me2 accumulate ~200 to 300 bp
upstream of the CTCF binding site. Enrichment of H2A.
Z at CTCF binding sites appears to be a general phenom-
enon [8,9,37]. In RNA polymerase II promoters, H2A.Z
and H3K4me2 marks are associated with active or
‘poised’ promoters. We propose that binding of CTCF to
the spacer promoter also maintains rDNA repeats
‘poised’ for transcription.
With one high affinity binding site per mouse rDNA,
and with CTCF preferring non-methylated (and thus
active) rDNA repeats, it is expected that only a small
number of DNA-bound nucleolar CTCF molecules
would be present. By contrast, UBF is abundantly pre-
sent in the nucleolus, where it binds rDNA with low
specificity [23] and is highly dynamic [15,38]. Thus, a
UBF-CTCF interaction is expected to be transient. How-
ever, the interaction is crucial, as CTCF binding
enhances UBF binding both in vitro and in vivo. Nucleo-
lar UBF in turn ensures that rDNA repeats remain
accessible to RNA polymerase I [18]. UBF, as part of the
architectural HMG-box protein family, could change the
topology of the rDNA, thereby facilitating binding of
other factors [39], and allowing formation of small ~175
bp DNA loop structures called enhanceosomes [40]. In
addition, CTCF and UBF may together recruit RNA
polymerase I to the spacer promoter. Binding by CTCF
to components of the RNA polymerase I complex would
aid in this recruitment.
The biological function of the spacer promoter and
the ncRNA transcript that is generated from it are still
not completely understood. Early experiments suggested
that the spacer promoter and the enhancer region act
together to stimulate pre-rRNA transcription [27,41].
More recent data have shown that ncRNAs generated
from the spacer promoter are unstable; transcripts are
rapidly processed and degraded, and only the 3’ end
(~150 nucleotides) of the transcript, which matches the
rDNA gene promoter, is bound to the nucleolar remo-
deling complex (NoRC) and is required for the estab-
lishment and maintenance of inactive rDNA repeats
[24,30]. In this context, the spacer promoter transcript
functions in rDNA silencing instead of activation.
Recent data implicate UBF in the balance between
active and inactive rRNA genes, via a ‘pseudosilencing’
mechanism that is reversible and does not involve DNA
methylation [18]. Thus, there appear to be two different
epigenetic mechanisms that regulate the number of
active rRNA genes. An attractive hypothesis is that
CTCF, by binding to the spacer promoter of non-
methylated (and thus active) rDNA repeats, and by
interacting with UBF and ‘loading’ it onto these repeats,
is involved in the ‘pseudo-silencing’ mechanism and
maintains rDNA repeats ‘poised’ for transcription. At
the same time, by generating spacer promoter tran-
scripts, CTCF is ‘feeding’ NoRC with its 3’ end degrada-
tion product, allowing this protein complex to function
in a second epigenetic rRNA gene silencing mechanism.
Consistent with this notion, ncRNA transcription
appears to take place on a small subset of hypomethy-
lated mouse rDNA repeats [26].
CTCF not only acts locally, but also regulates nucleo-
lar number. Results in MEFs are consistent with data
in T cells, where we found that the number of rDNA-
positive signals decreases when CTCF is deleted in vivo
[31]. Interestingly, B23 (or nucleophosmin) is a protein
partner of CTCF, and B23-enriched insulator sequences
are tethered to the nucleolar rim in a CTCF-dependent
manner [42]. B23 is important for nucleolar structure
[43]. Moreover, the borders of lamina-associated
domains, detected by lamin B1, are demarcated by
CTCF binding sites [44]. Lamin B1 interacts with B23,
and is also involved in maintaining nucleolar structure
[45]. We hypothesize that control of nucleolar number
by CTCF is linked to its global function as an architec-
tural factor, in association with proteins such as B23
and lamin B1.
Ribosome biogenesis controls cell growth and prolif-
eration, as it determines the protein synthesis capacity
of a cell. Recently, we showed that CTCF positively reg-
ulates cell growth in rapidly dividing thymocytes [31]. In
the present study we detected multiple components of
the RNA polymerase I complex in the mass spectrome-
try analysis of CTCF-bio-interacting partners. Knock-
down of CTCF in ES cells resulted in slightly lowered
levels of pre-rRNA. Conversely, under conditions of
repressed pre-rRNA transcription, as in differentiated
3T3L1 cells [29], CTCF binding to the spacer promoter
is reduced. Combined, these data suggest a link between
CTCF, rRNA synthesis and cell growth control, whereby
CTCF appears to act at a local and a global level.
Conclusions
We show that CTCF and CTCFL bind UBF directly.
CTCF organizes the local epigenetic state of rDNA
repeats by regulating the binding UBF and RNA poly-
merase I and of other crucial components, and by alter-
ing chromatin modifications near its binding site. By
tightly binding the rDNA spacer promoter, CTCF may
enhance UBF binding and ensure that rDNA repeats are
accessible to RNA polymerase I. CTCF binding at the
spacer promoter stimulates transcription of non-coding
RNA from the spacer promoter. The local organization
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of chromatin at CTCF sites near the RNA polymerase I-
regulated spacer promoter and near RNA polymerase II
promoters is remarkably similar. The CTCF-dependent
enrichment of H2A.Z and H3K4me2 near the spacer
promoter indicates that CTCF binding maintains rDNA
repeats ‘poised’ for transcription.
Methods
Accession numbers and primers
We used mouse (accession number BK000964), human
(U13369), rat (X04084) and hamster (DQ235090) rDNA
sequences for alignments, to design primers for PCR
and ChIP experiments and for probe generation. Pri-
mers used in all the different experiments are shown in
Tables S2 tp S7 (Additional file 12, 13, 14, 15, 16, 17
respectively).
Antibodies and cDNAs
CTCF mouse monoclonal antibodies were from BD
Biosciences (Breda, NL), and CTCFL polyclonal rabbit
antibodies (18337) were from Abcam. CTCFL (#4) poly-
clonal rabbit antibodies are described elsewhere (Sleutels
et al, manuscript in preparation). The anti-CTCF (N3)
and anti-RPA194 rabbit polyclonal antisera have been
described previously [31,46]. Anti-histone H2A.Z
(ab4174), anti-dimethyl-histone H3 (Lys4) (ab7766) and
anti-histone H3 (ab1791) antibodies were from Abcam.
Anti-acetyl histone H3 (06-599) and anti-acetyl Histone
H4 (06-866) antibodies were from Upstate (Millipore,
Amsterdam, NL). Anti-UBF (sc-13125) and anti-actin
(sc-8432) antibodies were from Santa Cruz Biotechnolo-
gies (Santa Cruz, CA, USA). Streptavidin-HRP
(RPN1231VS) and secondary HRP-labeled anti-mouse
(NA931VS) and anti-rabbit antibodies (NA934V) were
from Amersham (GE Healthcare, Uppsala, Sweden).
Anti-His antibody was from Qiagen (Valencia, CA,
USA), and anti-Flag M2 antibody was from Sigma Che-
mical Co. (St Louis, MO, USA).
His-tagged UBF fusion proteins were generated by
PCR using mouse UBF cDNA from a Flag-tagged UBF
construct as template (kind gift of Dr I. Grummt). Pri-
mers contained NheI and BamHI sites for subcloning
into the pET28a vector. GST-tagged fusions of mouse
CTCF and CTCFL were amplified using mouse CTCF
(IMAGE 6825952) and CTCFL (Sleutels et al, manu-
script in preparation) cDNAs as templates. cDNAs were
cloned into plasmid pGEX-3X and purified (glutathione-
Sepharose 4B; Amersham Biosciences). GST-tagged
fusion proteins derived from chicken CTCF have been
described previously [47].
Mass spectrometry
For mass spectrometry samples were treated and ana-
lyzed as described [48]. Data analysis and protein
identification was performed as reported [49]. The Mas-
cot search algorithm (version 2.0; MatrixScience) was
used for searching against the NCBI database (taxonomy:
Mus musculus). The Mascot score cut-off value for a
positive protein hit was set to 60. Individual peptide tan-
dem mass spectrometry (MS/MS) spectra with scores of
< 40 were checked manually, and either interpreted as
valid identifications or discarded. A number of CTCF-bio
interacting proteins are listed in Table S1 (see Additional
file 2). It should be noted that CTCF is difficult to purify
under the mild conditions that are required to isolate
associating proteins, although CTCF binds DNA tightly,
the majority of its protein-protein interactions are of a
transient nature.
Affinity chromatography and size fractionation
Nuclear extracts were prepared as described previously
[50]. Salt concentration in the extract was adjusted to
100 mmol/l NaCl. Unless stated differently, all IP and
pull-down reactions were performed in IP buffer (100
mmol/l NaCl, 0.3% NP40, 20 mmol/l Hepes pH8, 0.2
mmol/l EDTA, 10 mmol/l MgCl2, with protease inhibi-
tors) (Complete; Roche). Benzonase (Novagen) was
added where indicated to remove DNA and RNA.
Streptavidin pull-down assays were performed as
described previously [19], with the exception that the
wash buffer and binding buffer were the same as the IP
buffer described above. For IPs, nuclear extracts were
pre-cleared at 4°C (Protein A sepharose beads, Sigma).
Washes were performed at 4°C in wash buffer (100
mmol/l NaCl, 20 mmol/l Tris pH7.5, 0.3% NP40 and
protease inhibitors). IPs were performed by adding anti-
bodies to the samples and incubating for 1 hour at 4°C.
Subsequently, protein-A sepharose beads were added,
and incubation was continued for another hour at 4°C
while rotating. Beads were washed six times with wash
buffer.
Flag-IPs were performed using the same protocol as
for IPs, except that anti-Flag M2 agarose (Sigma) incu-
bation was performed for 3h at 4°C.
His-tagged proteins were bound to nickel-nitrilotria-
cetic (Ni-NTA) beads (Qiagen) in low salt buffer
(20 mmol/l Hepes pH 7.5, 100mmol/l KCl, 10 mmol/l
b-mercaptoethanol and 10% glycerol v/v). Proteins
were purified by extensive washing of the beads, first
in low-salt buffer, followed by washing in buffer with 1
mol/l KCl, and washing again in low-salt buffer. Pro-
teins were eluted from the beads with 200 mmol/l imi-
dazole in low-salt buffer, then the imidazole removed
by dialysis. GST-tagged proteins were purified on glu-
tathione-Sepharose 4B columns (Amersham Bios-
ciences), using low and high salt buffers as above. To
remove contaminating nucleic acids, benzonase was
first added to bacterial extracts and again during
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washing of the (Ni-NTA) and glutathione beads. GST-
based pull-downs were performed in binding buffer
(20 mmol/l Tris-HCl pH 8, 100 mmol/l NaCl, 0.05%
Triton X-100) containing benzonase, for 2 hours at 4°
C. Washes were performed in binding buffer, followed
by washes in high salt wash buffer (20 mmol/l Tris-
HCl pH8, 400 mol/l NaCl, 0.05% Triton X-100). GST
pull-downs on ES cell nuclear extracts were performed
using the binding and washing conditions as described
in the IP section.
Size fractionation of protein complexes was performed
on a fast protein liquid chromatography apparatus
(AKTA FPLC; Amersham Biosciences) with a Superose
6 10/30 column (Amersham Biosciences). Fractions
were precipitated with 100% trichloroacetic acid and
analyzed by western blotting as described previously
[51]. Molecular size standards were thyroglobulin (670
kDa) and albumin (66 kDa) (Amersham Biosciences).
SDS-PAGE, western blotting and EMSA
Bound proteins were eluted from beads by boiling in
sample buffer (1 × Laemmli buffer). For western blot ana-
lysis, samples were separated by electrophoresis in SDS
polyacrylamide gels and blotted onto poly(vinylidene
fluoride membranes), (MilliPore) using a semi-dry blot-
ting apparatus (BioRad). Signal detection was performed
using enhanced chemiluminescence (Amersham).
For EMSA or band-shift analysis, protein extracts were
preincubated with bandshift buffer (10% glycerol,
20 mmol/l Hepes pH7.4, 20 mmol/l KCl, 1 mmol/l
MgCl2, 5 mmol/l dithiothreitol (DTT), 10 μmol/l ZnCl2,
100 μg/ml bovine serum albumin (BSA), 0.02% NP40)
and 2 to 4 μg of salmon sperm DNA as a non-specific
competitor. The reaction was incubated for 20 minutes
at room temperature. Upon addition of probe the binding
reaction was performed for another 20 minutes. Com-
plexes were analyzed by electrophoresis through a 5%
acrylamide (37,5:1) 0.5 × Tris/borate/EDTA non-
denaturing gel at 8V/cm2 at 4°C. Where specified, 300-
fold excess of unlabeled probe or specific competitor was
added at the same time as the probe.
Mouse probes for EMSA were end-labeled with 32P,
whereas human probes (MYC-N, H42.1 rDNA and
H37.9 rDNA) were 32P-labeled PCR fragments. For
EMSA with in vitro methylated probes, purified H37.9
and H42.1 rDNA fragments (5 μl) were methylated in
vitro using 12 U SssI methyltransferase (New England
Biolabs) and 1 μl S-adenosyl-L-methionine (32 mmol/l)
in a final volume of 30 μl. Reactions were performed
twice for 4 hours at 37°C, after which probes were puri-
fied. For supershift experiments, 1 μl of anti-CTCF
mouse monoclonal or anti-actin (used as non-specific
antibody) was added to the binding reaction before the
radiolabeled probe.
ChIP
Preparation of cross-linked chromatin (2 × 107 cells
treated with 1% formaldehyde for 10 minutes at room
temperature), sonication of chromatin to yield fragments
of 300 to 800 bp, and immunoprecipitation were per-
formed as described in the Upstate protocol http://www.
upstate.com. At least two independent ChIPs were car-
ried out per experiment. For streptavidin ChIPs, minor
modifications were used: streptavidin beads were
blocked for 1 hour at room temperature in 0.2 mg/ml
sonicated salmon sperm DNA, elution was performed
for 16 hours at 65°C in elution buffer (0.1% NaHCO3,
1% SDS, 0.2 mol/l NaCl). Quantitative real-time PCR
(Opticon I, MJ Research and MyiQ, BioRad) was per-
formed using SYBR Green (Sigma), Platinum Taq DNA
polymerase (Invitrogen) and 100 ng of each primer
under the following cycling conditions: 95°C for 3 min-
utes, followed by 40 cycles of 10 seconds at 95°C, 30
seconds at 60°C and 15 seconds at 72°C (during which
measurements were taken). Values were normalized to
input measurements, and enrichment was calculated
relative to the Amylase gene using the comparative Ct
method. PCR products were all < 150 bp.
For ChIP analysis with nuclei derived from human cell
lines, 5 × 107 cells were fixed in 1% formaldehyde, lysed
and sonicated. ChIP was performed using Dynabeads-
protein G (Dynal Biotech) coupled to anti-CTCF, anti-
CTCFL or anti-UBF antibodies. Dynabeads were incubated
with lysates for 4 h at 4°C, and washed consecutively with
commercial buffers (Low Salt, High Salt and LiCl Immune
Complex Wash Buffers; Upstate). Chromatin was eluted
with 200 μl of elution buffer (Upstate), de-crosslinked for
8 hours at 65°C, and purified (Qiaquick columns; Qiagen).
Real-time PCR of immunoprecipitated DNA was per-
formed with primers shown in Table S7 (see Additional
file 17). The MYC-N and NY-ESO1 amplicons were used
as positive controls for CTCF and CTCFL, respectively,
and the MYC-H.1 amplicon as negative control. Enrich-
ment for a specific DNA sequence was calculated as
above.
Methylation-sensitive ChIP assay (ChIP-chop)
To analyze the methylation density of rDNA precipi-
tated with CTCF antibodies, post-ChIP hydrolysis
(’chopping’) of DNA was performed using the methyla-
tion sensitive enzyme HpaII and its isoschizomer MspI.
Input sample (60 ng) and DNA from the CTCF ChIP
reaction were divided into three equal aliquots, which
were digested with HpaII or MspI, or left undigested
(mock digested control). Digestions were carried out in
a final volume of 20 μl for 3 hours at 37°C. Enzymes
were inactivated for 30 minutes at 65°C. From each
digestion, 10 μl was subjected to quantitative PCR with
H42.1 rDNA primers, as described above. The uncut
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rDNA was set at 100%. The percentage of HpaII and
MspI resistance was calculated as a percentage of mock
digested DNA, by measuring the difference in Ct values
in the qPCR (mock-MspI or mock-HpaII), taking the
inverse of the fold difference in expression level, and
multiplying this value by 100.
Cell lines, transfections and lentiviral transduction
To generate the Ctcfbio-neo knock-in allele, a CTCF-TEV-
bio in-frame fusion DNA was generated by PCR. In this
construct, the biotinylation sequence [19] is preceded by
a tobacco etch virus (TEV) protease cleavage site of
seven amino acids. The neomycin-resistant LoxP-Neo-
loxP vector and targeting procedures have been described
previously [51]. IB10 129 ES cell DNA was analyzed by
Southern blotting using radiolabeled probes outside of
the region of homology (Figure 1A). For confirmation of
homologous recombination, we used different 5’ end and
3’ end probes, and a PCR-based genotyping assay.
Ctcf bio-neo ES cells were transfected with CMV-Cre to
remove the neomycin resistance cassette. A second
round of homologous recombination was performed to
target the Rosa26 locus with hemagglutinin (HA)-tagged
BirA [20]. Verification of homologous recombined
clones was performed by PCR. Control BirA-positive ES
cell lines have been described previously [20].
3T3L1 cells (CL-173; ATCC) [29] and 293T cells [10]
were cultured as described previously. The Ctcf f/f pri-
mary MEFs were isolated as described previously [51] at
embryonic day 13.5 from embryos derived from condi-
tional Ctcf f/f knockout mice [31].
Transient transfections in 293T cells with Flag-UBF
and pcDNA3-CTCFL were performed using a transfec-
tion reagent (Lipofectamine™2000; Invitrogen) in
reduced serum media (Optimem; GibcoBRL). Cells were
analyzed 24 hours after transfection. Cre-lentivirus pro-
duction and transduction of confluent primary MEFs
was performed as described [10], with the exception
that cells were split and diluted two-fold at 24 hours
after transduction. Virus titers and Cre functionality
were tested using serial dilutions. Recombination was
tested after 4 days of infection by quantitative RT-PCR.
KCTCFD11 is a sub-line derived from K562 myeloid
leukemia cells, which is stably transfected with a consti-
tutive CTCF expression vector that moderately overex-
presses CTCF (two to three-fold) compared with cells
transfected with the empty vector (KpCDNA subline)
[52]. For EMSA experiments, 293T cells or K562 cells
were transfected with pcDNA3-CTCF expression vector
(Lipofectamine™2000; Invitrogen).
Northern blot analysis
Total RNA was isolated using an isolation solvent
(RNA-Bee RNA Isolation Solvent; Tel-Test Inc.), size
separated by gel electrophoresis (~6 μg per lane) and
blotted onto membrane (Hybond N+; Amersham).
Probes were radioactively labeled by PCR. Blots were
exposed to screens (PhophorImager; Molecular
Dynamics) to quantify results.
Nuclear run-on
Cells were collected and washed twice with cold phos-
phate-buffered saline (PBS). The cells were lysed
in nuclear isolation buffer (10 mmol/l Tris pH7.5;
10 mmol/l NaCl, 10 mmol/l MgCl2, 0.5% NP40). The
nuclei were spun at 1000 g and resuspended in storage
buffer (50 mmol/l Tris pH8.5, 0.1 mmol/l EDTA,
5 mmol/l MgCl2, 40% glycerol). Approximately 10
6
nuclei (50 μl) were pre-incubated for 20 minutes on ice
with 100 μg/ml a-amanitin. Nuclei were then mixed
with 50 μl 2 × reaction buffer (300 mmol/l KCl,
5 mmol/l MgCl2, 10 mmol/l Tris pH 7.5, 5 mmol/l
DTT, 20 U RNA Guard, 0.5 mmol/l of each ATP, UTP
and GTP, and 100 μCi of a32P CTP (800 Ci/mmol,
10 mCi/ml); Amersham). The labeling reaction was per-
formed for 30 minutes at 30°C. The reaction was
stopped on ice by adding 1 ml of isolation solvent
(RNA-Bee) and total RNA was extracted as indicated
above. Using a slot blot hybridization system with nylon
membranes (Hybond-N+), 5 μg of DNA PCR fragments
were hybridized with2×105 cpm of labeled RNA. Hybri-
dization and detection was performed as described
above. Incubation was performed in 2 ml of Church
hybridization mix (0.5 mol/l Na2HPO4 pH 7.2, 7% SDS,
1 mmol/l EDTA) in a rotating hybridizer at 65°C for
24 h. Membranes were washed extensively at 65°C with
Church wash buffer (40 mmol/l Na2HPO4 pH 7.2, 1%
SDS). Hybridization signals were quantified with an ima-
ger (Phosphor Imager; Typhoon Amersham) using Ima-
gequant software. The signal was corrected for the
amount of CTG in the probe.
Real-time PCR on ES cell RNA
Total ES cell RNA was isolated using Trizol (Invitrogen),
treated with DNAseI, and converted into cDNA using ran-
dom hexamers and reverse transcriptase (Superscript II;
Invitrogen). Real-time PCR was performed using specific
rRNA-covering primers and Sybr Green mix (Quantitect;
Qiagen) on a performed on an automated PCR system
(7500 Fast RT-PCR; Applied Biosystems). The negative
control was as above with omission of the reverse tran-
scriptase. The obtained Ct values were normalized to the
Ct value of Hprt.
FISH and immunofluorescence analysis
For FISH in ES cells, the cells were grown on coverslips.
RNAi treatment of the cells was performed using a pSU-
PER vector-based system (CTCF RNAi sequence:
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5"-GCAGAGAAAGTAGTTGGTAAT-3”). After trans-
fection, cells were treated with puromycin to positively
select for infected cells, thereby increasing the number
of cells in which CTCF was knocked down. After 4 days
of RNAi treatment, cells were fixed for 10 minutes with
4% paraformaldehyde (PFA) in PBS. Slides were stored
in 70% ethanol until further use. For RNA FISH, cells
were pretreated by two PBS washing steps, followed by
a permeabilization step of 5 minutes in a solution of 25
μg/ml proteinase K in PBS. Slides were washed once in
PBS, dehydrated and hybridized as described previously
[53]. For DNA FISH, slides were pretreated by two PBS
washing steps followed by a permeabilization step
(4 minutes incubation in 0.1% pepsin in 0.01 mol/l HCl
at 37°C). Slides were washed once in PBS on ice and
fixed again for 5 minutes in 4% PFA in PBS. Slides were
washed twice in PBS and dehydrated. Denaturation was
performed for 2 minutes at 80°C in denaturing solution
(70% formamide, 2 × saline sodium citrate, 10 mmol/l
phosphate buffer pH 7), after which the slides were
cooled in 70% ethanol, dehydrated, and hybridized as
described previously [53].
The unstable 5” external transcribed spacers (ETS)
probe has been described previously [32]. The enhancer
probe used for DNA and RNA FISH (ncRNA; see Figure
7A for its position) was isolated as a 1.7 kb SalI frag-
ment from a cosmid covering a large part of the mouse
rDNA repeat [32]. Probes were labeled by nick transla-
tion (Roche) using digoxygenin or biotin. Control DNA
FISH experiments in ES cells showed that the ncRNA
probe specifically localized to the nucleolus, as on pro-
metaphase chromosomes the probe localized in discrete
spots adjacent to centromeric DNA, indicative of NORs
(see Additional file 11, Figure S10A), whereas in inter-
phase cells the ncRNA probe localized within the
nucleolus (see Additional file 11, Figure S10B). These
data strongly suggest that the ncRNA probe specifically
recognizes rDNA. When ES cells were treated with
a-amanitin to inhibit RNA polymerase II transcription,
both ncRNA and pre-rRNA signals remained visible
(data not shown), confirming that RNA polymerase I is
responsible for transcription of spacer and gene
promoters.
For immunofluorescence staining, cells were fixed in
4% PFA in PBS for 15 minutes at room temperature,
permeabilized in 0.15% Triton X-100 in PBS, blocked in
1% BSA in PBS and incubated with antibodies as
described previously [32,51]. Images of cells were col-
lected with a microscope (DMRBE; Leica) equipped with
a camera (ORCA ER; Hamamatsu) or with a confocal
lens (LSM510; Zeiss), as described previously [51].
For quantification of pre-rRNA signals, images of ES
cells were collected with a microscope (DMRBE; Leica),
using the same exposure time for all images. Five images
each were collected of non-treated ES cells, control
RNAi-treated ES cells and CTCF RNAi-treated ES cells.
Collectively, more than 300 cells were present in the
images, which were imported into Image J software
(Rasband W.S., ImageJ, U. S. National Institutes of
Health, Bethesda, Maryland, USA; 1997 to 2008; http://
rsb.info.nih.gov/ij/,). Regions of interest (ROIs) were
placed around individual pre-rRNA signals, using the
freehand tool of Image J. ROIs were saved with the ROI
manager. Both background fluorescence and mean
fluorescent intensities of ROIs were calculated in each
image. After deduction of the background fluorescence,
mean fluorescence intensity data were collected into a
spreadsheet (Excel; Microsoft), pooled and analyzed
(Aabel software; GigaWiz). Quantification was per-
formed in two independent experiments using different
ES cell cultures, different probes and different RNAi
treatments. Both experiments yielded similar results;
that is, knock-down of CTCF leads to mildly reduced
pre-rRNA levels.
Additional material
Additional file 1: Figure S1: Characterization of CCCTC binding
factor (CTCF) and biotin tagged CTCF (CTCF-bio) interactions. (A)
CTCF-bio interacts with known CTCF binding partners. To identify CTCF-
interacting proteins, CTCF-bio was purified from embryonic stem (ES) cell
nuclear extracts under mild conditions. We validated our approach by
showing that known interaction partners of CTCF, such as Yin Yang (YY)-
1 [54], poly(ADP-ribose) polymerase (Parp)1 and nucleophosmin [42] co-
precipitate with CTCF-bio. (B) CTCF-bio interacts with upstream binding
factor (UBF) in vivo. Streptavidin pull-downs were performed using lung
nuclear extracts isolated from mice expressing biotinylated (CTCF-bio) or
normal (-) CTCF. Western blot analysis (b = bound fraction, i = input
(5%)) revealed that CTCF-bio interacts with UBF. (C) Immunoprecipitation
(IP) analysis of CTCF and UBF. IP was carried out on extracts of ES cells
expressing both CTCF and CTCF-bio. We used specific antibodies against
CTCF and UBF to precipitate endogenous proteins (IgG = control rabbit
IgG). CTCF-bio was detected with horseradish peroxidase-coupled
streptavidin. B = bound fraction, i = input (5%).
Additional file 2: Table S1: Mass spectrometry results for biotin
tagged CTCF (CTCF-bio).
Additional file 3: Figure S2: Direct interaction of CCCTC binding
factor (CTCF) and CTCFL with UBF. (A) Schematic representation of the
glutathione-S-transferase (GST)- and histidin (His)-tagged fusion proteins
used. (B) Expression of GST- and His-tagged fusion proteins. Proteins
were expressed in bacteria and affinity purified. Fusion proteins are
indicated by asterisks. (C) Interaction between bacterially produced
proteins. Purified GST- and His-tagged fusion proteins were incubated
together, followed by GST pull-down. Western blots were incubated with
an anti-His antibody. The experiments revealed a direct interaction
between the CTCF and CTCFL zinc finger (ZF) domains and the
upstream binding factor (UBF) dimerization domain plus high mobility
group (HMG)-box 1. His-tagged proteins containing either the
dimerization domain of UBF or HMG-box 1 only weakly bound CTCF and
CTCFL, indicating that both regions are necessary for efficient interaction.
(D) Bacterially produced CTCF and CTCFL interacted with UBF derived
from embryonic stem (ES). GST pull-down assays of bacterially produced
CTCF and CTCFL mutants were performed with nuclear protein extracts
from ES cells. Equal amounts of GST fusion proteins were incubated with
nuclear extracts from ES cells. Binding was performed under low-salt
conditions, and washing was performed under more stringent
conditions. Western blots were incubated with an antibody against UBF
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to detect ES cell-derived UBF. GST-tagged CTCF and CTCFL were both
able to pull down specifically UBF. The ZF domains of CTCF (1) and
CTCFL (5) displayed prominent interaction with ES cell-derived UBF. (E)
Bacterially produced ZFP37 did not interact with histidine (His)-tagged
UBF. The ZF domain of murine ZFP37 a protein that is enriched in the
nucleolus [55] was tagged with GST. To provide further evidence for the
specificity of the CTCF-UBF interaction, we examined whether this ZF
domain interacts with UBF. Purified GST-tagged ZFP37 was incubated
with His-tagged UBF (constructs 9, 10, 13). The interaction between CTCF
(construct 1) and UBF was clear, but we could not detect any binding
between UBF and ZFP37.
Additional file 4: Figure S3: Both CCCTC binding factor (CTCF) and
biotin-tagged CTCF (CTCF-bio) bind the ribosomal (r)DNA spacer
promoter in vivo. Extracts of adult thymus from wild type and Ctcfbio/+;
Rosa26bira/+ mice were analyzed for CTCF and CTCF-bio binding to the
rDNA spacer promoter using anti-CTCF antibodies or a control serum (-).
Additional file 5: Figure S4: Comparison of mouse, rat and hamster
ribosomal (r)DNA repeat regions. Comparison of nucleotide sequences
of the mouse, rat and hamster rDNA repeats [27]. Only the regions
around the spacer promoter are indicated. Numbers to the left indicate
distance (in base pairs) from the transcription start site of the gene
promoter. The CCCTC binding factor (CTCF) consensus site [3] is
underlined. Highly conserved CTCF consensus site residues are indicated
by a dot (the asterisk indicates deviation between consensus site
prediction and real residue). Conserved CpG dinucleotides are boxed.
The transcription start site of the spacer promoter is indicated by a right-
pointing arrow.
Additional file 6: Figure S5: Comparison of mouse and human rDNA
repeat regions. (A-C) Matrix plot comparisons of nucleotide sequences
of (A) mouse versus mouse, ((B) human versus human and (C) human
versus mouse rDNA repeats in the region upstream of the gene
promoter. CCCTC binding factor (CTCF) binding sites are indicated
(mCTCF BS for mouse, H37.9 and H42.1 for human). A highly repetitive
Alu sequence is present ~2.5 kb upstream of the gene promoter of the
human rDNA. Mouse rDNA does not have this repeat, but instead
contains the well known ‘enhancer repeat’ region. Why CTCF binds twice
in human and only once in mouse rDNA is unclear. One possibility is
that CTCF has additional regulatory functions in the human rDNA repeat.
For example, the H37.9 site is conserved in the rDNA of the great apes,
as is the highly repetitive Alu repeat [56]. We speculate that H37.9 might
be linked to the presence of this repetitive region in human and great
ape rDNAs. (D) Similar chromatin organization of mouse and human
rDNA repeat regions upstream of the gene promoter. The upper line
represents the mouse rDNA (enhancer repeats are indicated by the open
rectangles), and the lower line represents the human repeat. Only
regions upstream of the gene promoter are shown. Right-pointing
arrows indicate transcription from the gene promoter, giving rise to pre-
rRNA. The spacer promoter has been clearly identified for the mouse but
its location has not yet been mapped accurately for the human RNA.
The chromatin organization surrounding the CTCF binding site (indicated
by a lollipop) that is most proximal to the gene promoter, is strikingly
similar in both mouse and human. In both organisms, the CTCF binding
sites are embedded within a CpG island (as predicted with EMBOSS-CpG
Plot [57]; the length of the CpG domains is indicated below the
respective rDNAs). Immediately upstream of the CTCF binding site,
mouse rDNA chromatin is enriched in ‘active’ histone modifications. A
surprisingly similar result was previously obtained in the human locus
(see Figure 5, site H42 in the paper by Grandori et al. [36]). Furthermore,
TATA binding protein (TBP) has been shown to accumulate near the
CTCF binding site, both in human [36] and mouse [25] rDNA repeats. We
therefore propose that the spacer promoter in the human rDNA is
located immediately downstream of the H42.1 CTCF binding site.
Additional file 7: Figure S6: CCCTC binding factor (CTCF) and CTCFL
interact with human ribosomal (r)DNA in vivo. (A) Chromatin
immunoprecipitation (ChIP) analysis on human rDNA. ChIP analysis with
CTCF, CTCFL (two independent antibodies (Abs) were used) and UBF
antisera, showing binding to the IGS of the rDNA repeat (sites H4, H37.9
and H42.1). Chromatin was prepared from non-transfected K562 cells or
from cells stably transfected with CTCF (KCTCFD11) or the empty vector
(KpCDNA). Relative enrichment was quantified by real-time PCR with the
indicated primer sets. Known CTCF (MYC-N) and CTCFL (NY-ESO1) target
sites were used as positive control for ChIP. Data were normalized
against the enrichment for the negative control MYC-H.1. The value for
the amount of PCR product present from the ChIP assay without
antibody was set as 1 (white bars). Error bars represent the SEM of five
to seven independent experiments for CTCF, eight to 10 for upstream
binding factor (UBF), and four for CTCFL. (B) Sequential ChIP (ChIP-
reChiP) analysis on human rDNA. Primary ChIP was performed as above,
and CTCF or UBF ChIP products were subjected to a second
immunoprecipitation (reChIP) with anti-UBF or anti-CTCF antisera,
respectively. Relative enrichment was quantified by real-time PCR with
primers for H37.9 or H42.1 rDNA, and data were normalized as in part
(A). Error bars represent SEM of three independent experiments. Results
show in vivo binding of CTCF and UBF simultaneously at rDNA sites. (C)
CTCF interacts with human rDNA in vitro. Electrophoretic mobility shift
assay (EMSA) analysis with nuclear extracts from 293T cells or K562 cells
transfected with CTCF or mock transfected. 32P-labeled PCR fragments of
MYC-N (positive control), H42.1 rDNA and H37.9 rDNA were used as
probes. Unlabeled (cold) probes were used as competitors (Myc-N = 90%
competition (compare lanes 1 and 3); H42.1 = 95% competition
(compare lanes 5 and 7); H37.9 = 85% competition (compare lanes 11
and 13). Arrowheads indicate binding of CTCF; asterisks indicate
supershift bands that appear after incubation with anti-CTCF antibody.
Additional file 8: Figure S7: CCCTC binding factor (CTCF) binds
human ribosomal (r)DNA in a methylation-sensitive manner. (A)
Influence of methylation on the binding of CTCF to mouse rDNA. Band-
shifts were performed using the mouse rDNA probe (R30) and the same
probe methylated on two cytosine residues (R30-CmE). Competition was
assessed by adding increasing amounts of unlabeled probe. (B) Control
and SssI methyltransferase-treated H37.9 and H42.1 rDNA probes were
digested with the methylation-sensitive enzyme HpaII to assess the level
of in vitro methylation. Fragments were separated in 8% polyacrylamide
gels.
Additional file 9: Figure S8: Chromatin immunoprecipitation (ChIP)
analysis in embryonic stem (ES) cells. (A) Outline of mouse rDNA
repeat. The position of the primer pairs used in the ChIP in panel B is
indicated by downward-pointing arrows. Transcription initiation from the
spacer promoter (yielding ncRNA) and the gene promoter (yielding pre-
rRNA) is indicated by right-pointing arrows. The 47S pre-rRNA is divided
into 5’ and 3’ external transcribed spacer (ETS), internal transcribed
spacers (ITS), and 18S, 5.8S and 28S rRNA genes. The approximate
positions of the CCCTC binding factor (CTCF) consensus site (gray box)
and enhancer repeats (white boxes) are indicated. (B) ChIP assay on
mouse rDNA. Binding of CTCF (black), upstream binding factor (UBF)
(purple/blue) and RNA polymerase I (red) to mouse rDNA was analyzed
using the primer pairs indicated in part (A). Embryonic stem (ES) cells
were treated with control (straight lines) or Ctcf (stippled lines) RNAi
constructs. ES cell nuclei were fixed with 1% formaldehyde, and protein-
DNA complexes were immunoprecipitated with antibodies against the
indicated proteins. Upon depletion of CTCF, binding of both RNA Pol I
and UBF was diminished. Strikingly, for both proteins, loss in binding was
greatest near the CTCF binding site, strongly suggesting an important
role for CTCF in the binding of these proteins at or near the spacer
promoter (RNA Pol I, UBF) and on the enhancer repeat (UBF). The fact
that RNA Pol I binding was not affected at or downstream of the gene
promoter is consistent with previous data.
Additional file 10: Figure S9: CCCTC binding factor (CTCF) regulates
histone deposition. (A) Binding of histone H3 to mouse ribosomal (r)
DNA. Chromatin immunoprecipitation (ChIP) analysis is the same as
shown in Figure 6, but a lower y-axis scale is used to demonstrate the
histone H3 binding pattern. Enrichment was normalized to input and is
shown relative to the Amylase gene (note that in this case the Amylase
gene is not a negative control, because histone H3 will also bind this
gene, hence the ‘low’ relative enrichment). Histone H3 was distributed in
a similar manner in Cre-treated Ctcf f/f mouse embryonic fibroblasts
(MEFs) compared with non-treated cells. Interestingly, binding appeared
to diminish as the ribosomal gene promoter area is approached. This
might be due to the fact that active ribosomal genes contain fewer
nucleosomes [12]. (B) Binding of CTCF and H2A.Z to the c-Myc gene.
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ChIP analysis was performed as in Figure 6C, using the regulatory region
upstream of the c-Myc transcriptional start site (SD of three independent
experiments indicated). The position of the primer sets is indicated with
arrows. (C) Binding of modified and variant histones to human rDNA.
ChIP analysis was performed as in Figure S6A (see Additional file 7).
Chromatin was prepared from K562 cells. Protein-DNA complexes were
immunoprecipitated with antibodies against the indicated proteins. ChIP
analysis showed specific binding of H2A.Z, H3ac and H3K4me2 to sites
H37.9 and H42.1 of the rDNA.
Additional file 11: Figure S10: Spatial segregation of non-coding
(nc)RNA and pre-rRNA transcription. A, (B) DNA fluorescent in situ
hybridization (FISH) analysis. The ncRNA probe (biotin-labeled, green) was
hybridized to fixed and denatured ES cells. (A) Cell in prometaphase,
with chromosomes condensed but not yet aligned. The ncRNA probe
localized in distinct spots (arrows) adjacent to the strongly 4’,6-
diamidino-2-phenylindole (DAPI)-stained centromeric DNA. (B) An
interphase cell, with the ncRNA probe localized to the nucleolus
(visualized as weakly staining DAPI regions). Scale bars = (A) 2 μm, (B)
3 μm. (C-F) RNA FISH analysis. The ncRNA probe (biotin-labelled, green)
and pre-rRNA probe (digoxygenin-labeled, red) were hybridized to fixed
non-denatured ES cells. (C-E) Embryonic stem (ES) cells contain normal
levels of CCCTC binding factor (CTCF), whereas (F) ES cells transfected
with a pSUPER plasmid have CTCF knockdown. (C) Low resolution image
of a small ES cell colony (cells in the middle are less well visualized
because these cells grow in clumps). Multiple nuclei (one is outlined),
particularly on the edge of the colony, had readily detectable ncRNA and
pre-rRNA signals. Scale bar = 10 μm. (D) High resolution confocal image
of a single DAPI-stained ES cell nucleus. Both ncRNA and pre-rRNA
signals were localized exclusively to the three nucleoli present within this
cell. Five ncRNA spots are visible (arrows), localized at the periphery of
the nucleoli. Scale bar = 1 μm. (E, F) Confocal images taken with similar
settings. (E) non-treated ES cells; (F) CTCF RNAi-treated ES cells. The
ncRNA signal is indicated by arrows. Depletion of CTCF led to a
reduction in ncRNA. ncRNA was lacking in many cells throughout a 3D
confocal stack. In cells lacking ncRNA, pre-rRNA levels also seemed to be
affected (see asterisks). Scale bars (E, F) = 8 μm. (G) Knock-down of CTCF
in ES cells. ES cells were transfected with a pSUPER plasmid to knock
down CTCF. After 4 days, < 50% of the cells expressed detectable levels
of CTCF (red), as detected by immunofluorescent staining with anti-CTCF
antibodies. Nuclei were stained with 4’,6-diamidino-2-phenylindole
(DAPI). By contrast, cells treated with a control RNAi vector all expressed
CTCF (not shown). Scale bar = 8 μm.
Additional file 12: Table S2: Primers used for band-shift assays [58].
Additional file 13: Table S3: Primers used for genotyping.
Additional file 14: Table S4: Primers used for mouse chromatin
immunoprecipitation (ChIP).
Additional file 15: Table S5: Primers used for northern blotting and
nuclear run-on assays.
Additional file 16: Table S6: Primers used for real-time PCR on
embryonic stem (ES) cell ribosomal (r)RNA.
Additional file 17: Table S7: Primers used for human chromatin
immunoprecipitation (ChIP) and band-shift assays [59-61].
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Identif ied Protein
Molecular 
w eight 
(kDa)
Acc. Number Mascot 
Score*
Identif ied 
Peptides*
UBF 97 gi 136653 110, 85 2, 2
RNA pol I (RPA116) 116 gi 38614338 38 1
RNA pol I (RPA194) 194 gi 2330007 210, 294 6, 8
RNA pol I (RPA40) 40 gi 120538451 124 1
PAF49 49 gi 38602694 165, 213 4, 6
PAF53 53 gi 12328816 115, 108 2, 2
WDR5 36 gi 14250247 47 1
CTCF 80 gi 6681073 69, 102 2, 2
Supplemental Table S1. 
Mass spectrometry results for CTCF-bio
*When two numbers are listed the data are from two independent mass spectrometry 
experiments. Proteins listed above were not detected in the control samples (cells expressing 
BirA only)
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2
name sequence (5’ to 3’)
R30s
TGTATGGTTGATCGAGACCATTGTCGGGCGACACCTAG
TGGTGACAAGTTTCGGGAACGCTCCAGGCCTCT
R30as
AGAGGCCTGGAGCGTTCCCGAAACTTGTCACCACTAGG
TGTCGCCCGACAATGGTCTCGATCAACCATACA
R30mut-s
TGTATGGTTGATCGAGACCATTGTCGGGCAATACCTAG
TAGTGACAAGTTTCGGGAACGCTCCAGGCCTCT-3’
R30metss1)
TGTATGGTTGATCGAGACCATTGT[5Me-dC]GGG[5Me-
C]GACACCTAGTGGTGACAAGTTTCGGGAACGCTCCAG
GCCTCT
R30 metas1)
AGAGGCCTGGAGCGTTCCCGAAACTTGTCACCACTAGG
TGT[5Me-dC]GCC[5Me-
dC]GACAATGGTCTCGATCAACCATACA
F1 _F2)
CTAGATGAAGAAATTGAGACCTCTACTGGATAGCTATG
GTATTTACGTGTCTA
F1_B2)
AGCTTAGACACGTAAATACCATAGCTATCCAGTAGAGG
TCTCAATTTCTTCAT
name sequence (5’ to 3’)
Probe 1F TCCTGCCTCTGTCCAGTCAGAGA
Probe 1B GCAGATCACTGTGTGTTCAAGGC
Probe 2F CGAATGCCACCTTTGACTCTACC
Probe 2B AAGCCTCGTCCTTCCGAGCCT
Rosa26 F (265) GTGTAACTGTGGACAGAGGAG
Rosa26 F (266) GAACTTGATGTGTAGACCAGG
BirA_F (91) TTCAGACACTGCGTGACT
BirA_B (92) GGCTCCAATGACTATTTGC
CTCFGB1 AGCAAAAGCAAAACCAGGTTA
CTCFGF14 AGGAGCCAGATGCCGAGCCTG
Supplemental Table S2. Primers used for band-shifts
Supplemental Table S3. Primers used for genotyping
1) Ordered at Operon Biotechnologied, Germany
2) From the chicken lysozyme gene [58]
Genotyping yields fragments of 350 bp (Rosa26), 514 bp (BirA). 599 bp (Ctcfbio), and 549 bp 
(wild type allele).
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name sequence (5’ to 3’)
Enh4_F (APS1) -
4736 GTCACCATTCTGCACTTGCAA
Enh4_B (APS1) -
4584 ACATGTGCATGGCAGCCATCTTG
Enh5_F -3736 GTGTGTTTGTGCTCTATCTGCTG
Enh5_B -3641 CACTTATTCTCAGGAGCTGCATG
Enh6_F -3088 GTGAGTTCCAGGACTTACCAGAG
Enh6_B -2988 CTGTGTAGCCCTATCGGACTTG
Enh3_F -2561 CACTGCTTAGATGCTCCCTTCC
Enh3_B -2446 ATCGTTCTTGAAGTCAAAGTACGTC
Enh2_F (spacer 
prom.) -2087 AGGAGGCCGGGCAAGCA
Enh2_B (spacer 
prom.) -1975 CGTACAGCAACTCGGTCTGCT
Enh_F (enhancer 
repeat) -1882 CCTCCAGAAGCCCTCTCTTGTCCC
Enh_B (enhancer 
repeat) – 1779 CAGCTGGCCGAGCCACACCGG
Prom_UCE_F -162 AGTTGTTCCTTTGAGGTCCGGT
Prom_UCE_B -52 GAGACAGGGAGGAAAGTGACAG
ChIP1s ACCTCACTATGACCGGCTGAGATTC
ChIP1a CCACCCGTAATGAGATCTGATGTCC
ChIP2s ATGTGCCACCACTGCCCGGACTGA
ChIP2a CACCTTTAACCTTAGGCAAATTTTA
ChIP3s CACTGCTTAGATGCTCCCTTCC
ChIP3a CACTGCTTAGATGCTCCCTTCC
ChIP4s TGTTCGGGCGGGACGATG
ChIP4a AGGTGTCGCCCGACAATG
ChIP5s TGACAGGAGGCCGGGCAAGCA
ChIP5a GCGTACAGCAACTCGGTCTGCT
ChIP7s GTCACCCGGGGCGCTTGTACTTCTGAT
ChIP7a TCGTGTCCTCTAGGCCTCAGATGTAA
ChIP9s CCAAGTGTTCATGCCACGTG
ChIP10s GCGCAGCGTTTGCTCTCT
ChIP10a CACACAAGCCGAGCCACAT
Supplemental Table S4. Primers used for mouse ChIP
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2
name sequence (5’ to 3’)
ChIP11s GCTTGTCTCAAAGATTAAGCCATGC
ChIP11a TATTAGCTCTAGAATTACCACAGTT
ChIP12s CCGGCTTGCCCGATTTCCGCGGGT
ChIP12a GCCAGCAGGAACGAAACG
ChIP13s GTAACTATGACTCTCTTAAGGTAGCCA
ChIP13a CTTCACCGTGCCAGACTAGAG
ChIP14s TGGTTGCTGGGATTTGAACTC
ChIP14a CAGAGAAATACTGTCTCAGAAG
ChIP15s ACTTGCAAACCGGGCCACTAAA
ChIP15a TTCCTTGTTCTGTCACTCGGTTGC
amylase 99 CTCCTTGTACGGGTTGGT
amylase 100 AATGATGTGCACAGCTGAA
Myc_ChIP_1F 
(cMyc 1,5kb 
dow nstr prom.)
GCTCCTAAACCAGAGTCTGCTG
Myc_ChIP_1B 
(cMyc 1,5kb 
dow nstr prom.)
CATACACCTCCACACAGTTCCAG
Myc_ChIP_2F 
(cMyc promoter) TGACTCGCTGTAGTAATTCCAGC
Myc_ChIP_2B 
(cMyc promoter) TCTCACTCCAGAGCTGCCTTC
Myc_5’INS_F 
(cMyc insulator) CAGAACCTGGAAACCCTGCAG
Myc_5’INS_B 
(cMyc insulator) GTTGTGGCTCTCGGATTTGTG
3’HS1_529_F 
(3’HS1) AATCAGTGGAACACTTCTGC
3’HS1_530_B 
(3’HS1) GTCTCAGGTTGTCAACTAAAGC
80
12
name sequence (5’ to 3’)
5’ETS_F GTTCCTATTGGACCTGGAGA
5’ETS_B CGGTTGGAATGGTGGAGCCA
GAPDH_F TGAACGGGAAGCTCACTGG
GAPDH_B TCCACCACCCTGTTGCTGTA
rDNAprom_F - 
161 GTTGTCAGGGTCGACCAGTTGT
IGS_F_B +129 GACAGCTTCAGGCACCGC
IGSB_F -2140 CAGGTTGGTGACACAGGAGAG
Enh_B - 1779 CAGCTGGCCGAGCCACACCGG
Actin-exon5-F ATCATGTTTGACACCTTCAACACC
Actin-exon5-B GAACCGCTCGTTGCCAATAGT
Histone H3i-F AAGCAGCTGGCCACCAAG
Histone H3i-B CTCCTGCAGAGCCATGACG
Northern blot
Run-on : promoter probe (290 bp; 129bp overlap transcript)
Run-on: spacer promoter probe (361bp; 219bp overlap transcript)
Run-on: actin and histone H3 probes
name sequence (5’ to 3’)
ncrRNA2s 
(ChIP7s) GTCACCCGGGGCGCTTGTACTTCTGAT
ncrRNA2a 
(ChIP7a) TCGTGTCCTCTAGGCCTCAGATGTAA
ncrRNA1s
(IGSB_F -2140)
ncrRNA1a
(Enh_B - 1779)
45S forw ard GACACGCTGTCCTTTCCCTA
45S reverse AGGCTGGACAAGCAAAACAG
CAGGTTGGTGACACAGGAGAG
CAGCTGGCCGAGCCACACCGG
Supplemental Table S5. Primers used for northern blot
and nuclear run-on
Supplemental Table S6. Primers used for real-time PCR 
on ES cell rRNA
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Supplemental Table S7. Primers used for human ChIP 
and band-shifts
1) See ref [59]
2) See ref [60]
3) See ref [61]
4) For the position of the CTCF binding sites H37.9 and H42.1 in the IGS of the human rDNA 
repeat, see Figure S5 (additional File 6).
5) See ref [15]
Name Sequence Human rDNA 
coordinate site
MYC-N_F1) ACAAGGAGGTGGCTGGAAAC
MYC-N_B TTCCCCTCCTGGCTTTTAGT
MYC-H.1_F2) CAACGCAACACAGGATATGG
MYC_H.1_B TTCCCCTCCTGGCTTTTAGT
NY-ESO1_F3) ACCCGCAACCCACCCCACAC
NY-ESO1_B GGGGCAGGCCTCTAACTGGG
H42.1 rDNA_F4) GCTTCTCGACTCACGGTTTC 42012-42031
H42.1 rDNA_B CCGAGAGCACGATCTCAAA 42117-42135
H37.9 rDNA_F4) CCCTGGTCGATTAGTTGTGG 37818-37837
H37.9 rDNA_B GTGCTCCCTTCCTCTGTGAG 37997-38016
H4 rDNA_F5) CGACGACCCATTCGAACGTCT 3990-4010
H4 rDNA B CTCTCCGGAATCGAACCCTGA 4072-4092
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Abstract
The multifunctional and highly conserved chromatin organizer CTCF binds 
25,000-50,000 sites in mouse and human genomes using its eleven zinc finger (ZF) 
domain. To determine how the different ZFs of CTCF contribute to binding specificity and 
how this relates to cellular function, we replaced the endogenous CTCF gene in mouse 
embryonic stem (ES) cells with wild type GFP-CTCF and with mutants in which individual 
ZF domains were deleted. We find that ZF1, and ZF8-11 of CTCF are not required for ES 
cell viability. Fluorescence-based microscopy studies reveal that more than a million 
immobile GFP-CTCF molecules are present in an ES cell nucleus. Compared to wild 
type protein GFP-CTCF-∆1, and 8 are relatively mobile. Interestingly, ES cells expressing 
GFP-CTCF-∆1 and -∆8 grow less fast, revealing a link between defective dynamic 
behavior of mutant CTCF proteins and aberrant cell growth. Based on ChIP-Sequencing 
analysis of GFP-CTCF- and GFP-CTCF-ZF-mutant-expressing ES cells we propose that 
ZF1-3 bind nine contiguous nucleotides immediately downstream of the CTCF core 
motif bound by ZF4-7, and that ZF8-11 are required for binding a spacer sequence and 
upstream motif. CTCF binding sites containing the upstream motif are specifically 
depleted from transcription start sites and exons, and are associated with the repressive 
chromatin mark H3K9me3. These sites are less well bound by GFP-CTCF-∆8-11. Genes 
in the vicinity of affected CTCF binding sites can show altered expression. Combined 
our data suggest that CTCF organizes chromatin at two distinct levels: 1) the protein 
binds DNA throughout the genome to regulate nuclear processes essential for ES cell 
growth and proliferation. 2) CTCF also binds conserved CTCF target sites near genes 
to regulate transcription locally, but its position to the TSS is independent on effects on 
transcription. Additionally, CTCF does not act as a classic transcription factor, but rather 
makes chromatin near genes (in)accessible i.e. by mediating long-range interactions. 
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Introduction
Eukaryotic genomes are tightly organized in order to maintain proper transcriptional 
regulation in a cell type-specific and developmental fashion (Misteli, 2007). Chromatin is arranged 
into dynamic higher-order structures, which can localize to various subnuclear compartments 
that affect genome configuration and consequently transcription (Brown et al., 2008; Capelson et 
al., 2010; Guelen et al., 2008; Nemeth et al., 2010; Peric-Hupkes et al., 2010; van Koningsbruggen et al., 2010). 
Regulatory regions are marked by specific chromatin features and combined through long-
range interaction to influence transcription. Long-range interactions can also separate domains 
to establish independent transcription regulation in each individual domain (Dixon et al., 2012; 
Handoko et al., 2011; Sanyal et al., 2012).
One of the key players in chromatin structure and spatial organization is CTCF (for 
review, see (Phillips and Corces, 2009)). CTCF is characterized by an eleven zinc finger (ZF) 
domain that is surrounded by N- and C-terminal regions, which do not contain any conspicuous 
motif, except for an AT-hook motif (Ohlsson et al., 2001). CTCF is a highly conserved ubiquitously 
expressed nuclear protein (Heger et al., 2012; Heger et al., 2009; Moon et al., 2005; Pugacheva et al., 2006), 
which is essential for cell viability (Fedoriw et al., 2004; Heath et al., 2008; Moore et al., 2012). CTCF has 
been identified in independent studies as a transcriptional repressor (Baniahmad et al., 1990; Klenova 
et al., 1993; Lobanenkov et al., 1990) and as well as transcriptional activator (Quitschke et al., 1996; Vostrov 
and Quitschke, 1997). The protein has since been implicated in many other cellular processes, 
including the regulation of genomic imprinting to maintain mono-allelic gene expression. 
Additionally, CTCF is often located at transitions of distinct chromatin states where it appears 
to act as a boundary element that prevents spreading of distinct chromatin signatures across 
the genome (Barski et al., 2007; Cuddapah et al., 2009). It also organizes chromatin by binding to the 
borders of topological domains and mediating long-range interactions within subdomains (Dixon 
et al., 2012; Guo et al., 2011; Phillips-Cremins et al., 2013; Splinter et al., 2006; Tolhuis et al., 2002; Zuin J, Submitted). 
CTCF mediates its function via protein-DNA, protein-protein, and protein-RNA 
interactions (Ohlsson et al., 2001; Phillips and Corces, 2009; Sun et al., 2013). CTCF binds to DNA via its ZF 
domain, and genome-wide studies reveal that it can bind approximately 25,000-50,000 sites in 
human and mouse genomes (Boyle et al., 2011; Kim et al., 2007; Ohlsson et al., 2001; Rhee and Pugh, 2011). 
Initial genome-wide study in IMR90 human fibroblasts using ChIP-on-chip revealed that 46% 
of the CTCF binding sites are located in intergenic regions, 20% within 2.5 kb of transcription 
start sites, 22% in introns and 12% in exons (Kim et al., 2007). An independent study in human 
CD4+ T cells using ChIP-Seq, which has been reanalyzed, identified a similar distribution in 
which CTCF binds in 45% in intergenic region, 7% in 5’ UTR, 3% in exons, 29% in introns, 
2% in 3’UTR, and 13% within 5 kb of the transcription start site (Barski et al., 2007; Xie et al., 2007). 
About 80% of all CTCF binding sites harbor a 20 base pair (bp) motif that contains a subset of 
highly conserved nucleotides and are contacted by ZFs of CTCF (Boyle et al., 2011; Chen et al., 2008; 
Kim et al., 2007; Nakahashi et al., 2013; Rhee and Pugh, 2011; Schmidt et al., 2012; Xie et al., 2007). Additionally, 
about 15-30% of the CTCF binding sites contain another motif of ~9 nucleotides (nt), which 
is upstream of the canonical CTCF motif and which is separated from the core motif by a 
spacer of 5-6 nt (Boyle et al., 2011; Nakahashi et al., 2013; Rhee and Pugh, 2011; Schmidt et al., 2012). The 
upstream and core motif together are called either bipartite motif or upstream and core (UC) 
motif. Recently, a 10 bp motif downstream of the CTCF core motif was discovered in a small 
subset of all CTCF sites (Nakahashi et al., 2013). This motif is not bound by CTCF itself, but by a 
factor that might compete with CTCF.
The binding orientation of CTCF to its motifs is ‘inverted’, with the N- and C-terminal 
ZFs binding to the 3’ and 5’end of the motif, respectively (Nakahashi et al., 2013; Renda et al., 2007). 
Initial in vitro experiments revealed that subsets of ZF were needed to establish DNA binding 
(Burcin et al., 1997; Filippova et al., 1996; Quitschke et al., 2000). This is in line with in vivo data that indicate 
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that CTCF binds its different motifs using groups of adjacent ZFs (Nakahashi et al., 2013). Both 
approaches identified ZFs 4-7 as the most essential ZFs to establish CTCF binding (Nakahashi 
et al., 2013; Renda et al., 2007). The peripheral ZFs would contribute to binding affinity and are 
required for stabilizing CTCF binding to its target sites (Quitschke et al., 2000; Renda et al., 2007). 
It is not known how each ZF contributes to CTCF’s function. To address this question 
we generated CTCF mutants with deletions of individual ZFs and expressed these in ES cells 
lacking endogenous CTCF. We find that mutants with individual deletions of ZF 1, 8, 9, 10, 
and 11 are able to substitute for wild type CTCF. Genome-wide binding profiles reveal the 
full CTCF binding motif and suggest that ZF1 binds to nucleotides downstream of the core 
consensus, whereas ZF8-11 are important for binding the 9 bp motif upstream. Our data 
also show that CTCF sites containing a bipartite motif are virtually absent from transcription 
start sites and more often localized to intronic and intergenic regions and are associated with 
repressive chromatin mark H3K9me3. We propose that CTCF regulates transcription locally, 
but this regulation is independent of the position of CTCF to the TSS. Additionally, CTCF does 
not act as a classic transcription factor, but rather makes chromatin near genes (in)accessible 
by mediating long-range interactions. 
Results 
Generation of ES cells expressing GFP-tagged CTCF mutants
In order to determine which ZFs are important for CTCF function and which specific 
nucleotides are bound by each ZF, we generated cDNAs encoding CTCF with mutations in 
individual CTCF ZFs (Figure 1A, B and Table S1). To express these ZF mutants in a Ctcf-
negative background, we isolated embryonic stem (ES) cells from Ctcf floxed mice (Ctcflox/lox, 
see (Heath et al., 2008)), and removed the neomycin resistance cassette at the 5’ end of the Ctcflox 
allele using Cre recombinase, thereby generating Ctcfdelneo/delneo ES cells (Figure S1A). This 
genotype will be further referred to as wild type (WT). We then substituted the endogenous 
Ctcf gene with GFP-tagged wild type CTCF (referred to as GFP-CTCF) or with CTCF mutants 
carrying individual ZF deletions (referred to as GFP-CTCF-ZF or GFP-CTCF-∆ZF), by infecting 
ES cells with lentiviral vectors expressing either wild type or mutant GFP-CTCF driven by a 
CAG promoter (CMV early enhancer/chicken beta actin) in combination with Ires-driven Cre 
recombinase (Figure 1C, (Sleutels et al., 2012)).
Deletion of Ctcf results in lethality, both in mice (Heath et al., 2008) and in ES cells (Sleutels 
et al., 2012). Rescue of knock out ES cells from this fate requires exogenous expression of a 
functional CTCF (fusion) protein to support ES cell growth and proliferation. After lentiviral 
infection, clones that were both GFP-positive and neomycin-resistant were picked. Genotyping 
of each clone by southern blot analysis of Hind III-digested DNA (Figure 1D and S1B) revealed 
which clones had a deletion of both Ctcfdelneo alleles, of only one allele or of neither of the 
endogenous alleles. One clone of each mutant ES cell line with a homozygous deletion 
was further analyzed by DNA-, RNA-Sequencing (Figure S1C and S2) and further assays. 
In addition to the individual ZF deletions, we found one (silent) mutation (GA) at position 
1476, counted from the A of the ATG of the CTCF cDNA sequence, in GFP-CTCF-∆8 (data 
not shown). We did not obtain any ES cell clone expressing mutants with individual deletion 
of GFP-CTCF-∆2-6 in a Ctcflox/lox background, indicating that each of these ZFs is essential 
for the function of CTCF. We could, however, replace endogenous CTCF with wild type GFP-
tagged CTCF (see also (Sleutels et al., 2012)), as well as with GFP-CTCF-∆1, GFP-CTCF-∆8, 
GFP-CTCF-∆9, GFP-CTCF-∆10 and GFP-CTCF-∆11 (Figure S1C). Thus, these 5 ZFs are not 
absolutely essential for ES cell viability.
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In order to examine the expression of GFP-CTCF-ZF mutants we performed a western 
blot analysis. Endogenous CTCF was only detected in WT ES cells, whereas in mutant cell 
lines expression of the respective GFP-CTCF(-ZF) fusion proteins was detected (Figure 1E). 
Interestingly, mutants were expressed without major differences as endogenous CTCF, both at 
the protein level (Figure 1E), as well as at the RNA level (Figure S1D, see also Table S2), as 
determined by RNA-sequencing.
Rescued ES cells retained the expression of the pluripotency markers Pou5f1, Nanog, 
Sox2 and Alpl (alkaline phosphatase) (Table S2, and data not shown). We next examined 
their proliferation capacity. GFP-CTCF-expressing cells proliferated like WT ES cells (Figure 
1F), indicating that the addition of the GFP tag to the N-terminus of CTCF does not grossly 
affect the function of the protein. Strikingly, ES cells expressing mutant GFP-CTCF-ZF proteins 
proliferated less efficiently compared to WT and GFP-CTCF-expressing cells (Figure 1F). 
Thus, while ZFs 1, and 8-11 are not essential for ES cell viability, they are required for optimal 
ES cell growth. Interestingly, GFP-CTCF-∆9, GFP-CTCF-∆10 and GFP-CTCF-∆11 were only 
moderately affected in their growth capacity, while GFP-CTCF-∆1 and GFP-CTCF-∆8 were 
severely affected (Figure 1F). These data suggest that individual ZFs have distinct contributions 
to CTCF functionality.
To link defects in ES cell growth to deregulated gene expression we performed RNA-
Sequencing on each cell line. Genes with a significant change in expression (p<0.05) in at 
least one of the ZF mutant-expressing ES cells compared to GFP-CTCF were clustered 
and data was plotted in a Venn diagram (Figure 1G). This analysis revealed 135 commonly 
deregulated genes and many more uniquely deregulated genes in ES cells expressing mutant 
CTCF proteins (Figure 1G). Of all mutant ES cells, those expressing GFP-CTCF-∆1 and GFP-
CTCF-∆8 had the highest number of deregulated genes, 1685 and 1729, respectively (Figure 
1H). Except for GFP-CTCF-∆11, all other deletions showed a nice correlation between the 
number of affected genes and the inhibition of proliferation.
GFP-CTCF-ZF mutants with a high impact on gene regulation are highly 
mobile
To examine the properties and dynamic behavior of wild type and mutant GFP-CTCF 
in ES cells, we performed time-lapse imaging experiments, including fluorescence recovery 
after photobleaching (FRAP). Consistent with published studies in fixed cells using antibodies 
against CTCF (Sleutels et al., 2012; van de Nobelen et al., 2010), GFP-CTCF was detected in a speckled 
pattern throughout the interphase nucleus of ES cells (Figure 2A). 
Figure 1. Generation and characterization of CTCF mutant ES cell lines
(A) Schematic representation of zinc fingers (ZF) 1, 7 and 11 and the amino acid sequence, which have been deleted. 
Red strips mark the points that are fused to each other after deletion. Amino acid sequences of all zinc fingers are 
shown in Table S1.
(B) Schematic representation of the CTCF protein structure and the individual ZF deletions (∆).
(C) Lentiviral constructs used for ES cell rescue experiments. GFP is fused to the N-terminus of CTCF (GFP-CTCF) 
or CTCF with an individual ZF deletion (GFP-CTCF-ZF). Green arrows show where translation starts. Cre: cre 
recombinase, neo: neomycin.
(D) Southern blot analysis of Ctcfdelneo (WT) and Ctcfdel genotypes in GFP-CTCF-Δ8- and GFP-CTCF-Δ9-expressing 
ES cell lines.
(E) Western blot analysis of WT and rescued ES cell lines, expressing GFP-CTCF, GFP-CTCF-Δ8, GFP-CTCF-Δ9, 
GFP-CTCF-Δ10, GFP-CTCF-Δ11 and GFP-CTCF-Δ1. Blots were incubated with rabbit polyclonal CTCF (upper panel) 
and GFP (middle panel) antibodies to detect (GFP-tagged) CTCF, and with mouse p150glued antibody (lower panel) as 
loading control. The 150 kDa band is represented as 150.
(F) Proliferation assay of WT and mutant ES cell lines. Cells were seeded at time 0hr with 100000 cells and were 
counted every 48 hours. Y-axis represents the number of cells (x 105), hr: hours. Data are presented ± SEM, N=3
(G-H) Venn diagram and table displaying the number of significantly deregulated genes in ES cells expressing the 
indicated ZF mutants. Venn diagram shows number of unique and overlapping deregulated genes in each mutant.
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Although fluorescence intensity varied per cell and over time, it did not fluctuate greatly 
(Figure 2B). We used a purified protein (i.e. GFP-EB3, a GFP tagged microtubule associated 
protein) to generate a standard curve of soluble GFP fluorescence versus concentration 
(Figure 2C). Using this curve we estimated that on average the concentration of GFP-CTCF in 
ES cells is ~3 µM (Figure 2C). Given a nuclear volume of 1 picolitre in an ellipsoid nucleus of 
10x5x5 micrometers, these data suggest that ~2 million molecules of GFP-CTCF are present 
inside an ES cell nucleus.
We next performed FRAP experiments on GFP-CTCF- and GFP-CTCF-ZF-expressing 
ES cells. In order to prevent excessive bleaching of highly mobile GFP-CTCF molecules, we 
bleached small circular regions of interest (ROIs) in the nucleus of ES cells for a limited period 
of time (Figure 2D). However, ES cell nuclei are mobile within the time scale of the experiment 
(data not shown). Nuclear movement combined with small ROIs caused inaccuracies in recovery 
curves at later time points. We therefore used two FRAP regimes. To obtain an accurate view 
of the mobility of GFP-CTCF molecules we measured recoveries for 2 minutes, using image 
acquisition times of 2 seconds (Figure 2E). To observe the dynamic behavior of GFP-CTCF 
and selected mutants for longer times, we performed FRAP experiments for 10 minutes, 
using image acquisition times of 5 seconds (Figure 2F). Both regimes gave similar results 
and showed that the vast majority of GFP-CTCF molecules is relatively immobile, recovering 
to 50% of the initial fluorescence in ~5 minutes (Figure 2E, G). Taken together these results 
indicate that GFP-CTCF distributes over the complete genome and that at least half of the ~2 
million molecules of GFP-CTCF in an ES cell nucleus are bound to DNA.
The recovery kinetics of the GFP-CTCF-ZF mutants was different from GFP-CTCF. 
GFP-CTCF-∆9, GFP-CTCF-∆10 and GFP-CTCF-∆11 recovered slightly faster than GFP-
CTCF, whereas GFP-CTCF-∆1 and GFP-CTCF-∆8, the two mutants with a reduced ES cell 
growth rate, recovered much faster (Figure 2E, F). These data show that the strong increase 
in mobility of GFP-CTCF-∆1 or GFP-CTCF-∆8 correlates with a high number of deregulated 
genes.
 Time-lapse movies revealed that GFP-CTCF remains bound to mitotic chromosomes 
(Figure 2H) although its fluorescence intensity on metaphase chromosomes is decreased 
(Figure 2I). We estimate that ~10-fold fewer molecules are bound to metaphase chromosomes 
compared to interphase chromatin. Interestingly, upon completion of cytokinesis the pool of 
cytoplasmic CTCF is rapidly transported into the nucleus, presumably to establish proper 
CTCF-chromatin interactions at the beginning of G1 (Figure 2H, I). Because nuclei are smaller 
after mitosis, they appear brighter due to a higher CTCF concentration. We conclude that CTCF 
remains bound to chromatin during the complete cell cycle but that the number of molecules 
bound to DNA can differ depending on the stage of the cell cycle.
Figure 2. High mobility in GFP-CTCF-∆1 and -∆8 
(A) Images of GFP-CTCF-expressing ES cell clones showing that GFP-CTCF is located in the nucleus.
(B) Average fluorescence intensity (F.I.) of GFP-CTCF in ES cell nuclei. Data are presented ± SD, N=18 cells.
(C) Plot of the F.I. of purified GFP-EB3 versus its concentration. Data are presented ± SD, N=4. Red line represents 
F.I. and estimated concentration of GFP-CTCF.
(D) Images of GFP-CTCF-expressing ES cells used for FRAP experiment. Cells are shown before (Pre-Bleach, upper 
panel), immediately after (Bleach, middle panel) and at the end of the FRAP experiment (Post-Bleach, lower panel). 
White circles indicate bleached ROIs.
(E-G) FRAP analysis of GFP-CTCF- and GFP-CTCF-ZF-mutant-expressing ES cells. FRAP experiments were done 
for 2 minutes with image acquisition times of 2 seconds (E), and for 10 minutes with image acquisition times of 5 
seconds (F). Fluorescence recoveries were corrected for background and normalized, and then again corrected for 
fluorescence intensity variations, both in non-bleached cells as well in non-bleached ROIs in the bleached cells. Table 
displays the times after bleaching at which 50% of the signal was observed (G).
(H-I) GFP-CTCF- behavior during mitosis. In panel (H) still images are shown of a time-lapse movie in which two GFP-
CTCF-expressing cells go through mitosis. Arrows point to segregating chromosomes after mitosis. Panel (I) displays 
FI of chromosomes over time (cell 1, blue, cell 2, red).
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GFP-CTCF-∆8-11 specifically loose binding to the upstream consensus 
site and differ from GFP-CTCF-∆1
To determine the DNA binding specificity of CTCF ZF mutants we performed ChIP-
Sequencing (ChIP-Seq) on the different ES cell lines using antibodies against CTCF. We 
discovered ~22,000 CTCF target sites, defined as a peak region with a p<0.05 overlap with 
a predicted core consensus motif, in ES cells expressing GFP-CTCF. ChIP-Seq data was 
validated by ChIP-qPCR (data not shown). To detect specific patterns in the binding of ZF 
mutants we selected sites with a log2-fold binding change larger than 2 in at least one of the ZF 
mutants compared to GFP-CTCF and applied k-means cluster analysis. K-means clustering 
allowed us to distinguish 6 different groups (Figure 3A). Interestingly, many more sites showed 
reduced binding as opposed to increased binding of mutant CTCF (Figure 3A), and reduced 
binding was more pronounced than increased binding (Figure 3A, B). These results suggest 
that ZF1 and 8-11 are required for optimal DNA binding by full length CTCF.
Binding of GFP-CTCF-∆1 was clearly different from that of the other mutants, as 
this mutant was least affected in the total number of binding sites and clustered in a distinct 
manner (Figure 3A, B). In contrast, GFP-CTCF-∆8-11 clustered together, with GFP-CTCF-∆8 
and GFP-CTCF-∆9 being affected at more sites than GFP-CTCF-∆10 and GFP-CTCF-∆11. 
Together, these data suggest that ZF 1 and ZF 8-11 contribute in distinct ways to the binding of 
CTCF. In addition, while nuclear mobility of the different ZF mutants is linked to proliferation of 
ES cells, DNA binding is not. For example, the GFP-CTCF-∆1-expressing ES cell line is most 
affected in its growth but GFP-CTCF-∆1 is least reduced in DNA binding. Furthermore, in the 
FRAP studies GFP-CTCF-∆8 was the most mobile mutant protein, with ~70% of the molecules 
recovering within 2-3 minutes, whereas GFP-CTCF-∆9 behaved more like GFP-CTCF. By 
contrast, in the ChIP-Seq analysis these two mutants are comparably poor in terms of DNA 
binding. This suggests that ZF 8 is involved in additional, e.g. mediation of protein interactions, 
functions of CTCF compared to ZF 9.
 Binding defects in CTCF ZF mutants could be due to a failure to recognize specific 
nucleotides within the conserved CTCF binding sites. To examine this we performed a motif 
analysis on the 6 clusters defined above - thus, we analyzed sequences that were not bound 
by a particular mutant ZF protein (Figure S3). Additionally, we performed a motif analysis on 
the GFP-CTCF dataset as control by gathering random CTCF binding sites. We found that 
each cluster contained the ~20 bp core CTCF motif, which was previously identified (Boyle et al., 
2011; Chen et al., 2008; Kim et al., 2007; Nakahashi et al., 2013; Rhee and Pugh, 2011; Schmidt et al., 2012; Xie et 
al., 2007). Binding sites affected in clusters 1, 3, 4 and 6 (i.e. sites to which ZF 8-11 bound less 
efficiently) contained a small motif ~8 nt upstream of the CTCF core, suggesting that ZFs 8-11 
are required for binding these nucleotides. This upstream motif is smaller in cluster 5, which 
contained sites that were affected in all zinc finger mutants. We also noted the presence of 4 
cytosines (at positions 42-45) in cluster 6 (Figure S3), which contains sites that are bound less 
efficiently by ZFs 8-11. These data suggest that defective binding by ZFs 8-11 can affect binding 
downstream of the core domain. In cluster 2 (i.e. sites to which ZF 1 binds less efficiently) 
we did not observe the upstream signature; instead a cytosine ~10 nt downstream of to the 
Figure 3. GFP-CTCF-∆8-11 are specifically impaired in UC motif binding
(A) Heatmap of a k-means clustering of sites with at least 4 fold absolute change in at least one condition. Clustering 
reveals 6 subgroups. Scale represents log2 fold binding change between GFP-CTCF and GFP-CTCF-ZF mutant.
(B) Binding within the subgroups of GFP-CTCF-ZF mutants compared to GFP-CTCF. #N represents the number of 
affected binding sites within each cluster. 
(C) Motif analysis of DNA binding by GFP-CTCF-ZF mutants. Sites with at least 4 fold reduction in each GFP-CTCF ZF 
mutant dataset and random sites in the GFP-CTCF dataset were taken along in the analysis. An upstream and core 
motif are visible in the GFP-CTCF-∆8-11 mutants. Additionally, downstream of the core motif nucleotides are visible 
that indicate the 3’end border of the full CTCF binding motif in the GFP-CTCF-∆1 mutant. Red, green, yellow and blue 
represent T, A, G, and C nucleotides, respectively.
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CTCF core motif, and a less prominent guanine showed up (positions 44 and 41, respectively) 
(Figure S3).
 To understand how individual ZFs contribute to the recognition of CTCF binding sites 
we generated ZF mutant-specific motifs by applying motif analysis to sites that showed at least 
4-fold reduction in the binding of a particular ZF mutant. Additionally, we performed a motif 
analysis on the GFP-CTCF dataset as control by gathering random CTCF binding sites. Again, 
all affected binding sites in each ZF mutant contained the core CTCF motif (Figure 3C). In 
addition, GFP-CTCF-∆1-affected sites contained a prominent cytosine at position 44, as well 
as additional nucleotides between the core motif and position 44 (positions 37, 39, 41 and 43), 
indicating the binding signature of ZF 1 and possible ZF 2 and ZF 3 (Figure 3C). Sites that 
were not bound by GFP-CTCF-∆8-11 again contained the upstream motif. Furthermore, we 
noticed four cytosines at positions 42-45 in sites defective in binding of ZF mutants 9-11, most 
prominently in GFP-CTCF-∆10 and 11. Together these data reveal three closely positioned 
regions important for CTCF binding: the core and upstream motifs, which have been described 
before (Boyle et al., 2011; Chen et al., 2008; Kim et al., 2007; Nakahashi et al., 2013; Rhee and Pugh, 2011; Schmidt et 
al., 2012; Xie et al., 2007), and a novel region downstream of the core. Similar to another publication 
(Nakahashi et al., 2013), our data suggest that ZF 9-11 are important for binding the upstream motif. 
In addition, we find that ZF 8 is also required for binding this region. By contrast, ZF 1 appears 
to mainly recognize a cytosine located 10 nt downstream of the core domain (at position 44 in 
Figure 3C). ZFs 1-3 might actually bind CTCF target sites as a module, since deletion of ZF 
1 coincides with the appearance of other nucleotides between position 44 and the core motif. 
Finally, in clusters deficient in binding of ZFs 9-11 nucleotides downstream of the core domain 
appear. Although these nucleotides are less prominent than the upstream motif, they coincide 
exactly with the domain defective in ZF 1 binding. These data indicate that binding of ZFs 9-11 
affects binding downstream of the core, indicating that there is an interplay between ZFs to 
establish DNA binding upstream and downstream of the core motif. Combined our data reveal 
the complete binding motif of CTCF involving all ZFs. 
We next plotted for each ZF deletion the fold change in binding to all 22,000 CTCF 
target sites as compared to those 2718 sites with the core and upstream motif at -18bp (UC) 
(Nakahashi et al., 2013; Schmidt et al., 2012). An obvious relation appeared: ZF8-11 showed strongly 
reduced binding to these sites whereas ZF1 did not (Figure S4). Thus not only did we identify 
the UC sites among the sites with strongly reduced binding by ZF8-11, but also virtually all UC 
containing CTCF target sites show decreased binding of ZF8-11.
CTCF UC sites show reduced binding for GFP-CTCF-∆8-11, are depleted 
from TSS and show heterochromatic features
To explore the genomic distribution of affected sites we plotted their location with 
respect to transcription start sites, genes and intergenic regions, and compared this to all 
CTCF target sites in the GFP-CTCF dataset (Figure 4A, B). We found that sites to which all 
mutant proteins bound less efficiently were less often located in exons, and sites affected in 
ES cells expressing GFP-CTCF-∆8-11 were found less frequently at TSSs compared to the 
relative frequency observed in GFP-CTCF. We next examined the genomic location of CTCF 
binding sites containing the UC motif and compared them to all CTCF target sites. This also 
revealed a specific depletion of UC containing sites at TSSs and in exons (Figure 4C, D). We 
therefore conclude that GFP-CTCF-∆8-11 are required to bind UC CTCF target sites efficiently 
and that these sites are relatively rare in exons and at TSSs.
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Figure 4. Reduced binding of ZF mutants 8-11 to UC motif, which is depleted from TSS
(A-B) Comparison of the genomic distribution of binding sites. Binding locations are separated into upstream of 
transcription start site (Upstream TSS), transcription start site (TSS), exon, intron, intergenic, and transcription end 
site (TES), and plotted as frequencies of total (Y-axis). The contribution of binding sites belonging to each location 
class to total number of binding sites is plotted in (A). The distribution of all CTCF binding sites over the different 
location classes is plotted (left), as well as the percentage of annotated locations on the entire genome (Genome). 
The middle histograms in (A) represent the distribution of sites that show a more than 4 fold absolute binding change 
in the respective mutant proteins. Actual differences between binding frequencies observed in GFP-CTCF-ZF mutant 
compared to GFP-CTCF are plotted in (B). Relative binding is plotted as log2 fold change (Y-axis). Thus, compared to 
all CTCF binding sites, the sites that are not bound by GFP-CTCF-∆8-11 are less present in TSSs and exons.
(C-D) Distribution of genomic features for all CTCF binding sites and UC-containing CTCF binding sites. In (C) binding 
locations are depicted as in (A). In (D) all CTCF binding sites and UC-containing CTCF binding sites are plotted with 
respect to distance to the nearest TSS. ZF mutant 8-11-sensitive binding sites show preference for genic regions.
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We used published ChIP-Seq datasets (H3: (Mullen et al., 2011), H3.3: (Goldberg et al., 2010), 
H3K27ac: (Creyghton et al., 2010), H3K27me3: (Rugg-Gunn et al., 2010), H3K36me3: (Mikkelsen et al., 
2007), H3K9me3: (Mikkelsen et al., 2007), OCT4: (Chen et al., 2008), Pol II-ser5P: (Kagey et al., 2010), 
SMC1: (Kagey et al., 2010) and CTCFL: (Sleutels et al., 2012)) to compare CTCF binding sites sorted for 
the two subsets (i.e. all CTCF sites and CTCF sites containing the UC motif) and plotted these 
in an area of -20 kb to +20 kb relative to the center of the peak, with specific chromatin marks 
and transcription factors (Figure 5). This revealed that UC motif sites were reduced in H3.3 
and H3K27me3 occupancy, and virtually depleted of H3K27ac and H3K4me3. Interestingly, 
a substantial enrichment for the chromatin mark H3K9me3, which is often associated with 
constitutively repressed genes, was observed in UC motif containing CTCF sites. Consistent 
with the relative absence of UC motif sites from TSSs, RNA polymerase II was highly reduced 
at these sites. Pluripotency factor OCT4, cohesin subunit SMC1 and CTCFL profiles revealed 
a small reduction in binding. Thus, UC motif sites, which are specifically affected in CTCF 
binding in ES cells expressing GFP-CTCF-∆8-11, are less often found at TSSs and in exons 
and preferentially associate with a mark for repressive chromatin.
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Figure 5. CTCF bound to UC sites shows heterochromatic features
Cumulative average profiles of all CTCF (black) and upstream core (UC) motif (red) containing binding sites with 
respect to chromatin context. Average binding was determined in 20 kb intervals around binding sites. We used 
published ChIP-sequencing data sets in mouse embryonic stem cells for CTCF, H3, H3.3, H3K27Ac, H3K27me3, 
H3K36me3, H3K4me3, H3K9me3, RNA polymerase II, SMC1, OCT4, and CTCFL.
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Figure 6. Correlation between loss of binding of CTCF and RNA expression of associated gene
CTCF binding sites were divided into sites near TSSs (± 2 kb) and sites with a UC motif (UC). Sites were subsequently 
categorized depending on whether the binding by a particular GFP-CTCF-ZF mutant was affected. 
In (A-B) all binding sites with at least a 2-fold reduced binding were included, in (C) only sites were included with at 
least 4-fold reduced binding. We examined RNA expression of the gene nearest to the affected site. In (A) we looked at 
absolute expression levels without taking into account whether a gene is up- or down-regulated, and included outliers. 
In (B) we examined whether loss of binding resulted in increased or decreased expression levels and we also included 
outliers. In (C) we examined whether loss of binding resulted in increased or decreased expression levels, this time of 
the genes nearest to the most affected binding sites, excluding outliers.
A
B
C
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Correlation between loss of binding of CTCF and RNA expression
The loss of binding of CTCF ZF mutants to a subset of CTCF binding sites in the 
genome provided us with the unique opportunity to ask whether there is a correlation between 
loss of CTCF binding and changes in gene expression. Importantly, for the first time we could 
address this issue in cells in which CTCF expression itself was not ablated. We generated a 
set of ~22,000 CTCF binding sites and linked each site to its nearest gene. We next divided 
sites into two categories: 1) CTCF binding sites near a TSS (± 2 kb, 2578 genes), and 2) 
CTCF binding sites with an upstream motif at -17 to -19 bp of the core binding sequence (i.e. 
UC sites, 2949 genes). We selected sites that showed a 2 fold binding change observed in 
a particular ZF mutant for each category. We only examined sites in which ZF binding was 
reduced, because reduction is observed in the majority of affected sites. 
 We next examined RNA levels of genes associated with affected TSS- and UC-linked 
CTCF binding sites, by comparing ChIP-Seq and RNA-Seq data in mutant and GFP-CTCF-
expressing ES cells. To determine the overall effect of reduced CTCF binding on associated 
genes, we first examined absolute differences in RNA expression (i.e. without taking into 
account whether loss of binding resulted in increased or decreased gene expression and 
including outliers). This revealed that CTCF binding to target sites near genes regulates 
transcription (Figure 6A). We observed a log2 fold change in transcription of ~2 on the TSS 
in each mutant. Interestingly, RNA expression level differences are similar in the different ZF 
mutant-expressing ES cells in the TSS category. These results indicate that it is the loss of 
binding that is important for transcriptional regulation by CTCF.
 There is not much difference in the RNA levels of genes in which CTCF binding is 
affected near a TSS compared to genes where CTCF binding is reduced at a UC motif (Figure 
6A). These data indicate that CTCF regulates gene transcription irrespective of where it binds in 
a gene. To verify this conclusion we compared the expression data of all genes (this time taking 
into account whether loss of binding resulted in increased or decreased gene expression) in 
which CTCF binding was affected (two-fold or more) and in which CTCF was either near a TSS 
or bound to a UC motif (Figure 6B). We performed a similar analysis as in (Figure 6B) but 
with CTCF binding showing a 4-fold or more reduction in each binding category (TSS and UC) 
and excluding outliers in the transcriptional data (Figure 6C). In none of these analyses did we 
observe profound differences in the pattern of expression of genes when we compared loss-
of-binding on TSS-linked CTCF sites versus UC-linked sites. These data suggest again that 
the position of CTCF binding within a gene is not essential for the regulation of transcription of 
that gene. Thus transcriptional regulation of CTCF is apparently independent of the position of 
CTCF to the TSS.
 
Discussion 
We deleted endogenous Ctcf using conditional Ctcfdelneo/delneo knockout ES cells and 
rescued ES cells by expressing GFP-tagged CTCF-ZF mutants to study the role of the different 
ZFs. This is a unique system since it excludes interference by wild type CTCF. It allowed us to 
examine effects that are specific to individual ZFs with respect to cell growth, dynamic protein 
behavior, DNA binding and genomic distribution, and transcription regulation. All ZFs of CTCF 
are highly conserved indicating that each ZF is important for proper CTCF function (Moon et 
al., 2005; Pugacheva et al., 2006).  Nevertheless, we were able to generate ES cells expressing 
GFP-CTCF-∆1, GFP-CTCF-∆8, GFP-CTCF-∆9, GFP-CTCF-∆10 and GFP-CTCF-∆11 mutants 
replacing endogenous CTCF. It is remarkable that we were able to delete the highly conserved 
zinc fingers ZF1 and ZF8-11, which suggests that they contribute to a lesser extent to the 
functionality of CTCF compared to ZF2-7 in ES cells. It may also be that these zinc fingers 
act as functional unit in which deletion of one zinc finger slightly disrupt CTCF function but 
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deletion of more zinc fingers might result in cellular lethality. ES cells could not be rescued by 
GFP-CTCF-∆2-7, which indicates that these ZFs are essential for cell survival, even if we had 
screened sufficient ES cell clones to find a rare GFP-CTCF-∆2-7-expressing mutant cell line 
the conclusion would have remained the same.
 Fluorescence-based microscopy measurements suggest that there are >1 million 
molecules of GFP-CTCF in an ES cell nucleus. By contrast, there are only ~25,000 conserved 
CTCF target sites, that consistently appear in every cell line tested (Li et al., 2013). Since 
the majority of CTCF molecules are immobile and CTCF distributes in a speckled pattern 
throughout the nucleus, it is likely that the protein binds DNA at many more positions than 
just the ~25,000 conserved CTCF binding sites. ES cells expressing GFP-CTCF-∆1 and -∆8 
have a growth defect and these mutant proteins display increased mobility, in particular GFP-
CTCF-∆8. These results suggest that binding of CTCF throughout the nucleus via ZF1 and -8 
is important for proper ES cell growth and proliferation.
 Our FRAP data are different from a recent publication, in which the recovery of 
fluorescent CTCF molecules in B cells was found to be in the order of seconds instead of 
minutes (Nakahashi et al., 2013). In this study individual CTCF ZF mutants were overexpressed 
in primary lymphocytes in the presence of wild type CTCF, creating a situation where mutant 
protein competes with endogenous CTCF. Furthermore, the overexpression of CTCF-GFP 
proteins (both wild type and ZF mutants) by (Nakahashi et al., 2013) was not estimated with 
respect to endogenous CTCF. It is therefore unclear to what extent exogenous proteins were 
overexpressed. Performing FRAP under such conditions is likely to mask physiological CTCF 
dynamics. The rapid recovery times of the ZF mutants (Nakahashi et al., 2013) are not surprising 
if CTCF molecules are present in vast excess. By contrast, our system does not contain 
endogenous CTCF, hence no competition between wild type CTCF and mutant protein can 
occur. In addition, GFP-CTCF expression was comparable to endogenous levels in WT cells, 
creating a proper physiological situation to study CTCF dynamics.
 Interestingly, CTCF concentration fluctuates during the cell cycle, and is most reduced 
during mitosis. This reduction of CTCF concentration suggests that less CTCF sites are 
occupied. We hypothesize that CTCF binding sites involved in the regulation of open chromatin 
configuration or sites located at chromatin boundary elements are likely to be reduced in CTCF 
binding during M-phase due to chromosome condensation. It might be that loss of CTCF 
binding during M-phase could be caused by the condensation of the chromosomes. On the 
other hand it could also be that loss of CTCF binding of these sites would allow condensation 
of the chromosomes. 
 ChIP-Seq experiments show that in ES cells expressing GFP-CTCF-∆8-11 a subset 
of CTCF binding sites are affected, many of which are shared in the individual mutants. 
However, only GFP-CTCF-∆8-expressing cells grow poorly and only GFP-CTCF-∆8 shows 
aberrant protein dynamics. This underscores our conclusion that binding of CTCF throughout 
the nucleus is important for ES cell growth and proliferation and that binding defects on CTCF 
target sites are less important. Our data do not allow us to distinguish how exactly CTCF binds 
throughout the nucleus. However, it will be interesting to determine whether the in vivo CTCF 
genome-wide binding sites, which excess the ~25,000 conserved sites, documented here are 
as important for 3D interactions of chromatin, as are a subset of its conserved CTCF binding 
sites (Handoko et al., 2011). Moreover, CTCF can facilitate protein-protein interactions via its ZF 
domain (Chernukhin et al., 2000; Ishihara et al., 2006; Lutz et al., 2000; van de Nobelen et al., 2010), which could 
also be important for protein mobility and cell growth and could explain the different protein 
mobility observed between GFP-CTCF-∆8 and GFP-CTCF-∆9.
ZFs 4-7 were proposed to recognize the 20 bp core motif present in 80-99.5% of all 
CTCF binding sites (Nakahashi et al., 2013; Renda et al., 2007; Rhee and Pugh, 2011). Therefore, these 
ZFs are essential to establish CTCF binding to virtually all conserved CTCF binding sites in the 
genome. The peripheral ZFs were proposed to increase CTCF binding affinity (Renda et al., 2007), 
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with the C-terminal ZFs recognizing an upstream motif (Nakahashi et al., 2013) that was identified 
by other groups (Boyle et al., 2011; Rhee and Pugh, 2011; Schmidt et al., 2012). The upstream motif is 
identical to the one we identify in our work. The core and upstream motifs are separated by a 
10 bp ‘spacer’ that would allow one DNA helix turn in between the two CTCF binding motifs. 
We provide evidence that ZFs 8-11 together are important for recognition of the upstream motif. 
We hypothesize that ZFs9-11 might actually be involved in base contacts with the upstream 
motif, whereas ZF8 is required to bridge the 10 bp space between the motifs in the DNA. In 
the absence of ZF8 ZFs9-11 might not be positioned properly and fail to bind DNA altogether. 
The 20 bp core motif of CTCF is highly conserved and detected in all eutherian 
mammals, opossum, chicken, pufferfish Tetraodon, and a similar motif has been discovered 
in drosophila (Chen et al., 2008; Holohan et al., 2007; Jothi et al., 2008; Kim et al., 2007; Smith et al., 2009; Xie et 
al., 2007). By contrast, the conservation of the bipartite motif has been investigated to a lesser 
extent than the core motif. The bipartite motif and the 10 bp spacing between the core and 
upstream motif are so far only conserved in eutherian mammals (Schmidt et al., 2012). It could be 
that the bipartite motif is less conserved than the core motif, which would indicate that these 
sites serve a less important role in the function of CTCF. Moreover, this would be an additional 
explanation why deletion of ZF8-11 did not result in cellular lethality.
Our data reveal that ZF1 recognizes nucleotides downstream of the core, in particular 
a C around position 44 of the CTCF consensus sequence (10 nt downstream of the core motif). 
Furthermore, sites deficient in binding of ZFs 9-11, contain nucleotides downstream of the 
core. Although these nucleotides are less prominent than the upstream motif, they coincide 
exactly with the domain defective in ZF 1 binding. These data indicate that binding of ZFs 9-11 
affects binding downstream of the core, indicating that there is an interplay between ZFs and 
the DNA to establish DNA binding upstream and downstream of the core motif. Together our 
results identify the full CTCF consensus sequence. We propose a model in which ZFs 1-7 bind 
adjacent to each other, with ZF 1 binding to position 44 marking the 3’end of the CTCF binding 
site. ZF7 binds the 5’end of the core motif. The 10 bps in between the 2 motifs form a helical 
turn such that ZF9-11 continue proximal binding to the upstream motif. 
Our data support previous findings (Boyle et al., 2011; Nakahashi et al., 2013; Rhee and Pugh, 
2011; Schmidt et al., 2012) regarding sequence and position of the upstream motif relative to the 
core motif. However, important to realize that the majority of CTCF binding sites contain only 
the core motif, and that in ChIP-Seq experiments these sites show similar CTCF occupancy as 
bipartite motif sites. Our data show that disruption of CTCF’s C-terminal ZFs results in a severe 
reduction of CTCF binding to bipartite motif sites. Thus, the presence of the core motif within 
bipartite motif sites is not sufficient to maintain binding of CTCF-ZF8-11 mutants, whereas on 
sites with only a core motif these mutants bind as efficiently as WT CTCF. This indicates that at 
UC sites a tight CTCF binding is required and that in the absence of ZF8-11 binding is reduced 
such that other factors or epigenetic modifications can displace mutant CTCF from the core 
site. On the other hand it might also suggest that the tight CTCF binding at the bipartite motif is 
required to maintain a proper chromatin environment.
The genomic distribution and chromatin context of CTCF’s bipartite motif was unknown. 
Our data reveal that the bipartite motif is often located in intergenic and intronic regions and 
is reduced at active chromatin areas and TSSs. Interestingly, the bipartite binding sites are 
associated with the repressive chromatin mark H3K9me3, which suggests that CTCF is 
involved in establishing or maintaining repressive chromatin areas at bipartite sites. Changes in 
chromatin marks need to be explored in CTCF ZF mutants in order to understand the functional 
relevance of CTCF binding to bipartite motif sites.
In conclusion, our data indicate that CTCF organizes chromatin at two distinct levels. 
First, CTCF binds DNA at many sites throughout the genome and this binding is essential 
for proper ES cell growth and proliferation. Second, CTCF binding near genes regulates 
transcription locally. This transcriptional regulation is apparently independent of the position 
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of CTCF to the TSS. CTCF does not act as a classic transcription factor, but rather makes 
chromatin near genes (in)accessible via e.g. by long-range interactions.
Materials and Methods
Generation of lentivirus
Fusion PCR with fusion primers (Table S3) flanking each individual ZF on CTCF-
encoding cDNA, amino acid sequence of each deleted zinc finger are depicted in (Table S1), 
was used to generate individual ZF mutants. Primers contained an Xho I site before the ATG 
and after the stop codon. PCR products were cloned in lentiviral vectors using Xho I restriction 
site. Lentiviral constructs were generated as described earlier (Sleutels et al., 2012). Constructs 
contained a CAG promoter (CMV early enhancer/chicken beta actin) driving the expression of 
a “bi-cistronic” cDNA encoding GFP-tagged wild type or mutant CTCF, followed by an IRES 
sequence to generate Cre-recombinase. A neomycin resistance cassette driven by a PGK 
promoter was also present. Lentivirus particles were produced as described (Addgene). 
Generation of GFP-CTCF-expressing ES cells 
Ctcflox mice were generated as described previously (Heath et al., 2008). Ctcflox/lox embryonic 
stem cells (ES cells) were isolated and transiently treated with Cre-recombinase to delete 
the neomycin resistance cassette generating Ctcfdelneo/delneo ES cells selected on puromycin 
sensitivity. These ES cells were infected with lentiviral particles in suspension for 4 hours, 
plated and selected with 0.2 mg/ml G418 one day after infection. Neomycin-resistant, GFP-
positive clones were picked and expanded as described (Sleutels et al., 2012).
ES cell culture and proliferation assay
ES cells were grown on plastic dishes coated with 0.2% gelatin (Merck) in the presence 
of ES cell medium containing: Dulbecco’s Modified Eagle Medium (DMEM) (Lonza), 15% heat-
inactivated fetal calf serum (FCS), Non Essential Amino Acids (Lonza), 100 U ml-1 penicillin 
and 100 mg ml-1 streptamycin, 0.1 mM β-mercaptoethanol (Sigma) and 1000 U/ml leukaemia 
inhibitory factor (LIF). ES cells were cultured 37°C with 5% CO2 levels. Cells were passaged 
by trypsinization in 1xTE (trypsin/EDTA) for 5 minutes at 37°C. 
 To measure ES cell growth and proliferation 100000 ES cells (N=3 for each cell line)
were counted and plated on a 6-well dish. After 48 hours ES cells were harvested, counted and 
100000 cells were plated back. This was repeated 3 times (144 hr). 
DNA, RNA and protein isolation
Genomic DNA was isolated by incubating cell pellets with 50 mM Tris-HCl pH 8.0, 5 
mM EDTA pH 8.0 and 0.5% SDS, 0.3 mg/ml proteinase K and 0.01 mg/ml RNase at 55°C on a 
rocking platform. 1.2 M NaCl was added to samples followed by centrifugation on 13,000 rpm 
for 10 minutes at room temperature (RT). Isopropanol and 70% ethanol were used for DNA 
precipitation and pellets were dissolved in 10 mM Tris and 1 mM EDTA. 
 Total RNA isolation of 2 replicates of each ES cell line was performed with Trizol-
chloroform extraction. After Trizol addition, samples were incubated for 5 minutes at 30°C. 
Chloroform was added and aqueous phase was transferred after centrifugation on 13,000 rpm 
for 10 minutes 4°C. 100% ethanol was added and RNA was isolated using the RNeasy Mini Kit 
(Cat. no. 74104, Qiagen).  
Nuclear protein extracts from 10 cm2 cell culture dishes were generated by resuspending 
ES cells in 500 µl buffer A (10 mM Hepes, 1.5 mM MgCl2, 10 mM KCl, and protease inhibitors 
(Complete, Roche)) followed by 10 minutes incubation on ice. Samples were centrifuged on 
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6000 rpm for 1 minute at 4°C and pellets were sub taken in 250 µl buffer C (420 mM NaCl, 
1.5 mM MgCl2, 200 mM EDTA, 20 mM Hepes hOH, 21.75% glycerol and protease inhibitor) 
followed by 20 minutes incubation on ice. After centrifugation on 10,000 rpm at 4°C supernatant 
was used for further assays. 
Antibodies, Western blot and Southern blot analysis
Nuclear protein extracts were loaded on a SDS-PAGE gel. After electrophoresis 
proteins were transferred to PVDF membranes (Millipore) via semi-dry blotting (Bio-Rad, trans-
blot SD, semi-dry transfer cell). Membranes were blocked either in 2% BSA, or in 5% Milk 
powder (Sigma) in PBS containing 0.05% Tween-20. Antibody incubations were done in the 
same buffer. The following antibodies were used: GFP (rabbit home made 1:1000), CTCF (rat, 
1:1000, Absea) and p150 glued (mouse, 1:1000, Bd transduction laboratories). The following 
secondary antibodies conjugated with HRP were used for detection anti-rabbit HRP (1:10000, 
GE healthcare), anti-rat HRP (1:10000, GE healthcare) and anti-mouse HRP (1:10000, GE 
healthcare).
 Genomic DNA was digested with Hind III and loaded on an agarose gel for size 
fractionation. Samples were blotted onto a Hybond N+ membrane (Amersham) and hybridized 
with radioactive probes using α32P dATP as described previously (Sleutels et al., 2012). Signals 
were detected with a Phosphor Imager (Typhoon Trio variable mode imager, GE healthcare). 
Fluorescence after photobleaching (FRAP) and fluorescence intensity 
measurements
We bleached ES cells expressing either normal GFP-CTCF or a mutant protein 
with a deletion in a single ZF. FRAP experiments were performed on a Leica TSP5 confocal 
microscope, essentially as described (Dragestein et al., 2008). We bleached ES cells expressing 
either GFP-CTCF or GFP-CTCF-ZF mutant. In each ES cell colony we bleached 3 nuclei, 
using circular ROIs with a diameter of 3 mm. We measured fluorescence recovery in the 
bleached region. We also measured fluorescence intensity over time in similarly sized ROIs in 
non-bleached regions of the same nuclei, as well as in non-bleached cells (to show there was 
non monitor bleaching) and in the culture medium. After background deduction fluorescence 
intensity values were normalized. We then compensated for fluctuations in fluorescence 
intensity by dividing the normalized fluorescence intensity in the bleached ROI by that of the 
non-bleached ROI in the same nucleus.
 We performed two types of FRAP experiment. In the first we measured recovery 
for two minutes with image acquisition times of two seconds. In this case 12 GFP-CTCF-, 
23 GFP-CTCF-∆1, 18 GFP-CTCF-∆8-, 12 GFP-CTCF-∆9-, 12 GFP-CTCF-∆10- and 19 GFP-
CTCF-∆11-expressing nuclei were bleached and measured. In the second FRAP experiment 
we measured the recovery of selected GFP-CTCF proteins (>8 nuclei for each protein) for 10 
minutes with image acquisition times of 5 seconds.
 To calculate the concentration of GFP-CTCF in ES cell nuclei we measured the 
fluorescence intensity of a purified fluorescent protein, (i.e. GFP-EB3, a GFP tagged microtubule 
associated protein) of a known concentration. Using two-sided tape and a rectangular coverslip 
we assembled small glass sample chambers on objective holders, with an opening on opposite 
sides of the coverslip to allow flow-through of buffer and proteins.To block aspecific binding of 
GFP-EB3 to the glass surface inside the chamber, we first added buffer containing K-CASEIN 
(1mg/ml) to the chamber and incubated at RT for 15 minutes. After blocking the purified GFP-
EB3 was flowed through the chamber. We used separate chambers to measure GFP-EB3 
at different dilutions. We measured fluorescence intensity of each sample with a Leica TSP5 
confocal microscope. Average fluorescence intensities were used to generate a standard 
curve. Using exactly the same microscope settings we imaged GFP-CTCF in ES cell colonies. 
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We outlined the nucleus of 18 cells and measured total and average fluorescence intensity of 
GFP-CTCF in these nuclei. The average fluorescence intensity was compared to that of the 
purified GFP-EB3 to obtain the GFP-CTCF concentration in ES cells.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described (van de Nobelen et al., 2010). Briefly, 40-80*106 cells were 
harvested and cross-linked with 1% formaldehyde (Sigma) for 10 minutes at room temperature 
and quenched with Glycine (Sigma). Cell lysates were prepared with cell lysis buffer (10 mM 
Tris pH 8.0, 10 mM NaCl, 0.2% NP-40 (Sigma), Protease Inhibitor) followed by nuclei lysis buffer 
(50 mM Tris pH 8.0, 10 mM EDTA, 1% SDS, Protease Inhibitor). Sonication was performed 
with the bioruptor (Diagnode) to yield fragments up to 800 bp. Immunoprecipitation with CTCF 
antibody (N2.2, home made) or pre-immune serum rabbit (home made) was performed. ChIP-
Seq was validated by three independent ChIP-qPCR experiments. Ct values from qPCR were 
normalized to input measurements, and enrichment was calculated relative to CTCF negative 
binding site. For primer sequences see (Table S4).
ChIP-Sequencing
A ChIP DNA library was prepared according to the Illumina protocol (www.illumina.
com). Briefly, 10 ng of end-repaired ChIPped DNA was ligated to adapters, size selected on gel 
(200±25 bp range), and PCR amplified using Phusion polymerase as follow: 30 sec at 98ºC, 
18 cycles of (10 sec at 98ºC, 30 sec at 65ºC, 30 sec at 72ºC), 5 min at 72ºC final extension. 
Cluster generation was performed using the Illumina Cluster Reagents preparation. The library 
was sequenced on the Illumina HiSeq2000 systems to generate 36 bp reads and a 7 bp index 
read. Images were recorded and analyzed by the Illumina Genome Analyzer Pipeline (GAP) 
and processed using the IPAR (Integrated Primary Analysis Reporting Software). Samples 
were de-multiplexed and mapped against mouse build mm9 reference genome. 
RNA-Sequencing
Purity and quality of the isolated RNA was assessed by the RNA 6000 Nano assay 
on a 2100 Bioanalyzer (Agilent Technologies). Two independent RNA-Seq experiments were 
performed for each ES cell line (n=2). 1 µg total RNA of each sample was used as starting 
material for Illumina Truseq sequencing. Poly-A tail containing mRNA was purified with oligo-dT 
attached to magnetic beads. Subsequently, mRNA was fragmented into ~ 200 bp fragments 
followed by first-strand cDNA synthesis using reverse transcriptase and random primers. Next, 
second-strand synthesis was performed using DNA polymerase I and RNaseH treatment. 
End-repair, phosphorylation and A-tailing were carried out followed by adapter ligation, 
size selection on gel and PCR amplification. PCR products were purified by Qiaquick PCR 
purification. Samples were sequenced on HiSeq 2000 to generate 36 bp reads and a 7 bp 
index read. Samples were de-multiplexed and aligned to mouse build mm9 reference genome 
using Tophat alignment software. 
Bioinformatic analysis
 Aligned reads from RNA-Seq were used to identify differentially expressed genes by 
CuffDiff (Trapnell et al., 2013) using standard settings (adjusted p-value <0.05). The resulted gene 
lists were imported into R and the overlap was visualized using the venn function from the 
gplots package. 
 ChIP-Seq reads were aligned to mm9 reference genome using Bowtie2 (Langmead 
and Salzberg, 2012). Peaks were identified using PeakRanger with standard settings (Feng et al., 
2011). Here, peaks were identified based on read dense regions defined by p-value < 0.0001. 
The negative (mock) control was used to subtract the background (FDR <0.05 and > 3 fold 
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enrichment between ChIP and mock). In order to obtain a general set of peaks we used the 
presence of the core CTCF motif as criteria (Kim et al., 2007). We used the top 1000 sites from 
each dataset and constructed a position specific scoring matrix (PSSM). This PSSM was used 
to perform a genome-wide prediction of CTCF motifs across the complete mouse genome 
using the Patser tool (Thomas-Chollier et al., 2008) with a Patser score > 7. Peak intervals detected 
with the GFP-CTCF dataset that overlapped with at least one instance of a core motif were 
used for subsequent analysis (22,216 sites). 
For these intervals we calculated the number of reads for the individual zinc finger 
deletion as well as for the GFP-CTCF dataset. DEseq (Anders and Huber, 2010) was used for 
proper normalization of the data as well as to determine the fold change between the individual 
zinc finger mutants and the GFP-CTCF dataset. Fold changes were log2-transformed and 
those sites with an absolute log2 (fold change) larger than 2 in at least one zinc finger mutant 
were further subjected to cluster analysis using k-means in order to identify co-regulated CTCF 
binding sites (Figure 3A and 3B). 
All sites within a single cluster sequence around the core consensus were collected 
in a 70 bp window (using the BioConductor package BSgenome.Mmusculus.UCSC.mm9). 
Sequences were summarized as a weblog using the R package webLogo (Figure S3). 
Alternatively all sites with a log2 (fold change) <-2 for an individual zinc finger deletion were 
identified and the corresponding sequences were extracted and collected in a 70 bp window 
(using the BioConductor package BSgenome.Mmusculus.UCSC.mm9). Sequences were 
summarized as a weblog using the R package webLogo (Figure 3C).
 The mm9 genome was partitioned into regions based on RefSeq annotations, TSS: 
+/- 1kb around RefSeq TSSs, TSS upstream: -1 to -10 kb, exons, introns, TES: +/- 1kb, rest: 
intergenic. All intervals of a given feature class were taken together and the ratio relative to 
the complete genome size was calculated to obtain the genomic background distribution. 
The same analysis was performed for the intersection between the genomic feature intervals 
and the respective peaks that showed a greater than 4-fold reduction of CTCF binding in 
at least one zinc finger mutant compared to GFP-CTCF (Figure 4A). Alternatively, reduced 
CTCF binding in a zinc finger mutant was expressed as a ratio relative to GFP-CTCF and 
data were additionally log2-transformed and plotted in a histogram (Figure 4B). In addition, 
RefSeq annotations for mm9 were used to calculate the distance for each of the 22,216 CTCF 
core motifs to the next transcriptional start site. Data were plotted in a histogram for the range 
between +/- 40 kb around the TSS. We compared all CTCF sites to CTCF sites containing the 
upstream motif (Figure 4C). RefSeq annotations for mm9 were used to calculate the distance 
for each of the ~22,000 CTCF core motifs to the next transcriptional start sites. Data is plotted 
as a histogram within a window of +/- 40 kb around the TSS. We compared all CTCF sites with 
CTCF sites containing the UC motif (Figure 4D).
 CTCF sites containing core and upstream motif (UC) were identified using the top 200 
reduced sites identified in the GFP-CTCF-∆9 dataset to construct a position specific scoring 
matrix (PSSM). This matrix was used to identify potential motif (core and upstream motifs) 
instances across the complete mm9 genome using Patser (Thomas-Chollier et al., 2008). Under the 
applied setting we identified about 1 million instances of the upstream and core motifs. Next, 
we identified the 22,216 CTCF core motifs from the UC sites and found 2718 cases were the 
upstream motif was located at a position -18bp relative to the CTCF core motif. We determined 
the log2 (fold change) binding change for a given zinc finger mutant compared to all GFP-
CTCF for those sites having an upstream motif at position -18 bp (Figure S4).
 Average cumulative plots show binding of histones, histone modification marks and 
chromatin factors in the context of all CTCF sites and UC-containing CTCF sites (Figure 5). 
All data were published previously (H3: GSE23830 (Mullen et al., 2011), H3.3: GSE16893 (Goldberg 
et al., 2010), H3K27ac: GSE24164 (Creyghton et al., 2010), H3K27me3: GSE15519 (Rugg-Gunn et al., 
2010), H3K36me3: GSE12241 and H3K9me3: GSE12241 (Mikkelsen et al., 2007), OCT4: GSE11431 
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(Chen et al., 2008), Pol II-ser5P: GSE20485 and SMC1: GSE22557 (Kagey et al., 2010) and CTCFL 
GSE34094 (Sleutels et al., 2012)) and downloaded from the Gene Expression Omnibus in short 
read archive format (sra). FASTQ data were extracted using SRA tools version 2.18. Reads 
were aligned to the mm9 genome as described above. After read extension coverage vectors 
were produced. These were used to collect binding data in a +/- 20 kb window with a 200 bp 
step size around the CTCF binding sites. 
 Based on stringent selection criteria, we obtained 21,030 genes linked to CTCF sites 
containing the core motif of CTCF. Subsequently, genes were either sorted according to the 
distance from the TSS (± 2000 bp, 2578 genes), or according to the distance from the up-
stream motif (ranging 17 to 19 bp in distance from the core, 2949 genes) (UC motif). The 
TSS- and UC-linked genes were subsequently sorted according to lack of binding of each of 
the respective GFP-CTCF-ZF mutants. We only considered sites in GFP-CTCF-ZF mutant 
bound less efficiently compared to wild type GFP-CTCF. As cut-off we either took a 2-fold or 
a 4-fold reduction in binding. Defective binding was next coupled to the fold change in RNA 
expression of that gene in a particular GFP-CTCF-ZF-expressing ES cell line, as compared to 
GFP-CTCF-expressing ES cells. Absolute differences in expression were obtained by making 
all negative values positive. This allowed us to compare transcriptional effects on genes to 
altered binding of GFP-CTCF-ZF mutants, separating the effects of CTCF binding sites near a 
TSS to those of genes with CTCF binding sites near an UC motif
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CTCF constructs % Deleted % Partially Deleted % Not Deleted Verified with 
sequencing
Functional CTCF 
substitution
(No. of colonies) (No. of colonies) (No. of colonies)
GFP-CTCF 95% (40/42) 2% (1/42) 2% (1/42) Yes Yes
GFP-CTCF- 1 6.25% (1/16) 6.25% (1/16) 87.5% (14/16) Yes Yes
GFP-CTCF- 2 0% (0/4) 25% (1/4) 75% (3/4) No No
GFP-CTCF- 3 0% (0/9) 55% (5/9) 44%(4/9) No No
GFP-CTCF- 4 0% (0/6) 0% (0/6) 100% (6/6) No No
GFP-CTCF- 5 0% (0/7) 28% (2/7) 71% (5/7) No No
GFP-CTCF- 6 0% (0/5) 60% (3/5) 40% (2/5) No No
GFP-CTCF- 7 40% (2/5) 0% (0/5) 60% (3/5) No No
GFP-CTCF- 8 81% (9/11) 9% (1/11) 9% (1/11) Yes Yes
GFP-CTCF- 9 83% (5/6) 0% (0/6) 16% (1/6) Yes Yes
GFP-CTCF- 10 83% (10/12) 0% (0/12) 16% (2/12) Yes Yes
GFP-CTCF- 11 75% (6/8) 0% (0/8) 25% (2/8) Yes Yes
CTCF constructs Expression (FPKM)
WT 54.66
GFP-CTCF 31.49
GFP-CTCF- 1 52.43
GFP-CTCF- 8 23.64
GFP-CTCF- 9 25.61
GFP-CTCF- 10 29.09
GFP-CTCF- 11 29.38
Supplemental Figure S1
Supplemental Figure 1. Characterization of CTCF mutant ES cell lines
(A) Schematic representation of Ctcfwt and Ctcfdelneo alleles. Exons are represented by rectangles and numbered. Exon 
3 and 12 contain start and stop codon, respectively. The Ctcfdelneo allele contains a single loxP site at the 5’end (small 
triangle), and two more loxP sites (small triangles) flanking a PGK-puromycin cassette (puro) at the 3’end. A LacZ 
reporter cassette containing a splice acceptor (SA) site is also present at the 3’end of the gene.
(B) Southern blot analysis of Ctcfdelneo (WT) and Ctcfdel alleles in neomycin-resistant and GFP-positive clones. Rescued 
cell lines are marked in green. 
(C) Overview of results of the ES cell rescue experiment. Percentage (and number) of colonies is shown in which both, 
one or none of the endogenous Ctcfdelneo alleles was deleted. Colonies were analyzed with DNA and RNA sequencing 
to verify mutation. The final conclusion regarding functional CTCF substitution is depicted in the right hand column. 
(D) RNA levels of wild type and mutant CTCF encoding RNAs. RNA-sequencing was performed on RNA from ES cells 
expressing endogenous (WT) or the indicated GFP-CTCF proteins. Values are depicted in FPKM (Fragments Per 
Kilobase of transcripts per Million mapped reads).
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Supplemental Figure 2. RNA-sequencing profile shows zinc finger deletion
IGV profile of the Ctcf gene together with the mapped reads of each GFP-CTCF mutant. Arrows show the location of 
each ZF deletion confirming that each mutant cell line deleted endogenous Ctcf alleles and express only mutant CTCF.
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Supplemental Figure 3. Characterization of GFP-CTCF-ZF binding
Motif analysis of random GFP-CTCF binding sites and the 6 subgroups shown in Figure 3. This reveals a strong up-
stream motif in clusters 3, 4, and 6 (affected binding sites of GFP-CTCF-Δ8-11) and nucleotides downstream of the 
core motif in clusters 1, 2 (affected binding sites of GFP-CTCF-Δ1), and 6. Bold text indicates most affected mutant(s) 
in each cluster. Red, green, yellow and blue represent T, A, G, and C nucleotides, respectively.  
Supplemental Figure S3
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GFP-CTCF-Δ1 - All
GFP-CTCF-Δ1 - UC
GFP-CTCF-Δ8 - All
GFP-CTCF-Δ8 - UC
GFP-CTCF-Δ9 - All
GFP-CTCF-Δ9 - UC
GFP-CTCF-Δ10 - All
GFP-CTCF-Δ10 - UC
GFP-CTCF-Δ11 - All
GFP-CTCF-Δ11 - UC
Log2 (fold binding change)
420-2-4
Supplemental Figure 4. Reduced binding of GFP-ZFΔ8-11 to (UC) motif-containing CTCF sites
Fold change in binding to all CTCF target sites (All) and upstream motif-containing CTCF sites (UC) is depicted for 
each mutant. Log2 fold binding changes for these two groups are plotted (Y-axis). ZF8-11 show strongly reduced 
binding to UC sites whereas ZF1 does not.
Supplemental Figure S4
ZF 
deletion
Deleted amino acid sequence AA position No of AA
ZF1 TFQCELCSYTCPRRSNLDRHMKSHTD 265-290 26
ZF2 RPHKCHLCGRAFRTVTLLRNHLNTHTGT 292-319 28
ZF3 RPHKCPDCDMAFVTSGELVRHRRYKHTHE 320-348 29
ZF4 KPFKCSMCDYASVEVSKLKRHIRSHTGE 349-376 28
ZF5 RPFQCSLCSYASRDTYKLKRHMRTHSGE 377-404 28
ZF6 EKPYECYICHARFTQSGTMKMHILQKHTEN 404-433 30
ZF7 VAKFHCPHCDTVIARKSDLGVHLRKQHSYI 434-463 30
ZF8 QGKKCRYCDAVFHERYALIQHQKSHKNE 465-492 28
ZF9 RFKCDQCDYACRQERHMIMHKRTHTGEK 494-521 28
ZF10 KPYACSHCDKTFRQKQLLDMHFKRYHDPNFV 521-551 31
ZF11 PAAFVCSKCGKTFTRRNTMARHADNCAG 552-579 28
Supplemental Table S1
Supplemental Table 1. Zing finger amino acid sequence
Amino acid sequence and position number of each zinc finger. Number of amino acids deleted in each zinc finger are 
described in outer right column.
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CTCF constructs CTCF 
Expression 
(FPKM)
Pou5f1 
Expression 
(FPKM)
Nanog 
Expression 
(FPKM)
Sox2 
Expression 
(FPKM)
Alpl 
Expression 
(FPKM)
WT 54.66 1173.69 173.85 195.15 73.7
GFP-CTCF 31.49 1005.14 193.06 216.97 56.3
GFP-CTCF- 1 52.43 1343.45 222.64 186.37 67.24
GFP-CTCF- 8 23.64 1187.15 95.85 178.31 93.77
GFP-CTCF- 9 25.61 890.61 129.89 183.33 71.31
GFP-CTCF- 10 29.09 1149.04 119.72 185.74 74.53
GFP-CTCF- 11 29.38 897 86.7 120.88 40.95
Zinc finger primer 
name
Primer sequence
Zinc finger 1 F TTAAAAAAAAAGGTGTAAAGAAAGAGAGACCACACAAATGCCAC
Zinc finger 1 R GTGGCATTTGTGTGGTCTCTCTTTCTTTACACCTTTTTTTTTAA
Zinc finger 2 F CATGAAAAGCCACACTGATGAGCGTCCTCACAAGTGCCCAGAC
Zinc finger 2 R GTCTGGGCACTTGTGAGGACGCTCATCAGTGTGGCTTTTCATG
Zinc finger 3 F ATCTGAACACACACACAGGTACTAAACCATTTAAGTGTTCCATG
Zinc finger 3 R CATGGAACACTTAAATGGTTTAGTACCTGTGTGTGTGTTCAGAT
Zinc finger 4 F CGTTATAAACACACTCATGAGCGCCCGTTCCAGTGCAGTTTG
Zinc finger 4 R CAAACTGCACTGGAACGGGCGCTCATGAGTGTGTTTATAACG
Zinc finger 5 F CATTCGCTCTCATACTGGAGAGTGTTATATTTGTCACGCTCGG
Zinc finger 5 R CCGAGCGTGACAAATATAACACTCTCCAGTATGAGAGCGAATG
Zinc finger 6 F CATTCAGGGGAAAAACCTTATGTGGCCAAATTTCATTGTCCC
Zinc finger 6 R GGGACAATGAAATTTGGCCACATAAGGTTTTTCCCCTGAATG
Zinc finger 7 F TTACAGAAGCACACAGAAAATGAACAGGGCAAAAAATGTCGC
Zinc finger 7 R GCGACATTTTTTGCCCTGTTCATTTTCTGTGTGCTTCTGTAA
Zinc finger 8 F AAGCAGCATTCCTATATTGAAAAGCGCTTCAAGTGTGACCAG
Zinc finger 8 R CTGGTCACACTTGAAGCGCTTTTCAATATAGGAATGCTGCTT
Zinc finger 9 F TCAAAAATCACACAAAAATGAGAAGCCTTATGCCTGCAGCCAC
Zinc finger 9 R GTGGCTGCAGGCATAAGGCTTCTCATTTTTGTGTGATTTTTGA
Zinc finger 10 F CAAGCGCACTCACACGGGGGAGCCTGCTGCCTTTGTCTGTTCC
Zinc finger 10 R GGAACAGACAAAGGCAGCAGGCTCCCCCGTGTGAGTGCGCTTG
Zinc finger 11 F CTATCATGATCCCAACTTTGTCCCAGATGGCGTAGAGGGGGAA
Zinc finger 11 R TTCCCCCTCTACGCCATCTGGGACAAAGTTGGGATCATGATAG
Znmutforward CACGCTCGAGCATGGAAGGTGAGGCGGTTGAAG
Znmutreverse TCCGCTCGAGTCACCGGTCCATCATGCTGAGG
Supplemental Table S2
Supplemental Table 2. Gene expression levels from RNA-Sequencing
Gene expression levels of Ctcf, Pou5f1 (OCT4), Nanog, Sox2 and Alpl by RNA-Sequencing. Values are depicted in 
FPKM (Fragments Per Kilobase of transcripts per Million mapped reads). Full excel sheet is available upon request.
Supplemental Table S3
Supplemental Table 3. Fusion primers used to generate zinc finger deletions
Green: XhoI rescrtiction site, red: start codon
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ChIP primer name Primer sequence
Amylase_ChIP_F AATTCTCCTTGTACGGGTTGGTG
Amylase_ChIP_R TAGCAATGATGTGCACAGCTGAA
Pcdha6_ChIP_F TAATGATAACCCGCCTGTGTTC
Pcdha6_ChIP_R TCGCTGGGACTGAGTTTATAGG
Pcdhac1_ChIP_F GTCCAGAGCCAGACAAAGGAC
Pcdhac1_ChIP_R CATTGCAAGCTCCAAGTGTTG
Hs5-1_ChIP-F TGGCCATGGAGATTTTCTTTAC
Hs5-1_ChIP_R CTAGCCTTTCCTCATCTTCCAG
Pcdhb3_ChIP_F GATCAAAACCAGTGACAAAACC
Pcdhb3_ChIP_R ATCTACCCAGGTTCACACAAGC
Pcdhga3_ChIP_F AACAAAGGGTAACTTGGGTTTG
Pcdhga3_ChIP_R TAGCTTTACAGCAGGGAAATGG
Pcdhga12_ChIP_F GGTTCACAGACCAAAAATCCTC
Pcdhga12_ChIP_R ATCTGTCCGCATTGTGTTTTAG
Pcdhgc3_promoter      
_ChIP_F
CGTGTCCTGCTCAAAGAACC
Pcdhgc3_promoter     
_ChIP_R
TGTTCAGTCTCTGCCTCATCC
Pcdhgc3_downstream
_ChIP_F
GCGAAGTTGTGATCCTGTGTTC
Pcdhgc3_downstream
_ChIP_R
GACCCATACCTCTGTGAAGGAG
Supplemental Table S4
Supplemental Table 4. ChIP-pPCR primers
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Abstract
Background: CTCF is a highly conserved and essential zinc finger protein expressed in virtually all cell types. In
conjunction with cohesin, it organizes chromatin into loops, thereby regulating gene expression and epigenetic
events. The function of CTCFL or BORIS, the testis-specific paralog of CTCF, is less clear.
Results: Using immunohistochemistry on testis sections and fluorescence-based microscopy on intact live
seminiferous tubules, we show that CTCFL is only transiently present during spermatogenesis, prior to the onset of
meiosis, when the protein co-localizes in nuclei with ubiquitously expressed CTCF. CTCFL distribution overlaps
completely with that of Stra8, a retinoic acid-inducible protein essential for the propagation of meiosis. We find that
absence of CTCFL in mice causes sub-fertility because of a partially penetrant testicular atrophy. CTCFL deficiency
affects the expression of a number of testis-specific genes, including Gal3st1 and Prss50. Combined, these data
indicate that CTCFL has a unique role in spermatogenesis. Genome-wide RNA expression studies in ES cells
expressing a V5- and GFP-tagged form of CTCFL show that genes that are downregulated in CTCFL-deficient testis
are upregulated in ES cells. These data indicate that CTCFL is a male germ cell gene regulator. Furthermore,
genome-wide DNA-binding analysis shows that CTCFL binds a consensus sequence that is very similar to that of
CTCF. However, only ~3,700 out of the ~5,700 CTCFL- and ~31,000 CTCF-binding sites overlap. CTCFL binds
promoters with loosely assembled nucleosomes, whereas CTCF favors consensus sites surrounded by phased
nucleosomes. Finally, an ES cell-based rescue assay shows that CTCFL is functionally different from CTCF.
Conclusions: Our data suggest that nucleosome composition specifies the genome-wide binding of CTCFL and
CTCF. We propose that the transient expression of CTCFL in spermatogonia and preleptotene spermatocytes serves
to occupy a subset of promoters and maintain the expression of male germ cell genes.
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Background
Three-dimensional folding of the eukaryotic genome
occurs in a highly organized manner so as to compact
chromatin while allowing temporal and spatial expression
of genes. The genome contains regulatory elements, such
as promoters, enhancers, locus control regions, insulators
and enhancer blockers, that can orchestrate chromatin
folding and gene activity over short and long distances,
both in cis and in trans [1]. CTCF is a key coordinator of
three-dimensional chromatin structure, allowing loop for-
mation and specific chromatin compositions [2,3]. Gene
activity is controlled in a positive or negative manner de-
pending on the regulatory sequences present in the loops
that are formed. The importance of CTCF in chromatin
organization is emphasized by its evolutionary conserva-
tion, its ubiquitous expression, and its essential role in vir-
tually all cells and tissues examined [4,5]. Hence, CTCF
has been termed the “master weaver” of the genome [3].
The genome-wide binding by CTCF has been studied
by different groups (see, for example, [6-10]). This has
revealed ~35,000 CTCF-binding sites in the mammalian
genome, of which more than 70% are shared between cell
types. A relatively long consensus-binding motif for CTCF
has been determined, which displays variability when
compared to sites of transcription factors like KLF4,
SOX2 and MYC [7]. The majority of CTCF binding-sites
are found near genes, and ~8% is in the vicinity of tran-
scription start sites (TSSs). Arrays of positioned (or
“phased’) nucleosomes are found surrounding the
nucleosome-free CTCF-binding sites [11-13], suggesting
that CTCF binding promotes the ordered positioning of
histones in its vicinity. CTCF has also been proposed to
regulate the positioning of variant histones, such as H2A.
Z [6,14]. Interestingly, the cohesin complex binds at the
same position as CTCF in a CTCF-dependent manner.
Together with CTCF, cohesin is essential for a proper
three-dimensional chromatin structure and correct gene
regulation [15-17].
CTCF-dependent loop formation is of crucial import-
ance at imprinted loci. A well-studied example is the
imprinted Igf2-H19 locus, in which Igf2 is expressed
from the paternal and H19 from the maternal allele [18].
The imprinting control region (ICR) located in between
the Igf2 and H19 genes is methylated on the paternal al-
lele, preventing CTCF binding. As a result the enhancer
downstream of the H19 gene can interact with the Igf2
promoter and drive expression of this gene. On the non-
methylated maternally derived ICR, CTCF does bind,
thereby preventing enhancer-Igf2 interaction, resulting
in a chromatin loop that allows enhancer-H19 associ-
ation and H19 expression. By binding the ICR, CTCF
therefore acts as a regulator of imprinted sites.
The CTCF-like (CTCFL) protein, or Brother Of the
Regulator of Imprinted Sites (BORIS) [19], has a central
domain of 11 zinc fingers (ZFs) that is very similar to
that of CTCF and that is essential for DNA binding. The
N- and C-terminal domains of CTCF and CTCFL are
not homologous. CTCFL is less conserved across spe-
cies, and the protein arose later in evolution, as it is
detected in amniotes only [20]. Furthermore, expression
of CTCFL is restricted to testis, several types of cancers
and a number of cell lines [21-23].
Studies of CTCF and CTCFL protein distribution in
the testis have yielded contradictory results. Initially, a
mutually exclusive expression pattern of CTCFL and
CTCF was described [19], with CTCF being present in
round spermatids (i.e. after meiosis) and CTCFL in pri-
mary spermatocytes (i.e. during meiotic prophase).
Surprisingly, CTCFL was reported to be more abundant
in the spermatocyte cytoplasm than in the nucleus. This
led to the hypothesis that during germ cell development,
CTCFL substitutes for the absence of CTCF and might be
involved in reprogramming of DNA methylation in the
male germ line. CTCFL was later reported to be present
in gonocytes during embryonic development and, after
birth, in spermatogonia, whereas CTCF was reported to
localize to the supporting Sertoli cells [24]. In the same
study CTCFL, together with the protein methyltransferase
PRMT7, was suggested to regulate DNA methylation of
imprinted genes in the male germline. However, defects in
imprinting often result in embryonic phenotypes [25],
whereas Ctcfl knockout mice were shown to display a
phenotype only in the testis [26]. Recently, enrichment of
Ctcfl mRNA in round spermatids was reported, adding
perplexity to the localization and expression of CTCFL
[26,27].
While the whole genome DNA-binding profile for
CTCF has been elucidated, this has not been done for
CTCFL. It therefore remains unclear how CTCFL binding
relates to that of CTCF. In addition, it is unknown how
these proteins are related functionally and mechanistically.
To address these issues, we examined CTCFL function
and localization with respect to CTCF, and identified the
genome-wide binding sites of CTCFL and CTCF. We
show that CTCF and CTCFL are functionally different
proteins that co-localize within the nuclei of pre-meiotic
germ cells. CTCFL acts as a male germ cell gene regulator,
preferably binding near promoters with active chromatin
marks. Interestingly, CTCF and CTCFL bind a highly
similar DNA motif; nevertheless, only two-third of the
~5,700 CTCFL-binding sites are bound by CTCF. Con-
versely, the vast majority of CTCF sites are not bound by
CTCFL. We find that nucleosome composition specifies
CTCF and CTCFL binding. In contrast to CTCF, CTCFL
associates with relatively “open” chromatin, and we
propose that CTCFL promotes the maintenance of the
epigenetic state of a subset of gene promoters and hence
gene expression during spermatogenesis.
Sleutels et al. Epigenetics & Chromatin 2012, 5:8 Page 2 of 21
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Results
CTCFL and CTCF co-localize transiently in pre-meiotic
male germ cells
To resolve the localization of CTCF and CTCFL in testis,
and to address CTCFL function, we generated Ctcfl knock-
out and GFP-CTCF- and GFP-CTCFL-expressing knockin
mice. To obtain information about the organization of the
Ctcfl gene, we mapped its 5’ end and examined Ctcfl ex-
pression (Figure 1A, B). We next generated three separate
alleles using homologous recombination in ES cells: a Ctcfl
knockout allele (Ctcfldel), in which exons 1–8 of the Ctcfl
gene are deleted, and Ctcfl and Ctcf knockin alleles (Ctcflgfp
and Ctcfgfp, respectively), to express GFP-CTCFL and GFP-
CTCF instead of CTCFL and CTCF, respectively
(Figure 1C-I).
Mice were generated, and the distribution of CTCFL
was investigated by immunocytochemistry in sections of
seminiferous tubules from wild-type and Ctcfl knockout
mice. CTCFL was present in wild-type testis in cells lin-
ing the basal lamina (Figure 2A, B). Not all cells lining
the lamina were CTCFL-positive, and in some tubules
no CTCFL-positive cells were detected. Importantly, no
signal was detected on sections derived from CTCFL-
deficient mice (Figure 2C, see also Figure 2F), showing
that the
CTCFL staining in wild-type sections is specific. The
localization of the CTCFL-positive cells in the basal
compartment of the seminiferous tubules indicates that
these cells are spermatogonia or preleptotene spermato-
cytes, as only upon progression in meiotic prophase do
spermatocytes become disconnected from the basal lam-
ina and move through the Sertoli cell barrier into the
adluminal compartment of the seminiferous tubules.
The localization of CTCFL appeared reminiscent of
STRA8 (STimulated by Retinoic Acid), which is expressed
transiently from B spermatogonia to preleptotene sperma-
tocytes and is essential for retinoic acid-induced commit-
ment to meiosis [29-32]. An absolute overlap between
STRA8 and CTCFL was confirmed using dual-color im-
munofluorescence (Figure 2D, E). Immunofluorescent
staining experiments did not reveal an obvious change in
the number of STRA8-positive tubules in CTCFL-
deficient testis (Figure 2E, G, and data not shown). Thus,
absence of the CTCFL signal in Ctcfl knockout sections is
not due to the disappearance of a cell type.
To confirm CTCFL localization and compare its distribu-
tion to that of CTCF, we next analyzed expression and
localization of the two proteins ex vivo. We isolated intact
seminiferous tubules from the testes of Ctcflgfp and Ctcfgfp
male mice, which were injected with Hoechst via the rete
testis to stain nuclei of cells at the adluminal compartment
of the tubule. We then visualized GFP-CTCF(L) and Hoechst
concomitantly using a multiphoton confocal laser scanning
microscope setup [33]. Three-dimensional reconstruction of
images taken longitudinally through the seminiferous tubules
yielded an organizational view of the tubule, and the position
and type of the GFP-positive cells (Figure 2H-P). GFP-
CTCFL was detected in the nucleus of clustered cells repre-
senting a minor fraction of the total testis tubule (Figure 2H-
m, and Additional file 1: Movie S1). These cells stained nega-
tive for Hoechst, and since the luminally injected Hoechst
does not cross the Sertoli cell barrier, the GFP-CTCFL-
positive cells must reside on the basal side of this barrier. Ser-
toli cells, which form the tight junctions of the Sertoli cell
barrier, were Hoechst-positive (Figure 2I, J, L, M and Add-
itional file 1: Movie S1). Primary spermatocytes pass this bar-
rier in the preleptotene and leptotene stage [34]. Based on
Hoechst staining, morphology, size and location, we con-
clude that the GFP-CTCFL positive cells represent spermato-
gonia and preleptotene spermatocytes. The ex vivo GFP/
Hoechst results obtained in live tissue are consistent with
our data obtained in fixed paraffin-embedded sections of the
testis stained with the CTCFL antibodies (Figure 2A-C). To-
gether with the STRA8 colocalization data, they strongly
suggest that in the adult testis CTCFL is transiently
expressed in late spermatogonia and preleptotene germ cells.
In contrast to GFP-CTCFL, GFP-CTCF was present in
the nucleus of all cell types of the seminiferous tubule, in-
cluding all germ cells prior to spermiogenesis (Figure 2N-
P, and data not shown). GFP-CTCF was also expressed in
round spermatids, albeit at lower levels. This is consistent
with a primary role for CTCF in cells with histone-based
chromatin. Thus, live imaging in seminiferous tubules
shows that CTCF and CTCFL are co-expressed within late
spermatogonia and preleptotene spermatocytes. Measure-
ment of GFP fluorescence intensities indicate that in cells
where both proteins are expressed, the level of CTCF is
somewhat higher than that of CTCFL.
CTCFL is important for spermatogenesis
To study the role of CTCFL in the male germ line, we
analyzed Ctcfldel/+ and Ctcfldel/del mice. These mice
demonstrated no gross phenotypic defects and appeared
normal. Heterozygous and homozygous Ctcfldel females
showed normal fertility and yielded offspring with
expected ratios (data not shown), consistent with a role
for CTCFL in spermatogenesis only. Heterozygous
Ctcfldel/+ males generated offspring, and demonstrated
normal fertility (Table 1). However, homozygous Ctcfldel
male littermates generated offspring in only half (14 out of
27) of the breedings (Table 1). Breeding with Ctcfldel/del
males yielded significantly (p=0.01; chi test) fewer litters
than Ctcfldel/+ males, but not a different litter size
(p=0.11; t-test). These data indicate that CTCFL is im-
portant for male fertility.
To further investigate the CTCFL deficiency, we weighed
testes from 90-day-old Ctcfldel/del and Ctcfldel/+ mice and
plotted weight distributions. We found that, on average, the
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Figure 1 Ctcfl and Ctcf expression and targeting. A, B RNAse protection analysis of Ctcfl and Ctcf. For Ctcfl (A) RNase protection analysis
(RPA) was performed on polyA purified mRNA with probes covering parts of Ctcfl exon 8 and 9 (left, small fragment) or a 5’end RACE product
(right, large fragment). For Ctcf (B) the RPA was performed on total RNA with probes protecting Ctcf exon 2. The positions of the respective
protected fragments are indicated with arrows. Ctcfl mRNA mRNA can only be detected in polyA purified mRNA from testis (t), whereas Ctcf is
identified in total RNA from all three tissues tested. M, marker; p, input probe; c, tRNA control; h, heart; t, testis; b, brain. Aprt exon 3 is used as
loading control and marked by an asterisk [28]. This analysis identifies the first exon containing the ATG translation initiation codon in Ctcfl and
shows that Ctcfl is expressed in testis. C Schematic overview of the modified Ctcfl alleles and targeting constructs. The Ctcfl locus is shown on
scale, with the constructs (not on scale) used for homologous recombination in ES cells underneath. Targeting at the 5’end of Ctcfl yielded the
Ctcfl gpf- neo allele. Cre-mediated excision of the LoxP-embedded neomcyin resistance gene yielded the Ctcfl gfp allele (not shown). The 3’end
targeting was performed on the Ctcfl gpf- neo allele, and yielded the Ctcfl gfp-neo-puro allele. Cre-mediated excision of the sequence in between the
outermost LoxP sites yielded the Ctcfl del allele, in which exons 1–8 of the Ctcfl gene are deleted (not shown). A major difference between the
Ctcfl del allele described here and the Ctcfl knockout published earlier [26] is that in the Ctcfl del allele the GFP coding sequence is fused in frame
with the CTCFL coding sequence. Black boxes represent exons, GFP tag, neomycin and puromycin cassettes. Probes a, b, c, d and e are indicated
by lines. Oligos 1, 2, 3 and 4 are represented by arrowheads. White triangles are LoxP sites. B= BglII; N=NcoI; S= SpeI; A=AvrII. D DNA blot
showing Ctcfl targeting. Probes a and b were used on DNA blots from ES cells for identification of the Ctcflgfp-neo allele and probes c and d for
the Ctcflpuro allele. Probe e identifies the Ctcfldel allele from Ctcflgfp-neo-puro mice that were crossed to a chicken Actin-Cre transgene. Probe a,
HindIII digest (wt 8.9 kb, ko 5.7 kb); probe b, EcoRI digest (wt 14 kb; ko 11 kb); probe c, BamHI digest (wt 16.1 kb; ko 6.8 kb); probe d, BamHI
digest (wt 16.1 kb; ko 11.1 kb). E Absence of Ctcfl DNA in the Ctcfl del allele. PCR on tail DNA indicates that Ctcfl del/del mice are deleted for exons
1–8 (top three panels) and are positive for GFP (oligos 2 and 4). F Absence of Ctcfl RNA in Ctcfl mutant mice. PCR on cDNA derived from testis
mRNA shows that Ctcfl is absent from Ctcfl del/del mice. Acrosin and Gapd function as positive controls. G Schematic overview of the Ctcf allele
and targeting strategy for the Ctcf gfp-neo allele. The Ctcf locus is shown on scale, with the construct (not on scale) used for homologous
recombination in ES cells underneath. Cre-mediated excision of the LoxP-embedded neomcyin resistance gene yielded the Ctcf gfp (or Ctcf ki)
allele (not shown). Black boxes represent exons, GFP tag and neomycin cassette. Oligos 5, 6, 7 and 8 are represented by arrowheads. White
triangles are LoxP sites. E= EcoRI. H PCR confirming Ctcf gpf-neo allele. Identification of the CTCFgfp-neo (or Ctcf ki) allele by PCR with oligos 7 and 8
or oligos 5, 6 and 8 (see panel G). I Western blot confirming GFP-CTCF expression from the Ctcf gfp allele. We isolated MEFS from E13.5 day
wild-type (+/+), heterozygous Ctcf gfp/+ (or Ctcf ki/+) or homozygous Ctcf gfp/gfp (or Ctcf ki/ki) embryos, and identified the GFP-CTCF fusion protein
by Western blot of MEF extracts using anti-CTCF or anti-GFP antibodies. Note the increased size of the GFP-CTCF protein compared to the CTCF
protein due to the GFP tag.
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CTCFL-deficient testes weighed significantly less compared
to testes from heterozygous littermates (Figure 3A). In
addition, we found that lower testes weights coincided with
infertile males (Figure 3A). The weight distribution shows
that there are also normal testes in the Ctcfldel/del popula-
tion. Still, on average, the epididymides from homozygous
Ctcfl del mice contained only 15% of sperm compared to
heterozygous littermates (Figure 3B).
Figure 2 Expression of CTCFL and CTCF in the testis. A-C Immunohistochemical staining of testis sections. Paraffin-embedded sections from
day 90 testes from heterozygous (del/+) and homozygous (del/del) Ctcfl mutant mice were stained with anti-CTCFL, followed by
diaminobenzidine (DAB) coloring. Some of the CTCFL-positive cells are indicated with black arrowheads. Scale bars A, C: 100 μm, B: 50 μm. D-G
Immunofluorescence staining of testis sections. Sections as described in A-C were stained with CTCFL (D and F) or STRA8 (E and G) antibodies.
STRA8-positive cells in panels E and G are indicated with green arrowheads; the same cells are indicated with red arrowheads in the sections
stained with anti-CTCFL antibodies (panels D and F). In Ctcfl mutant mice, STRA8 distribution is not changed. Scale bar is 50 μm. H-P Ex vivo
confocal and multiphoton imaging of intact seminiferous tubules. Testis tubules were dissected from GFP-CTCFL- (H-M) or GFP-CTCF- (N-P)
expressing mice, exposed to Hoechst at the adluminal side of the seminiferous tubule, and analyzed with a confocal/multiphoton microscope
(GFP-CTCFL and GFP-CTCF, green; Hoechst, red). Panel H-J (see also Movie S1) shows a low magnification view of GFP-CTCFL distribution. Notice
the presence of GFP-CTCFL-positive cells in the upper half of the tubule and their absence in the bottom half, indicating a transient population
of cells. In (K-M) a high-magnification view of the same GFP-CTCFL-positive cells is shown. Notice the non-homogenous distribution of
GFP-CTCFL in the nucleus. In (N-P) GFP-CTCF staining is shown. For clarity, some of the cell types are encircled, and their position is indicated in
the other panels using white arrowheads. Pl=preleptone spermatocyte; rs= round spermatid; pa=pachytene spermatocyte; se= Sertoli cell. Bars,
H-J: 70 μm, K-M: 10 μm, N-P: 25 μm.
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From day 28 onwards Ctcfl mutant mice displayed loss of
germ cells by apoptosis and an increasing level of atrophy
that increased with age (Figure 3C, D). Mitotic spermato-
gonia, staining positive for BrdU incorporation, were still
often observed (Figure 3E), whereas SCP3, a marker for
spermatocytes, revealed severe tubule disorganization
(Figure 3F). In fact, the level of atrophy and disorganization
between individual mice and between individual
Figure 3 (See legend on next page.)
Table 1 Sub-fertility of CTCFL mutant mice
Genotype Ctcfl del/+ Ctcfl del/del
Number (percentage) of breedings
w/o offspring
3/60 (5%) 14/27 (51.9%)
Average number of offspring per
litter (± SD)
7.7 ± 2.6 6.4 ± 2.8
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seminiferous tubules within mice was variable, and normal
seminiferous tubules could even be adjacent to abnormal
ones. Thus, the penetrance of the atrophic testes and steril-
ity phenotype in CTCFL deficiency is incomplete and dif-
fers considerably per mouse.
Next we performed a microarray analysis on day 23
testis mRNA (a time point that precedes the start of apop-
tosis and degeneration in the testes of CTCFL-deficient
mice) on Ctcfldel/del and Ctcfldel/+ littermates. This
revealed several affected genes in Ctcfldel/del testes
(Figure 4A). The Prss50 and Gal3st1 genes were most
downregulated (~1.5 fold), which matches results from
another study [26]. Real-time RT-PCR verified results
from the microarray (Figure 4B).
GAL3ST1 is crucial for spermatogenesis as mutant mice
are infertile because of an arrest at the end of the meiotic
prophase [35]. PRSS50 (Testis Specific Protease) has an
exclusively testicular expression pattern, and is detected
both in CTCFL-positive cells as well as in later stages of
spermatogenesis [36], including STRA8/CTCFL-negative
pachytene spermatocytes (Figure 3G). Since a CTCFL-
deficiency affects differentiation of cells subsequent to the
preleptotene stage, the reduction in Prss50 and Gal3st1
mRNA may be the result of a reduction in the number of
cells going through meiosis or a reduction in Prss50 and
Gal3st1 mRNA per cell. We therefore investigated PRSS50
expression in sections of wild-type and CTCFL-mutant
mice and noted reduced protein levels per cell
(Figure 4C).
CTCFL regulates testis-specific gene expression
The whole genome DNA-binding profile for CTCF has
been elucidated in several cell systems (see, for example,
[6-9]). We sought to compare the DNA-binding profiles
for CTCF and CTCFL in the same cell type. Since CTCF
is ubiquitously expressed in the testis, whereas the pres-
ence of CTCFL is highly restricted, genome-wide DNA-
binding patterns derived from whole or partially purified
testis preparations cannot be compared (see Discussion).
We therefore generated ES cells, a cell type closely related
to germ cells [37-40], in which expression of a V5- and
GFP-tagged CTCFL protein could be induced (Figure 5A),
thereby mimicking the CTCFL-positive germ cells that ex-
press both CTCFL and CTCF. Advantages of this system
are furthermore the unlimited source of cells and the pos-
sibility to sort for GFP-positive cells that express the fu-
sion protein to obtain a pure population of cells. In
addition, the V5 tag permits stringent and exclusive
immunoprecipitation of CTCFL. Thus, with this system
genome-wide RNA (micro-arrays) and DNA-binding
studies (ChIP-Seq) were carried out (Figures 5B).
Comparison of the expression of all genes on the
microarray to expression of genes bound by CTCF or
CTCFL revealed that the CTCFL-bound genes were, on
average, more abundantly expressed (Figure 5C). The
same held true when CTCFL-bound genes were com-
pared to random gene sets (not shown). These data indi-
cate that CTCFL associates with active genes. Several
genes upregulated in CTCFL-GFP-V5-induced ES cells
were also detected in the list of genes downregulated in
CTCFL-deficient testes. Real-time RT-PCR confirmed
that Gal3st1, Prss50 and even Stra8 expression were
upregulated in CTCFL-induced ES cells (Figure 5D).
Thus, CTCFL can act on male-specific germ cell genes
in ES cells, and two of the most downregulated genes in
CTCFL-deficient testis are upregulated in CTCFL-GFP-
V5-expressing ES cells. These data underscore the no-
tion that ES cells resemble germ cells and indicate that
CTCFL acts as a male germ cell gene regulator.
Genome-wide binding of CTCFL and CTCF
To determine the genome-wide binding pattern of
CTCFL, we used GFP-sorted CTCFLV5-GFP-induced ES
cells, which express both CTCFL and CTCF. The V5
(See figure on previous page.)
Figure 3 CTCFL is important for spermatogenesis. A Testicular weight distribution. The testicular weight of Ctcfl heterozygous (Ctcfl del/+;
diamonds) and homozygous (Ctcfl del/del; circles) mice was measured and plotted as a normalized probability distribution (i.e., the surface under the
curve represents a total probability of 1). Testes of knockout mice are significantly smaller (p< 0.0005, t-test). White symbols represent infertile
males, black symbols are fertile males, and grey symbols correspond to males not tested for fertility. B Ctcfl mutant mice display reduced fertility.
Epididymal sperm count from Ctcfl heterozygous (Ctcfl del/+; black bar) and homozygous (Ctcfl del/del; grey bar) mice. Standard deviation is plotted
(p= 0.0002, n= 4). C Testis histology. In the left three panels a timed series of HE-stained testicle sections is shown (postnatal day 21, 28, 90), while
in the right hand panel an apoptosis assay (TUNEL staining) of testicle sections at day 90 is shown. Note that in CTCFL-deficient testes some
seminiferous tubules appear normal, whereas others (which can be adjacent to the normal ones) have lost most of their meiotic and
post-meiotic germ cells, leaving only mitotic spermatogonia (that stain positive for BrdU incorporation, see panel E) and Sertoli cells. Yet other
tubules contain disorganized spermatocytes, and some of them even elongated sperm. Thus, there is no absolute block in differentiation or
progression of germ cell development, but the incomplete penetrance of the infertility phenotype is however directly linked to the testicle
weight (panel A) and to the degenerative level of the seminiferous tubules. D Apoptosis plot. Number of TUNEL-positive apoptotic cells per 100
seminiferous tubules counted at day 28 and day 90. Standard deviation of three animals per genotype and time point is indicated. E DNA
synthesis marked by a 1-h pulse of BrdU in day 40 testicles reveals that mitotic spermatogonia are still present in degenerated tubules.
Counterstaining with hematoxylin. F SCP3 staining in spermatocytes of day 90 testicles as a marker for tubule organization. G PRSS50 co-localizes
only partially with STRA8. Immunofluorescence staining with a STRA8 antibody (top panel) or PRSS50 antibody (bottom panel) of adult testicle
sections shows that PRSS50 and STRA8 expression overlaps only partially. Scale bars are 50 μm.
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antibody was used for ChIP of CTCFL, with non-induced
ES cells as control. Normal ES cells and a rabbit poly-
clonal antibody to CTCF [4] were used for ChIP-
sequencing of CTCF. ChIP- sequencing revealed 5707
CTCFL and 37691 CTCF-binding sites (Figure 5E). To
validate our data, we compared the number and position
of CTCF sites determined by us with published data from
the same cell type [7] and found a very high overlap
(Figure 5F). Sorting the CTCFL-binding sites on the num-
ber of unique sequence reads yielded a list of genes that
was headed by Stra8 and Prss50 (Table 2), two genes that
are upregulated in CTCFL-inducible ES cells. Thus, the
most prominent CTCFL sites locate at genes that are im-
portant for germ cells.
Interestingly, only 64% (3677) of CTCFL sites overlap
with those of CTCF; conversely, only ~10% of CTCF sites
are bound by CTCFL (Figure 5E). Despite their partial over-
lap, CTCFL and CTCF bind almost identical consensus
sequences (Figure 5G). The most notable differences in the
DNA-binding motif are the lower prevalence of a C at posi-
tions 1 and 2, the absence of A at position 3 and a lower
prevalence for A at position 6, as well as a higher preva-
lence of G at positions 8 and 11, for the CTCFL motif rela-
tive to the one of CTCF. Whether subtle motif differences
relate to differences in numbers of binding sites or to
effects mediated through CTCFL and/or CTCF are ques-
tions currently under investigation. We also noted that,
similar to CTCF [6,9,41], not all binding sites for CTCFL
contain a consensus motif (Figure 5F).
Nucleosome occupancy specifies binding of CTCFL versus
CTCF
Further analysis of the genome-wide binding of CTCF(L)
revealed that CTCFL binds almost exclusively to CTCF
consensus sites near promoter areas, in contrast to CTCF
(Figure 6A, B). We next split CTCF(L)-binding sites into
three groups, i.e., CTCFL-only sites, CTCFL+CTCF sites
and CTCF-only sites, and compared CTCF(L) binding to
published data sets of transcription factors and other
chromatin constituents. Binding sites are shown as heat-
maps, which represent individual ChIP-Seq profiles from -
2 kb to +2 kb relative to the center (peak maximum) of
the analyzed peaks (Figure 6C) and as cumulative profiles
(Figure 6D, E), which represent average ChIP-Seq profiles.
Sites were sorted for binding strength within the three
subsets. This comparative analysis revealed, for example,
that CTCFL colocalizes with cohesin at CTCF consensus
sites that are not occupied by CTCF (Figure 6C, D). In
addition, CTCFL is enriched at transcriptionally active
promoters, which are marked by H3K4me3 and PolII
phosphorylation on serine 5 (Figure 6C, D). By contrast,
CTCF-only sites are not associated with these marks.
These data confirm the observation that CTCFL associ-
ates with transcriptionally active genes (see Figure 5C).
Figure 4 Regulation of testis-specific genes by CTCFL. A
Heatmap representation of microarray data. We compared five
samples from heterozygous and three samples from homozygous
Ctcfl knockout mice. Depicted are the top 27 deregulated genes,
where the log2-transformed fold change compared to the average
expression in heterozygous testis is shown. B Expression analyses in
Ctcfl mutant testes. Real-time RTPCR expression analyses on testis
RNA from Ctcfl mutant mice relative to wild type using Ccna1 as
reference. Genes were examined in 90-day-old testes. C Reduced
PRSS50 expression in Ctcfl mutant testis. Immunofluorescence
analysis of testis sections from heterozygous (del/+) and
homozygous (del/del) Ctcfl knockout mice, using antibodies against
PRSS50.
Table 2 Top ten CTCFL-binding sites in induced ES cells
Chr Position Gene CTCFL bound* CTCF bound
1 6 34,872,000 Stra8 134 Yes
2 9 110,760,000 Tsp50 113 Yes
3 14 103,450,500 Irg1 105 Yes
4 9 106,114,000 Twf2 101 Yes
5 9 50,260,500 - 100 Yes
6 5 125,061,000 Tctn2 97 Yes
7 8 107,058,500 Nae1 95 Yes
8 2 29,475,000 Rapgef1 94 Yes
9 9 108,838,500 Uqcrc1 93 Yes
10 12 112,970,500 Bag5 92 Yes
*Sites are ranked based on the number of ChIP-sequence reads, filtered for
duplicates.
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Figure 5 Genome-wide analysis of CTCFL expression in ES cells. A Inducible expression of CTCFL-V5-GFP in ES cells. Notice the nuclear
localization of CTCFL-V5-GFP in cells expressing the protein. B Flow chart of experiments. ES cells with a Tet-on inducible expression of a
CTCFLV5-GFP transgene were sorted for GFP and used for microarray and ChIP-Seq analyses. C CTCFL expression and DNA binding are associated
with elevated gene expression levels. We plotted gene expression levels, as determined by microarray analysis of induced (ind) or non-induced ES
cells, for all genes (all), or those bound by CTCF, or CTCFL, to the respective promoter region (−2 k to +1 kb around TSS). Differences are highly
significant (p-value CTCF-ind versus CTCFL-ind: 5.1 × e-14; p-value CTCF versus CTCFL: 5.9 × e-13). D Transcript analyses in ES cells expressing
CTCFL-V5-GFP. Real-time RT-PCR expression analyses of CTCFL-V5-GFP-induced and GFP-sorted ES cells, relative to non-induced ES cells, for
the indicated genes, referenced to Cdk2 expression. E Venn diagram of DNA-binding sites for CTCFL and CTCF. F Clustered heatmap
representation of three classes of CTCF/CTCFL-binding sites. Shown are the binding profiles of CTCFL and CTCF (1: our own data; 2: [7]) across
all CTCF/CTCFL-binding sites identified in mES cells. Sites are grouped into CTCFL-only, CTCF-only, and combined CTCFL and CTCF sites.
Within the three classes, data sets were sorted decreasingly from top to bottom for average binding across the interval from 2 kb to +2 kb
around the identified binding peak center positions. Additionally the occurrences of predicted CTCFL motifs within these intervals are plotted.
G Motif comparison of CTCF and CTCFL. DNA-binding motif for CTCFL-only (top panel), CTCF + CTCFL (middle panel) and CTCF-only binding
sites (bottom panel).
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When we compared binding of CTCF(L) to that of his-
tone H3 we noted that CTCFL preferentially binds large
H3-depleted areas (Figure 6C, D). By contrast, CTCF is
enriched on sites that display H3 phasing around the
CTCF-binding site (Figure 6D). These sites, in turn, do
not attract CTCFL. Shared CTCFL/CTCF sites associate
with “intermediate” H3-free regions (Figure 6C, D). As the
H3-binding site analysis was performed in ES cells that do
not express CTCFL, we conclude that the H3 depletion in
these cells is not caused by CTCFL, but that H3-depleted
regions appear to attract CTCFL.
It has been observed that many “H3-free” regions in
the genome in actual fact do contain histones, but that
these are loosely assembled and are lost upon DNA ex-
traction with high salt [44]. The variant histone H3.3 has
been shown to occupy these areas, often together with
another variant histone, H2A.Z [45]. We therefore com-
pared CTCFL binding to that of H3.3 (for which data
Figure 6 Characterization of CTCFL and CTCF binding. A A large fraction of CTCFL-binding sites is located close to promoters. We
determined for each CTCFL-only-binding site the distance to the nearest transcriptional start site (TSS) and plotted the frequencies of binding
sites in the depicted window from −40 kb to +40 kb around the center of CTCFL-binding sites. CTCF is plotted as comparison. B Comparison of
the genomic distribution of CTCF- and CTCFL-binding sites. Sites are separated into CTCF-only, CTCFL-only and (CTCF+ CTCF). The entire genome
is also plotted (all). The binding location is separated into exon, intron, intergenic, transcription start site (TSS) and transcriptional end sites (TES),
and plotted as frequencies of total (Y ax). C Clustered heatmap representation of the three different classes of CTCF/CTCFL-binding sites with
respect to chromatin context. We compared CTCF and CTCFL binding to published ChIP-sequencing data sets for the cohesin complex subunit
Smc1, H3K4me3, a phosphorylated form (serine 5) of RNA PolII, (PolIISer5P) and histone H3 [8,42,43]. D Cumulative profiles across the three
different classes of CTCF/CTCFL-binding sites with respect to chromatin context. The average ChIP-sequencing profiles are shown for the same
data sets as in (C). E Cumulative profiles across the three different classes of CTCF/CTCFL-binding sites with respect to H3.3.
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are available in mouse ES cells [46]) and found that
these two proteins colocalize (Figure 6E), whereas CTCF
does not associate with H3.3-enriched regions. We con-
clude that in addition to nucleotide sequence, nucleo-
some occupancy and composition specify the genome-
wide binding of CTCFL and, surprisingly, of CTCF.
Competition between CTCFL and CTCF on distinct sites
ChIP-sequencing and direct ChIP experiments showed
that CTCF and CTCFL bind the same site within the
Stra8 and Prss50 promoters, but not in the Gal3st1 pro-
moter (Figure 7A). We therefore tested the idea that
these two proteins compete for binding on selected sites.
Using in vitro band shift assays, we confirmed that
CTCFL and CTCF bind the Stra8 and Prss50 promoters
(Figure 7B, C). When proteins were added together we
did not observe a higher band, indicating that CTCF and
CTCFL do not interact to bind a probe simultaneously
(Figure 7C). Instead, with increasing amounts of CTCFL,
the amount of bound CTCF diminished (Figure 7C),
suggesting that CTCFL and CTCF compete for binding
sites in vitro.
To examine whether competition occurs in vivo, we used
ChIP analysis on CTCFL-induced and -non-induced ES
cells using a selected number of sites. In the presence of
CTCFL, the amount of bound CTCF was reduced for both
Stra8 and Prss50 (Figure 7D). CTCFL induction had no ef-
fect on CTCF in the CTCF-only-binding site within the
Chr10 locus (Figure 7D). However, for the shared CTCFL/
CTCF-binding site at Vps18 we also saw no effect on CTCF
binding (Figure 7D). These ChIP results indicate that
CTCFL can compete with CTCF, but only at specific sites.
To test this hypothesis on a genome-wide level, we transi-
ently transfected GFP-CTCFL into ES cells and examined
differences in CTCF binding in ES cells expressing GFP-
CTCFL compared to cells not expressing this protein. As
shown in Figure 7E (left panel), in the presence of CTCFL,
binding of CTCF was reduced on ~1,100 sites, whereas
binding on ~100 sites was increased. Binding of CTCF to
the affected sites was significantly reduced as compared to
all CTCF-binding sites (Figure 7E, right panel). Among sites
displaying reduced CTCF binding were the Prss50 and
Stra8 promoters, but not Vps18 and chromosome 10 bind-
ing sites (not shown). These results are consistent with the
ChIP data (Figure 7D). We conclude that in ES cells,
CTCFL and CTCF compete on distinct sites.
To estimate the physiological relevance of our genome-
wide ES cell data we performed ChIP using antibodies
against CTCFL and CTCF on selected sites in cells isolated
from wild-type testis by elutriation. Results show preferen-
tial binding of CTCFL to the Stra8 and Prss50 promoters,
and preferential binding of CTCF to Vps18 (Figure 7F), in-
dicating that the differential binding pattern of CTCF and
CTCFL observed in ES cells is present in testis as well.
CTCFL is functionally different from CTCF
The co-expression of CTCFL and CTCF in late sperm-
atogonia and preleptotene spermatocytes combined with
their differential genome-wide binding patterns raises
the question whether CTCFL and CTCF are functionally
redundant, complementary or antagonistic. To test
whether CTCFL can functionally substitute for CTCF,
we designed an ES cell rescue assay (Figure 8A). ES cell
lines were derived from mice carrying the conditional
Ctcf knockout allele (Ctcf lox/lox [4]). Ctcf is deleted upon
lentivirus-mediated Cre recombination, and these cells
fail to form colonies because CTCF-deficient cells
(Ctcfdel/del) do not survive. A rescue of cell death by
concurrent introduction of CTCFL would show that the
two proteins compensate for each other.
Using this strategy we co-expressed Cre with GFP-tagged
mouse CTCF, YFP-tagged chicken CTCF or GFP-tagged
mouse CTCFL in Ctcflox/lox ES cells (Figure 8A). Resulting
colonies were analyzed on the DNA level for Cre-mediated
CTCF deletion of Ctcf lox/lox into Ctcfdel/del (Figure 8B) and
on the protein level for expression of endogenous or ex-
ogenous protein (Figure 8C). A few surviving colonies
transduced with Cre-only were observed (Table 3), but
these had not performed the Cre-mediated CTCF deletion
completely and thus still expressed endogenous CTCF
(Figure 8B, C). However, nearly all colonies transduced with
N- or C-terminally tagged mouse CTCF, or with C-
terminally tagged chicken CTCF, had deleted endogenous
Ctcflox/lox, and expressed fluorescently tagged exogenously
introduced protein (Figure 8B, C, Table 3). Thus GFP-
tagged mouse CTCF and even chicken CTCF, which is 96%
identical at the amino acid level to mouse, can functionally
substitute for endogenous CTCF.
Strikingly, rescue experiments with GFP-tagged mouse
CTCFL yielded no ES cells in which both endogenous
Ctcflox/lox alleles were deleted and wild-type protein was
replaced (Figure 8B, C, Table 3). These data indicate that ei-
ther CTCFL and CTCF are not interchangeable or that
GFP-CTCFL is not a functional protein. To demonstrate
that GFP-CTCFL is functional, we transiently transfected
the protein into ES cells and examined DNA binding of
GFP-CTCFL on selected sites and the induction of expres-
sion of testis-specific genes. ChIP experiments showed that
GFP-CTCFL binds the three selected sites (Figure 8D) and
that Gal3st1, Stra8 and Prss50 expression is induced inES
cells expressing this fusion protein (Figure 8E). These data
demonstrate that GFP-CTCFL is functional.
Discussion
We have used a combination of approaches and technolo-
gies to unravel the physiological function of the testis-
specific paralog of CTCF, called CTCFL or BORIS. We find
that CTCFL is only expressed in late spermatogonia and
preleptotene spermatocytes, and that CTCFL-deficient mice
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Figure 7 Characterization of CTCF and CTCFL binding. A Examples of CTCF- and CTCFL-binding site location. The genomic location of CTCF
(upper part) and CTCFL (middle and bottom parts) binding sites in the absence (−CTCFL, middle) or presence (+CTCFL, bottom) of CTCFL, within
the Stra8, Prss50 and Gal3st1 genes. The vertical axes show the number of unique sequence reads. B CTCFL binds to Stra8 and Prss50. Band shift
analyses of GFP-CTCFL on Stra8 and Prss50 fragments. GFP-CTCFL binding can be super shifted (marked with asterisks) with anti-GFP, but not
with an Actin antibody. Band shifts were performed under excess probe conditions. C In vitro effect of CTCFL on CTCF binding. Band shift
analyses with GFP-CTCF and/or GFP-CTCFL on Prss50- and Stra8-bindings sites. GFP-CTCFL is added in increasing amounts (1-, 2-, 5- and 10-fold
compared to GFP-CTCF). To allow competition, the band shift was performed under probe-limiting concentrations. D Cellular effect of CTCFL on
CTCF binding. ChIP analyses with CTCFL (blue), CTCF (red) and pre-immune (yellow) antisera in ES cells that were either non-transfected (−) or
transiently transfected CTCFL-V5-GFP (+). According to ChIP-sequencing data, Prss50, Stra8 and Vps18 bind both CTCF and CTCFL, whereas
Gal3st1 only binds CTCFL, and Chr10 only binds CTCF. A CTCF- and CTCFL-negative site within the Amylase gene is used as reference and set to
1. Error bars represent standard deviations of biological replicates. E Competition between CTCF and CTCFL in ES cells. Genome-wide binding of
CTCF was compared to that of CTCFL by ChIP-Seq using non-transfected ES cells and ES cells transiently transfected with GFP-CTCFL. The left
hand panel shows the effect of CTCFL binding on shared CTCFL/CTCF sites that showed >1.5 fold difference in CTCF binding. The effect is
categorized into sites with increased (up) or decreased (down) CTCF binding. The right hand panel shows a more general effect of CTCFL binding
on CTCF binding. Here, we examined the change in CTCF binding in all shared CTCF(L)-binding sites (all) compared to those shared sites that
were significantly changed in CTCF binding (changed). The effect on CTCF binding is plotted as log2-fold difference. F In vivo CTCF(L) binding.
ChIP was performed using anti-CTCF (red) or anti-CTCFL (blue) antibodies, or pre-immune serum, on the indicated sites (A: Amylase, S: Stra8, P:
Prss50, V: Vps18) in nuclei from dissociated seminiferous tubules, partly purified by elutriation. Relative enrichment is shown compared to
Amylase.
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have defects in spermatogenesis. CTCFL and CTCF are
functionally different proteins. CTCFL therefore has a
unique role in the adult testis. It has been proposed that
CTCFL is involved in genomic imprinting of the Igf2-H19
locus and other sites [19,24]. However, imprint-related
mutations often have embryonic phenotypes [25]. We did
not observe this in Ctcfldel/del mice, and despite their
reduced fertility Ctcfldel/del mice could be bred through
multiple generations. Furthermore, we have not been able
to detect DNA methylation aberrations in specific loci in
Ctcfldel/del mutant mice and in CTCFL-over-expressing cells
(data not shown). This makes a role for CTCFL in DNA
methylation-dependent genomic imprinting unlikely. The
combined microarray data from CTCFL-deficient testis and
CTCFL-expressing ES cells, and the preference of CTCFL
for promoters instead suggest a function as a transcriptional
regulator, required for the proper expression of a subset of
male germ cell genes.
Figure 8 CTCFL is functionally different from CTCF A Strategy for the rescue of CTCF-depleted ES cells. Ctcf lox/lox ES cells were infected with
lentivirus containing the Cre recombinase and/or fluorescently tagged CTCF(L) proteins. After infection neomycin-resistant colonies were picked
and analyzed. m=mouse, g= chicken. B Analysis of Ctcf lox/lox deletion. After infection with CRE-containing constructs, Ctcf lox/lox ES cells were
scored for the status of the conditional Ctcf alleles by DNA blot. The position of wild-type (wt), deleted (Ctcf del, or del) and conditional (Ctcf lox, or
lox) loci in control ES cells (C), non-treated Ctcf lox/lox ES cells (1) and lentivirally transduced Ctcf lox/lox ES cells (2–5, see panel A for numbering of
constructs) is indicated. Cells are considered rescued when both conditional CTCF alleles have been deleted. C Analysis of CTCF protein
expression. Neomycin-resistant colonies were grown and analyzed by Western blot for CTCF (upper panel) or GFP (lower panel) expression. Note
that rescued cells are negative for endogenous CTCF. D, E GFP-CTCFL is a functional protein. ES cells were transiently transfected and harvested
after 1 day. ChIP (DNA, D) and RT-PCR (mRNA, E) analyses revealed that GFP-CTCFL binds Vps18, Stra8 and Prss50 promoters (D) and is able to
induce expression of Gal3st1, Stra8 and Prss50 (E).
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The most prominent CTCFL-binding sites in ES cells
are on the promoters of the testis-specific Stra8 and
Prss50 genes. The expression of these genes, and of
Gal3st1, is upregulated in ES cells expressing CTCFL.
Conversely, expression of Prss50 and Gal3st1 is downre-
gulated in germ cells lacking CTCFL, at all ages exam-
ined, whereas Stra8 expression is affected at some but
not all ages (data not shown). We speculate that the
combined transcriptional deregulation of genes causes
the testicular degeneration and reduction in fertility in
Ctcfl knockout mice. Note that the expression of these
genes is not completely hampered, which explains why
the testicular phenotype in the knockouts is milder than
the fully sterile phenotype described, for example, for
STRA8- and GAL3ST1-deficient mice [29,30,35].
The phenotype of the Ctcfldel/del mice reported here only
partly matches a recent report on another strain of CTCFL-
deficient mice, in which exons 1 to 8 of Ctcfl were also
deleted [26]. For example, the effect of a Ctcfl deletion on
the average testicular size and on Gal3st1 and Prss50 ex-
pression is similar. However, our analysis also reveals a re-
duction in fertility in the Ctcfldel/del mice not noted
previously [26]. In addition, the fact that some Ctcfldel/del
mice have normal testis size and others have a combination
of normal and abnormal seminiferous tubules was also not
described. This is relevant, as this incomplete penetrance of
the Ctcfl phenotype, even within a single testis, suggests
that a stochastic mechanism determines whether CTCFL-
deficient tubules degenerate or not. Finally, CTCFL was
proposed to be present in round spermatids and to function
during meiosis based on mRNA expression data [26]. By
contrast, our data show that CTCFL is expressed earlier,
just prior to the onset of meiosis, and we conclude that
CTCFL protein expression precedes the developmental
germ cell stages that show the major phenotypes in Ctcfl
knockout mice. We propose that in the absence of CTCFL,
epigenetic marks controlled by this protein gradually break
down in a stochastic manner. Spermatogonia and primary
spermatocytes exist in syncitia, in which each cell is con-
nected with the other cells at the same step of development
via intercellular bridges. Only in syncytia where the expres-
sion of CTCFL-controlled genes has been affected beyond a
specific threshold will degeneration become apparent.
Neither CTCFL nor CTCF is saturating all consensus-
binding sites present in the genome, and thus the DNA se-
quence is not the sole determinant of CTCF(L) binding.
DNA methylation and hydroxymethylation are not a de-
cisive aspect, as comparisons of DNA (hydroxy)methylation
data sets to our CTCF(L)-binding sites does not provide an
explanation for why CTCFL and CTCF occupy different
binding sites (data not shown) [47]. Instead, the data sug-
gest that binding of CTCFL and of the “master weaver”
CTCF is specified by nucleosome occupancy and compos-
ition. We find that CTCFL prefers CTCF consensus sites in
promoters that are embedded in regions that appear to be
nucleosome-free. By contrast, CTCF is enriched on distinct
sites, which are devoid of histone H3 on the binding site it-
self, but which are surrounded by ordered, or “phased,”
nucleosomes. This preference of CTCF has already been
described [11-13].
It has recently been shown that unstable nucleosomes are
lost when histones are prepared with conventional condi-
tions; thus, regions containing these histones appear as
nucleosome-free in the analysis, but are in reality not free
[45]. Nucleosomes containing the variant histone H3.3 are
quite unstable, and those containing both H3.3 and H2A.Z
even less [44]. Since we find a correlation between CTCFL
binding and H3.3 occupancy in ES cells, H3.3 and H3.3/
H2A.Z might be determinant factors able to attract CTCFL
and evict CTCF. It is important to realize that in ES cells
H3.3-enriched genomic regions do not require CTCFL to
be set up, yet the protein prefers such areas after its induc-
tion. A similar situation may exist in testis, i.e., specific
H3.3/H2A.Z-containing regions might be set up during
early phases of spermatogenesis; upon its expression,
CTCFL “lands” on these regions, possibly evicting CTCF
from some promoters. Notably, during male meiosis, and
thus subsequent to CTCFL expression, H3.3 is incorporated
into unsynapsed chromatin, which is transcriptionally in-
active [48]. The function of CTCFL might be to ensure the
expression status of genes by distinguishing specific
promoter-associated H3.3 domains from whole chromo-
some domains that also contain H3.3. Through its inter-
action with SET1A [49], CTCFL might enhance H3K4
trimethylation at a subset of its binding sites.
The cohesin complex has a role in chromosome segre-
gation, DNA-damage repair and gene regulation [50].
Although cohesin does not have a typical DNA-binding
motif, it was shown to bind primarily to CTCF consen-
sus sites [16,17,51]. Moreover, the SA2 subunit of cohe-
sin directly interacts with the C-terminus of CTCF [52].
Table 3 Rescue of CTCF-deficient ES cells by exogenously
introduced GFP-CTCF(L)
Species Construct Deletion
in ES
cells**
Partial
deletion in
ES cells**
No deletion
in ES
cells**
Functional
CTCF
substitution
N.a.* GFP-CRE 0% (0/65) 28% (18/65) 72% (47/65) No
Mouse GFPCTCFL- 0% (0/18) 50% (9/18) 50% (9/18) No
Mouse CTCFGFP-
CRE
83% (19/23) 0% (0/23) 17% (4/23) Yes
Mouse GFPCTCF-
CRE
95% (40/42) 2% (1/42) 2% (1/42) Yes
Chicken CTCFYFP-
CRE
90% (37/41) 2% (1/41) 7% (3/41) Yes
*: Not applicable.
**: Percentage and number of clones (between brackets) in which the
conditional CTCF alleles were deleted, partially deleted or not deleted are
shown.
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Cohesin’s role in gene regulation therefore seems tied
to that of CTCF. Recent studies revealed that also in ES
cells cohesin binding largely overlaps with that of CTCF;
however, there are ~2,000 cohesin sites with a CTCF
motif that do not bind CTCF, while ~270 other cohesin
sites do not have a CTCF consensus site [10]. Our data
suggest that CTCFL binds these ~2,000 cohesin sites in
CTCFL-GFP-V5-expressing ES cells.
However, in normal ES cells CTCFL is not expressed,
raising the questions how a specific nucleosome com-
position and occupancy can be built around CTCF con-
sensus sites that appear not to be occupied by CTCF,
and how cohesin can stably bind these very same sites.
We hypothesize that these sites might be bound by a
modified form of CTCF, such as poly(ADP-ribosyl)ated
CTCF [53]. This protein would not be able to bind DNA
tightly and could be replaced very efficiently by CTCFL.
Perhaps another molecular function of CTCFL in the
testes is to interfere with and/or change the dynamics of
CTCF and cohesin-mediated chromatin looping.
We observed competition between CTCF and CTCFL in
ES cells, but only on a small subset of all CTCF-binding
sites. Nucleosome occupancy and composition, CTCF(L)
expression levels and posttranslational modifications on
CTCF(L) could all determine whether competition between
the proteins occurs on a given site. Our data reveal that
CTCF and CTCFL co-localize within the nuclei of late
spermatogonia and preleptotene spermatocytes, and the
proteins might therefore also compete in vivo. ChIP experi-
ments in testis extracts indeed reveal preferential binding of
CTCFL at the Stra8 and Prss50 promoters and exclusive
binding of CTCF to the Vps18 site. These data are consist-
ent with binding profiles in ES cells. If competition on the
Stra8 and Prss50 genes does occur in vivo, then CTCFL
could be a gene activator by preventing the binding of
CTCF. In Ctcfl knockout mice binding of CTCF to these
genes might actually diminish their expression. However,
CTCF is ubiquitously expressed in the testis, whereas
CTCFL is only transiently present in spermatogonia and
preleptotene germ cells. One would expect to see significant
binding of CTCF to the Stra8 and Prss50 sites in the tes-
ticular extracts that we used, since most cells in these
extracts contain CTCF and not CTCFL. The questions why
CTCF is not highly enriched on the Stra8 and Prss50 pro-
moters in testis, and whether these proteins compete
in vivo can only be answered once there are tools available
to isolate CTCFL-positive and -negative cell populations
from testis so that genome-wide analyses can be performed
on purified testicular fractions.
In human germ cell tumors, CTCFL is specifically upre-
gulated in spermatocytic seminomas, which are benign
testicular tumors originating from a spermatogonium or
primary spermatocyte [54]. This fits with our observed
cellular localization of CTCFL and could potentially point
to an oncogenic role for CTCFL in these tumors. In fact,
CTCFL belongs to the group of cancer testis antigens
(CTAs), genes that are normally expressed in testis yet ab-
errantly expressed in a variety of cancers. One model
holds that competition between CTCF and CTCFL plays a
role in tumorigenesis, i.e., aberrant CTCFL expression
would displace CTCF, and affect DNA methylation and
the expression of other CTAs, including the NY-ESO-1
and MAGE-A1 genes [22,23], and even other important
genes, such as the TERT gene, which encodes telomerase
[55]. However, while there might be a relationship be-
tween DNA demethylation and the expression of CTAs
[56], recent reports have shown that expression of CTCFL
alone is not sufficient to induce expression of CTAs
[27,57]. Furthermore, our data in CTCFL- deficient testis
indicate that, if anything, CTCFL represses the Tert gene
instead of activating it. To address a potential role of
CTCFL in cancer, a correlation analysis of CTCFL bind-
ing, nucleosome occupancy and composition, and CTA
expression in different types of cancers might be more
revealing.
Conclusions
The three-dimensional folding of the eukaryotic genome
serves to compact DNA while allowing gene expression.
CTCF has been termed the “master weaver” of the gen-
ome, since this protein is a key coordinator of chromatin
loop formation. In this study we have analyzed the physio-
logical function and DNA-binding profile of CTCFL, a
protein that is highly similar to CTCF but that is only
expressed in the male germ line. Using a combination of
cell biological, biochemical and bioinformatics approaches,
we show that CTCF and CTCFL are functionally different
proteins that bind to similar sites in the genome, but
whose binding does not overlap completely. Our data sug-
gest that nucleosome composition specifies the genome-
wide binding of both CTCFL and CTCF. We show that
CTCFL is only transiently expressed, in spermatogonia
and preleptotene spermatocytes, prior to male meiosis.
We propose that during its expression CTCFL occupies a
subset of promoters and thereby maintains the expression
of selected male germ cell genes.
Methods
RACE PCR and RNase protection assay
Human CTCFL was shown to consist of 23 isoforms with
variations in N- and C-termini and zinc finger modules
with different DNA-binding and transcriptional character-
istics [58]. To analyze the genomic organization of the
murine Ctcfl gene, we cloned the 5’ end of the Ctcfl cDNA
by a rapid amplification of cDNA ends-polymerase chain
reaction (RACE-PCR) procedure, using first choice RACE
ready testicular cDNA from Balb/c mice (Ambion) and
nested oligos (see Table 4 for sequence). Compared to the
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published murine Ctcfl sequence [19], the RACE-PCR-
derived first Ctcfl exon is smaller and lacks an upstream
ATG, and it is preceded by an intron of 489 bp and an
additional exon of 130 bp (see also panel 1C). The se-
quence of the Ctcfl 5’end product has been submitted to
Genbank (accession no.: EU154995). Our cDNA structure
matches the HAVANA/VEGA curated sequences in
Ensembl, Build 36 [59].
RNase protection assay (RPA) was performed accord-
ing to the manufacturer’s instructions (RPAII, Ambion).
For Ctcfl the RPA was performed on poly A + purified
RNA with probes spanning Ctcfl exons 8 and 9 (pro-
tecting 146 bp), spanning bp 1–220 of the Ctcfl race
PCR product (up to oligo 3, see figure S1C) or, alterna-
tively, spanning bp131-220 (protecting 89 bp), to detect
the existence of another start site [19]. For Ctcf the
RPA was performed on total RNA with a probe protect-
ing 99 bp of Ctcf exon 2. The RPA with the 5’end
RACE confirms that Ctcfl mRNA mRNA contains the
additional upstream exon as identified by the RACE
PCR. We found no evidence for alternative splicing in
murine Ctcfl.
Mouse models
To generate the Ctcfl and Ctcf knockin alleles we inserted a
Gfp-encoding cDNA, followed by a Loxp-flanked neomycin
selection cassette, in the Ctcfl and Ctcf exons, respectively,
that contain the ATG start codons. Insertion of GFP imme-
diately downstream of the translational start sites yielded
Ctcflgfp-neo and Ctcfgfp-neo ES cells. Homology arms were
generated by cloning from the RPCI21 129 PAC library
(Geneservice). Constructs were sequenced, electroporated
into isogenic ES cells (129/IB10) and neomycin- (or, later
on, puromycin-) selected, analyzed by Southern blot and
PCR, and injected into C57/Bl6 blastocysts.
Mice generated from Ctcfl gfp-neo and Ctcfgfp-neo ES cells
were crossed to transgenic mice expressing Cre to delete
the LoxP-flanked neomycin cassette. This yielded Ctcfl gfp
mice in which the GFP is fused in frame to CTCFL and
Ctcfgfp mice where GFP is fused to CTCF. These mice are
phenotypically normal and fertile (data not shown).
The Ctcfl gfp-neo ES cells were retargeted with a LoxP-
flanked puromycin cassette downstream of exon 8. Mice
were generated using the Ctcfl gfp-neo-puro ES cells. The
Ctcfldel mice were subsequently generated by crossing
Ctcfl gfp-neo-puro mice to Cre-expressing mice. This resulted
in the in vivo deletion of Ctcfl exons 1–8 and both selec-
tion cassettes as these were in between the LoxP sites.
Mice were maintained on a C57/Bl6 background at the
Erasmus MC animal care facility under specific pathogen-
free conditions. Animal experiments were reviewed and
approved by the Erasmus University committee of animal
experiments.
Cell culture, transfection and infection
The Ctcflox/lox ES cells were isolated de novo from CTCF
conditional mice [4] and grown on plastic in the pres-
ence of LIF. Lentiviral constructs were generated with
Ctcf and Ctcfl cDNAs driven from a CAG promoter
(CMV early enhancer/chicken β actin), followed by an
IRES sequence and the Cre recombinase. Expression of
a neomycin selection cassette was driven by a PGK pro-
moter. Lentivirus particles were produced as described
(Addgene). ES cells were infected in suspension for 4 h,
plated and selected with G418 the next day. Clones were
analyzed by Southern blot for the status of the Ctcflox/lox
conditional allele [4] and by Western blot using GFP
(Abcam 32146) or CTCF antibody (BD Bioscience).
For the inducible CTCFL expressing ES cells, ROSA26-
rtTA ES cells were Lipofectamine transfected (Invitrogen)
with a TRE-mCTCFL-V5-GFP-neomycin construct and
selected with G418. Clones were analyzed for the induc-
tion and expression of CTCFL-V5-GFP by flow cytometry
for GFP (FACSAria, BD Biosciences), and by Western blot
and immunofluorescence using rat monoclonal anti-
CTCFL antibodies raised against mouse CTCFL (AA 1–
113 and AA 569–635) and V5 antibody (Sigma, V8012).
Transient transfections of mCTCFL-V5-GFP and of GFP-
mCTCFL in ES cells were done with Lipofectamine 2000
(Invitrogen).
Chromatin immunoprecipitation (ChIP)
\ChIP was performed as described [14] or according to
the Magnify system procedure (Invitrogen). Briefly, prep-
aration of cross-linked chromatin (2× 107 cells treated
with 1% formaldehyde for 10 min at room temperature),
sonication of chromatin to yield fragments up to 800 bp,
and immunoprecipitation with V5-Agarose beads (Sigma,
A7345) or with polyclonal CTCF(L) antibodies [4] were
performed as described in the Upstate protocol (http://
www.upstate.com). Ct values from real-time PCR were
normalized to input measurements, and enrichment was
calculated relative to the Amylase gene. For oligos used,
see Table 4. ChIP was performed on nuclei derived from
induced or transiently transfected ES cells (see above) or
from seminiferous tubules in which multiple testicular cell
populations were first dissociated by enzymatic digestion
of seminiferous tubules and subsequently isolated by
elutriation.
ChIP-sequencing and analysis
For ChIP-sequencing a DNA library was prepared from
the ChIPped DNA according to the Illumina protocol
(www.illumina.com). Briefly, 10 ng of end-repaired DNA
was ligated to adapters, size selected on gel (200 ± 25-bp
range) and PCR amplified using Phusion polymerase as
follows: 30 s at 98 °C, 18 cycles of (10 s at 98 °C, 30 s at
65 °C, 30 s at 72 °C) and 5 min at 72 °C final extension.
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Table 4 Oligos
Oligos used for RACE PCR
Name Forward Backward
RACE GGACACTCGTATTTGGGCACATTC CACAGGGAGCACTTGAAGGGCTTC
Oligos used in real-time PCR for ChIP
Name Forward Backward
Gal3st1 TCCTGGGTGAGGTCAGGAAG GGAACTCCGAGTAGCTTCAATG
Stra8 TCCTAGAGAAGGGGGTGTTACC AGCTGACCACCACACGTTTTC
Prss50 AGAGGAGGGTAGGGGTATCGAC TCGCCTCAGCTAATTTCTAAGC
Vps18 CTGCTGCAGTTCCTCATGTTG GTGTGACAGATGGAGGAGCAC
Chr10 AAGGTTGGTAGCTCTGCTTGGACTGCTCG AATGTCACAAGCAAAGAAAAGCACGCAAAT
Amylase AATTCTCCTTGTACGGCTTCGTG TAGCAATGATGTGCACAGCTGAA
Oligos used in real-time PCR for RNA expression
Name Forward Backward
Clgn TGTCTTCCTTACTCTTCTCTTCCG GAAGCCAGGTGAAGCTGAGGTC
Ctcf CCACCTGCCAAGAAGAGAAGG GCACCTGTATTCTGATCTTCGAC
Tcfl5 ACGAGATAGGAGGCGCAGAATC GTTGTTGCTTTATCTGTCTCCG
Gal3st1testis-specific form GCTACTCGGAGTTCCGGAAA GACTTGCAGGGCTTCTTTGG
Gal3st1 ACTGTATCCCAACATGGCCTTC ATATCTCGCCGAGGTTGACAC
Stra8 GGCAGTTTACTCCCAGTCTGATA CAACTTATCCAGGCTTTCTTCCT
Prss50 GACAGTTCTCTCTGCACTGTGAC CACATTTCTTGCTGTTCAGGATA
Ctcfl GCTCTGGCTGTGCACCTTACG CCCACTGTGCCACCATCATC
Ccna1 GAGTATGCAGAGGAGATTCATCG TCATGTAGTGAGCCTTGGGTCTG
lpcat2 AGCACCCAGTGAGGAAGAGA TTCGTAGGTGTGATCCGTCA
itfg3 ACGAGGTGTCTTCTGCCTGT GTTCCCACTAAAGCTGCTGG
dio2 TGCAGATCCTGCCAGTCTTT CACACTGGAATTGGGAGCAT
hgf GATGAGTGTGCCAACAGGTG GGTCAAATTCATGGCCAAAC
akr1c18 CCAGGCCATTCTAAGCAAGA TCAGGGAATTTTCCAAGCTG
Oligos used in EMSA
Name Forward Backward
Stra8 GGATCTGTGCTGTGTGTCCTCCTCGACTCCT CCTCTAGGAGTCGCAAGTGACCCACACATGCATGC
AGAGCATGCATGTGTGGGTCACTTGCGACTC
CTAGAGGA TCTAGGAGTCGAGGAGGACACACAGCACAGATCCT
Prss50 ATCTAGGGGGCGCCACGCAGGCTGGGCACC CCACAATGGCGCCCTCCATCGGGCGCCTCATGGT
AGCGCACCATGAGGCGCCCGATGGAGGGCG GCGCTGGTGCCCAGCCTGCGTGGCGCCCCCTAGATG
CCATTGTGGA
Oligos used for generating transgenic mice and cells
Name
Oligo 1 5-TCTTTTTCCATCAGGGGTCGTCAC-3
Oligo 2 5-GAGAAGCGCGATCACATGGTCCTG-3
Oligo 3 5-GCACCGTTTGCAGGGTCAGGATC-3
Oligo 4 5-TCCAAATCACAGCGCCACCTACAG-3
Oligo 5 5-GGTTCTTAGAGATAGGGTTTCTCTG-3
Oligo 6 5-GGTGTTCTGCTGGTAGTGGTC-3
Oligo 7 5-CGGCATCAGAGCAGCCGATTG-3
Oligo 8 5-GTTATGATCTGGGTATCGTCCACTG-3
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Cluster generation was performed using the Illumina
Cluster Reagents preparation, and the library was
sequenced on the Illumina Genome Analyzer IIx plat-
form to generate 36-bp reads. Images were recorded and
analyzed by the Illumina Genome Analyzer Pipeline
(GAP) and processed using the IPAR (Integrated Pri-
mary Analysis Reporting Software) and the GAP. The re-
sultant sequences were mapped against NCBI Build 37.1
of the mouse genome using the ELAND alignment soft-
ware (Illumina).
Published data sets generated for mouse ES cells were
downloaded from NCBI’s gene expression omnibus (GEO).
We used the following data sets: H3: GSM587479, CTCF:
GSM288351 [7], Smc1: GSM560341 and GSM560342 [8],
H3K4me3: GSM594581 [42], PolIIser5p: GSM515662 [43]
and H3.3-HA: GSM423355 [46]. Reads were converted to
the fastq format and aligned to a precompiled mm9 refer-
ence index with BOWTIE [60]. In case multiple sequencing
lanes were available, fastq files were merged before align-
ment. Unambiguously mapped and unique reads were kept
for subsequent generation of binding profiles and calling of
peaks using MACS with an fdr< 0.05 [61]. Downstream
analysis was done in R/BioConductor (http://www.biocon-
ductor.org), partly according to published strategies [62].
For comparative ChIP-Seq analysis mapped reads were
transformed to continuous binding profiles. Those were
used to collect data in 4-kb windows spanning CTCF and
CTCFL binding sites. The binding sites were grouped into
three classes based on intersection analysis: sites bound by
CTCF only, CTCFL only, or both CTCF and CTCFL. The
binding data were binned across binding sites in 50-bp
windows, and the mean was calculated at each position in
order to generate cumulative binding profiles. Alterna-
tively the complete data were plotted in heatmaps. The
identified CTCFL-binding motif was used to scan the
mm9 genome using the Patser tool [63] and plotted as a
heatmap after the motif data had been binned, as
explained for the binding profiles.
RNA analyses
Expression analyses by real-time PCR were performed as
follows: total RNA was isolated with RNA-Bee (Tel-Test
Inc.). RNA was reverse transcribed (RT) with a combination
of random and oligo-dT primers by Superscript reverse
transcriptase (Invitrogen), and real-time RT-PCR was per-
formed with a Sybrgreen platform on a Bio-Rad CFX
Cycler. For oligos used, see Supplemental Information.
For testis and ES cell microarray analysis, the purity
and quality of the isolated RNA were assessed by RNA
6000 Nano assay on a 2100 Bioanalyzer (Agilent Tech-
nologies). Then 5 ug testes RNA was used for the pro-
duction of cRNA. Labeled cRNA was hybridized to the
GeneChip Mouse Genome 430 2.0 array oligonucleotide
microarray (Affymetrix) according to manufacturer’s
recommendations; 300 ng ES cell RNA was used for
production of end-labeled biotinylated ssDNA. Labeled
ssDNA was hybridized to the Mouse Gene 1.0ST array
(Affymetrix) according to manufacturer’s recommenda-
tions. Measured intensity values were analyzed using the
Gene Expression Console (Affymetrix) and normalized
by quantile normalization.
Scanned microarray data were processed using R/Bio-
conductor using standard procedures. Normalization and
background correction were done by RMA. Differentially
expressed genes were determined using the limma pack-
age within R [64]. For visualization the mean expression
was determined across the heterozygous samples, which
was then subtracted from the expression levels for the in-
dividual samples. For the analysis of the association be-
tween gene expression and CTCFL/CTCF binding, RefSeq
genes were downloaded from the UCSC genome browser
homepage. For each gene represented on the MoGene 1.0
ST array, the nearest CTCF or CTCFL site was calculated.
Genes with a binding site within an interval from −2 kb to
+1 kb around the transcriptional start sites were deter-
mined as bound. Log2-transformed expression values
derived from Affymetrix analysis of mES cells was then
plotted for the identified genes.
All Chip-seq and Microarray datasets are available at
NCBI Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) under accessions: GSE34091, GSE34092,
GSE34093 and GSE34094.
Electrophoretic mobility shift analysis (EMSA) or band
shift analysis
Nuclear extracts were obtained from mock-transfected
HEK 293 T cells and HEK 293 T transfected with pEGFP,
pEGFP-mCTCF or pEGFP-mCTCFL. After 24 h, cells
were harvested, washed with cold PBS, resuspended in
buffer 1 [10 mM HEPES; 10 mM KCl; 0.25 mM EDTA
pH 8, 0.125 M EGTA-K pH 8, 0.5 mM Spermidin, 0.1%,
NP40, 1 mM DTT, protease inhibitor cocktail set I (Cal-
biochem)] and incubated for 10 min on ice. Cells were
then centrifuged 5 min at 1,500 rpm. The supernatant was
removed, and the pellet was resuspended in 50 μl of buffer
2 [20 mM HEPES; 0.4 M NaCl; 0.25 mM EDTA, 1.5 mM
MgCl2, 0.5 mM DTT, protease inhibitor cocktail set I
(Calbiochem)] and incubated 1 h at 4 °C. Samples were
centrifuged for 30 min at 15,000 rpm, and the supernatant
(nuclear extract) was frozen at −70 °C until used.
Radiolabeled probes were generated by PCR of genomic
DNA (for oligos used, see Table 4). In all cases the PCR
was performed in a final volume of 50 μl containing 3 μl
of [α-32P]dCTP (Hartman Analytic), 20 ng of genomic
DNA (from K562 cells), 0.2 mM each dNTP, 0.5 μM of
each primer and 1U of DFS-Taq DNA polymerase
(BIORON). The PCR fragments were purified using the
Wizard SV Gel and PCR CleanUp System (Promega).
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The EMSA reaction was performed by mixing 10 μg of
the nuclear extract with 6 μl of EMSA buffer (1.5 μg of
poli-dIdC, 20 mM HEPES pH 7.5, 50 mM KCl, 5% gly-
cerol, 0.175 mM EDTA) in a volume of 19 μl. Mixtures
were pre-incubated at 25 °C for 10 min. Then 162 μl of
the radiolabeled probe was added to each condition, and
the resulting mixture was incubated for 30 additional min
at 25 °C. For competition, 10 μg of CTCF nuclear extract,
followed by increasing amounts of competing extracts,
was added to the binding reaction. Then, the mixtures
were pre-incubated as previously described. For supershift
experiments, 1 μl of anti-CTCF mouse monoclonal anti-
body (BD Biosciences) or 1 μl of anti-actin (Santa Cruz,
sc-1616), used as a non-specific antibody, was added to
the binding reaction prior to the radiolabeled probe. Com-
plexes were analyzed by electrophoresis on a 4% polyacryl-
amide gel at 160 V for 2 h with 0.5×Tris-borate-EDTA
buffer. Gels were fixed using 10% acetic acid for 10 min
and then dried for 30 min using a Gel Dryer (Bio-Rad).
Radioactive complexes were revealed using a Molecular
Imager Fx (Bio-Rad).
Pathological analysis of ctcfl knockout mice
Testis weight was determined immediately after dissec-
tion. Weights were measured within the tunica albuginea,
excluding the cauda epididymis. Sperm analysis and
counts were performed as described [33]. The epididymis
was dissected and transferred into a small conical glass
grinder, and homogenized by hand. The total number of
sperm present in the epididymis was counted using a
Neubauer hemocytometer and a phase contrast micro-
scope (magnification 400×). At least 200 sperm in two dif-
ferent samples were counted. Fertility of mice was
determined by breeding the mice to multiple mates and
scoring the number of offspring.
Immunofluorescence and immunohistochemistry
techniques
For BrdU incorporation, mice were injected intraperitone-
ally with 1.2 μg BrdU. One hour after injection, testes
were dissected, fixed in 4% paraformaldehyde or Bouin,
paraffin embedded and sectioned. For H/E staining, Bouin
or PFA fixed testes were fixed overnight at 4 °C, washed
and dehydrated using ethanol and xylene, and embedded
in paraffin. Sections of 10 μm were cut, mounted on
SuperFrost Plus slides (Menzel-gläser), rehydrated and
stained with H/E.
For immunofluorescence analyses, Bouin or PFA fixed
and paraffin embedded testes were sectioned, treated
with the microwave (three times for 5 min, 750 W) in
10 mM NaCitrate buffer (pH 6.0) to expose antigens and
stained using standard procedures. Antibodies used: Rat
monoclonal anti-CTCFL (see abobe), PRSS50 (Abcam
49405) and STRA8 (Abcam 49405).
Live imaging in seminiferous tubules
Imaging of testis tubules was performed as described
[33]. Briefly, testis were injected through the rete testis
with Hoechst 33342 and Trypan blue (Sigma) in 3–5 μl
of PBS, 1 h prior to testis dissection, to allow spreading
of the vital DNA stain throughout the adluminal com-
partment of the testis tubules and uptake by nuclei on
the adluminal side of the Sertoli cell barrier. Trypan blue
served as a marker for injected tubules. Individual sem-
iniferous tubules were isolated from testes using a col-
lagenase and hyaluronidase method, and Trypan blue
positive tubules were transferred into a drop of PBS +
with 0.2% BSA in a live-cell chamber overlaid with PBS-
saturated mineral oil. The testis tubules were examined
at 33 °C, using a Zeiss LSM510NLO confocal/multipho-
ton setup, to allow simultaneous acquisition of phase-
contrast, GFP and Hoechst images.
Additional file
Additional file 1: Movie S1. Live imaging of GFP-CTCFL. Ex vivo
confocal imaging of a live seminiferous tubule derived from a Ctcflgfp
knockin mouse. Images were acquired throughout tubules using a
combined multiphoton (Hoechst) and confocal laser (GFP) scanning
microscope setup. Images were assembled for 3D reconstruction
afterwards. The GFP-CTCFL fusion protein is shown in green. The DNA
stain Hoecht, which was injected at the adluminal site of the testis
tubule, is shown in red. Hoechst-positive cells represent Sertoli cells,
leptotene stage IX and later stage spermatocytes, and spermatids, all of
which are negative for GFP-CTCFL. Notice the presence of the
GFP-CTCFL-positive cells on one side (basal lamina) of the tubule.
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Abstract
CTCFL, the testis-specific paralogue of the highly conserved chromatin organizer 
CTCF, is expressed in type B spermatogonia and pre-leptotene spermatocytes of adult 
male mice. CTCFL binds to a 20 bp consensus sequence similar to that for CTCF, but 
is mainly located on promoters, and was proposed to regulate expression of the germ 
cell-specific factors Prss50, Stra8 and Gal3st1. To examine the transcriptional function 
of CTCFL genome-wide and in more detail, we used a novel FACS-based approach to 
separate CTCFL-expressing cells from non-expressing cells. We have shown previously 
that CTCFL and STRA8 are present in the same cells in the adult testis. We therefore 
sorted GFP+ and GFP- cell populations from a Stra8-Gfp transgenic mouse maintained 
in either a wild type or Ctcfl knock out background. RNA-Sequencing revealed specific 
enrichment of Stra8, Prss50 mRNAs in the GFP+ fractions, validating our purification 
method. Many more genes were down-regulated than up-regulated genes in the GFP+ 
Ctcfl knock out fraction, confirming the hypothesis that CTCFL is a transcriptional 
activator. Aberrant expression of Stra8 was observed in ES cells expressing a mutated 
form of CTCF and a higher level of Stra8 expression could be obtained upon exogenous 
expression of CTCFL in these ES cells compared to CTCFL induction in wild type ES 
cells. Combined our data suggest that CTCFL activates transcription of a limited number 
of genes in the testis and that CTCF acts as repressor of these genes. This suggests 
that CTCFL competes with CTCF to maintain proper gene expression in the testis.  
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Introduction 
CTCF (CCCTC-binding factor) is a highly conserved and ubiquitously expressed 
nuclear protein that coordinates higher-order chromatin structures together with cohesin and 
other factors (for review see (Phillips and Corces, 2009)). CCCTC-binding factor-Like (CTCFL), also 
known as BORIS (Brother Of the Regulator of Imprinted Sites), is less conserved and is only 
present in certain vertebrates, including amphibians, reptiles, monotremes and mammals (Hore 
et al., 2008; Loukinov et al., 2002). Both proteins have N- and C-terminal regions surrounding an 
eleven zinc finger (ZF) domain. Whereas the N- and C-termini of CTCFL and CTCF are not 
homologous, the ZF domains of these proteins are 71% identical (Loukinov et al., 2002).
In mice and humans CTCFL is virtually only expressed in the testis, suggesting a role 
for CTCFL in gametogenesis (Loukinov et al., 2002). In adult mice CTCFL is detected during early 
spermatogenesis, where it localizes in the nucleus of late spermatogonia and pre-leptotene 
spermatocytes (Sleutels et al., 2012). Ctcfl knock out mice show defects in spermatogenesis, 
which results in small testicles and reduced fertility (Sleutels et al., 2012; Suzuki et al., 2010). CTCFL 
has been proposed to activate the Prss50 (Protease serine 50), Gal3st1 (Galactose-3-O-
Sulfotransferase 1), and Stra8 (Stimulated by retinoic acid) genes (Kosaka-Suzuki et al., 2011; 
Sleutels et al., 2012; Suzuki et al., 2010). Prss50 is expressed during early spermatogenesis from 
spermatogonia to pachytene spermatocytes (Sleutels et al., 2012), but not much is known about 
the function of this protein. By contrast, Gal3st1 is crucial for spermatogenesis, since Gal3st1 
knock out mice are infertile due to an arrest at the end of the meiotic prophase (Honke et al., 2002). 
Stra8 is essential for initiation of meiosis in both males and females (Anderson et al., 2008; Baltus et 
al., 2006; Mark et al., 2008).
Genome-wide binding studies in embryonic stem cells (ES) cells overexpressing 
CTCFL revealed ~5700 sites (Sleutels et al., 2012). Of these sites ~3700 could also be bound by 
CTCF, while ~2000 sites were only bound by CTCFL. CTCFL recognizes a similar consensus 
sequence as CTCF and is able to compete with CTCF on specific genes to regulate their 
expression. CTCFL binding sites are enriched on promoters and are marked by the active 
chromatin marks H3.3 and H3K4me3 (Sleutels et al., 2012). Altogether these data suggest that the 
main function of CTCFL is to regulate transcription of genes in a germ cell-specific manner by 
binding to their promoters. 
STRA8 and CTCFL showed a completely overlapping protein expression pattern in 
the testis of adult mice (Sleutels et al., 2012). Recently, a transgenic mouse strain was generated 
in which GFP expression is regulated by a 1.4 kb region encompassing the Stra8 promoter 
(Nayernia et al., 2004). Here, we explored the feasibility of using this mouse line, on wild type 
or Ctcfl-negative background, to specifically isolate the CTCFL-expressing cell population 
from seminiferous tubules of the testis using FACS. We show that this method enables the 
fractionation of Stra8 and Prss50 RNAs into a GFP+ cell fraction. RNA-Sequencing (RNA-Seq) 
reveals that ~600 genes are down-regulated in the Ctcfl knock out GFP+ cell fraction, whereas 
~100 genes are upregulated. These data suggest that CTCFL is a transcriptional activator in 
testis that competes with CTCF as shown by functional experiments using ES cells. 
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Results
Genome-wide transcription profiles of STRA8-GFP+ and STRA8-GFP- 
germ cell fractions
STRA8 and CTCFL protein distribution completely overlaps in the testis (Sleutels et al., 
2012), which makes STRA8 a suitable marker to discriminate between CTCFL-expressing and 
non-expressing cells. Therefore, Ctcflwt/del mice were crossed with Stra8-Gfp transgenic mice to 
mark the CTCFL-expressing cells with GFP (Nayernia et al., 2004). The Stra8-Gfp fusion construct 
was generated harboring the 1.4 kb promoter region of Stra8 followed by a Gfp cassette. 
This 1.4 kb region is sufficient to direct gene expression to the germinal stem cells in testis of 
transgenic mice (Giuili et al., 2002; Nayernia et al., 2004). Furthermore, this region does not contain 
the shared CTCF and CTCFL site located in the first intron of Stra8 as described previously 
(Sleutels et al., 2012). 
By crossing the Ctcflwt/del mice with the Stra8-Gfp transgenic mice we generated 
Ctcflwt/wt-Stra8-Gfp, Ctcflwt/del-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp double mutant mice. Testes 
from double mutant mice were isolated and germ cell preparation was performed in order to 
enrich for spermatogonia. After germ cell preparation testis extracts were either directly used 
in following assays or FACS-sorted using the GFP signal. This experimental set-up produced 
9 distinct cell populations; spermatogonia enriched samples from Ctcflwt/wt, Ctcflwt/del, Ctcfldel/
del mice, and spermatogonia enriched samples followed by FACS-sorting of Ctcflwt/wt, Ctcflwt/del, 
Ctcfldel/del mice, divided into GFP+ and GFP- (i.e. STRA8/CTCFL+ and STRA8/CTCFL-) fractions. 
Figure 1
Figure 1. Isolation of CTCFL positive cells from testis
(A) FACS profiles of testicular cells derived from 2 Ctcflwt/wt-
Stra8-Gfp and 4 Ctcfldel/del-Stra8-Gfp mice. Testicular cells were 
isolated from the indicated mouse lines and after dissociation 
of tissue and germ cell enrichment GFP+ (CTCFL expressing) 
and GFP- (CTCFL non-expressing) cell fractions were 
separated. Numbers indicate the percentages of gated cells. 
(B) Average values of GFP+ and GFP- cell fractions obtained 
from 4 FACS experiments. Gating was performed as shown 
in (A). Data are shown ± SEM; 4 independent FACS sorting 
experiments containing in total 10 Ctcflwt/wt-Stra8-Gfp (WT) and 
7 Ctcfldel/del-Stra8-Gfp (KO) mice. Student T-test was performed 
resulting in p>0.05.
A
B
146
5
Interestingly, our first FACS sorting experiment using 4 Ctcfldel/del mice (8 testes) and 
2 Ctcflwt/wt mice (4 testes) revealed a general increase in the percentage of GFP+ cells in the 
Ctcfldel/del mice (Figure 1A). We subsequently analyzed more mice, total 10 Ctcfldel/del-Stra8-Gfp 
and 7 Ctcflwt/wt-Stra8-Gfp (14 testes), in 4 independent FACS sorting experiments. Although 
not statistically significant, Ctcfldel/del mice showed a ~1.25 times increase of the percentage of 
GFP+ cells (Figure 1B). These results suggest that deletion of Ctcfl causes a developmental 
delay in the differentiation of late spermatogonia/pre-leptotene spermatocytes, leading to an 
increase in the fraction of GFP+ CTCFL- cells in the knock out.
CTCFL effects on transcription were examined by RNA-Sequencing of germ cell 
enriched and FACS-sorted GFP+ and GFP- cell populations derived from Ctcflwt/wt-Stra8-Gfp 
and Ctcfldel/del-Stra8-Gfp mice. We performed two independent experiments using in each 
experiment 1 Ctcfl wild type (2 testes) and 1 Ctcfl knock out (2 testes) mice. We analyzed 
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Figure 2. Characterization of gene 
expression in Stra8-GFP+ and Stra8-
GFP- testis fractions
mRNA isolated from Stra8-GFP+ and Stra8-
GFP- testis fractions was subjected to 
RNA-Sequencing. Raw RNA-Seq profiles 
were extracted from the IGV viewer. 
The Stra8 (A) and Prss50 (B) genes are 
exclusively expressed in the GFP+ cells. 
Whereas Actb (C) is equally well detected 
in both fractions. Numbers on the Y-axis 
represent the maximum number of reads in 
each sample. 
A B
C
147
5
changes in gene expression by comparing the Ctcflwt/wt GFP+ and the Ctcfldel/del GFP+ cells 
within each experiment with each other (further referred to as dataset 1 and dataset 2). To 
examine whether the FACS sorting worked properly, we checked genes that were known to be 
expressed in either GFP+ or GFP- cell population. In both experiments Stra8 and Prss50 RNAs 
were exclusively found in the GFP+ cell fractions, both in wild type as well as in Ctcfl knockout 
mice (Figure 2A, B, and data not shown). By contrast, Actb, encoding ACTIN, was found in 
both the GFP+ and GFP- fractions (Figure 2C).
Figure 3
A B
C
Figure 3. Characterization of gene expression in Stra8-GFP+ and Stra8-GFP- testis fractions
mRNA isolated from Stra8-GFP+ and Stra8-GFP- testis fractions was subjected to RNA-Sequencing. Raw RNA-Seq 
profiles were extracted from the IGV viewer. The Mageb4 (A) and Tex13a (B) genes are mutually exclusive expressed 
in the GFP+ and GFP- cells, respectively. In contrast, Ctcf mRNA (C) is not enriched in one of the GFP fractions. Ctcfl 
(D) is not abundantly expressed in WT, making its detection with RNA-Seq, and its localization to a certain fraction, 
less accurate. Ctcfl transcripts are not detected in KO. Grey dashed lines mark the deleted area in the Ctcfldel/del mice. 
Numbers on the Y-axis represent the maximum number of reads in each sample.
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Further visual inspection of the GFP+ and GFP- fractions from wild type and Ctcfl 
knock out mice revealed that the Mageb4 (Figure 3A) and Tex13a (Figure 3B) mRNAs, which 
encode a member of the cancer testis antigen (CTA) family and a testis-expressed sequence 
respectively, are enriched in either the GFP+ or the GFP- fraction. Ctcf mRNA is found in 
both fractions (Figure 3C), like Actb. Ctcfl is expressed at lower levels compared to Ctcf; 
nevertheless its segregation into the GFP+ fraction of wild type mice is obvious (Figure 3D). 
These data show that our FACS-based RNA-Seq approach is a valid method to separate Ctcfl+ 
and Ctcfl- cells from each other. 
Genome-wide analysis of the RNA-Seq data was performed to determine the degree 
of similarity of the two independent experiments. This revealed 691 and 787 deregulated 
genes between wild type and Ctcfl knock out in the GFP+ fractions of dataset 1 and dataset 2, 
respectively. In dataset 1 574 and 117 genes were down- and up-regulated, respectively, in Ctcfl 
knock out GFP+ cells, whereas in dataset 2 613 and 174 genes were down- and up-regulated, 
respectively. The two datasets did not share any of the up-regulated genes. However, 88 genes 
were down-regulated in both datasets (Table S1). This analysis revealed that only a subset 
(~11% of all genes) of deregulated genes was similar between the two datasets.  
Next, we examined Ctcfl, along with the Ctcfl-responsive genes Gal3st1, Prss50 and 
Stra8 expression. Expression of these genes were reduced in Ctcfldel/del GFP+ cells. Of all 
down-regulated genes, only Gal3st1 and the pseudogene Gm6525 showed a >10-fold fold 
change in expression, indicating that these genes depend on CTCFL confirming previous data. 
The other genes, including Prss50 and Stra8, showed less reduction in mRNA levels in the 
GFP+ Ctcfl knock out fractions compared to Gal3st1 and Gm6525 (Table S1). This suggests 
that CTCFL regulates these genes but is not the only (direct) regulator.
In addition to the known Ctcfl-responsive genes we detected other deregulated genes 
involved in gametogenesis. In Ctcfldel/del Stra8+ cells Dmrt1 (Table S1) and Kit (only in dataset 
1, data not shown) were down-regulated. Both genes are essential for spermatogonial differen- 
tiation (Brannan et al., 1992; Schrans-Stassen et al., 1999). Furthermore, DMRT1 represses Stra8 during 
spermatogenesis but stimulates Stra8 during oogenesis (Krentz et al., 2011; Matson et al., 2010). 
CTCFL is aberrantly expressed in multiple types of cancer and regulates transcription 
of several genes including the multi-gene family Mage. Interestingly, a subset of genes from the 
Mage-family was down-regulated in Ctcfldel/del STRA8+ cells (Table 1). Additionally, we noticed 
multiple other genes involved in carcinogenesis e.g. Brca1, Atm and Igf1r (Table S1). Overall 
these data show that CTCFL is a transcriptional activator. They also reveal a possible connec-
tion between genes involved in tumorigenesis and their regulation by CTCFL.
gene wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value gene wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value
Magea10 1.53978 0.52578 -1.5502 0.0477811 Magea10 2.56129 0.788557 -1.69958 0.0178293
Mageb4 13.7945 8.08269 -0.771181 0.0306431 Mageb4 24.3835 13.3884 -0.864923 0.0221595
Maged2 4.428 1.76505 -1.32694 0.021447 Magea5 3.50843 1.07114 -1.71168 0.0141532
Maged1 30.0477 20.1085 -0.57945 0.0426714 Magea8 3.65869 1.40882 -1.37683 0.0365106
Magea3 1.54297 0.343443 -2.16757 0.0433912
Magea6 1.5538 0.387263 -2.00442 0.0446153
Dataset 1 Dataset 2
Table 1
Table 1. RNA-Seq expression profiles of Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice
Gene expression levels of deregulated Mage genes by RNA-sequencing in Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-
Gfp mice from two independent experiments. Values are depicted in FPKM (Fragments per Kilobase of transcripts 
per Million mapped reads). Fold change (log2) between wild type and knock out mice are depicted together with the 
p-value.
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To gain more insight in the developmental expression pattern of Stra8 and Prss50 
genes and their regulation by CTCFL, we examined Ctcfl, Stra8 and Prss50 expression in 
whole testis of Ctcflwt/del and Ctcfldel/del mice at various time points after birth. As described before 
(Suzuki et al., 2010), there is a massive Ctcfl expression at postnatal day 13; levels drop down 
before and after this point, and Ctcfl was undetectable in Ctcfldel/del mice (Figure 4A, D). Prss50 
and Stra8 levels peaked with Ctcfl (Figure 4B, C). Prss50 expression was generally reduced 
in Ctcfldel/del testis with the exception of day 13 (Figure 4B, E). Stra8 expression was also 
reduced in Ctcfldel/del mice, except for day 13, 17 and 48 (Figure 4C, F). Developmental defects 
in Ctcfl knock out mice may lead to a delay in differentiation and could give rise to increased 
populations of Stra8-positive cells. This would explain the higher levels of Stra8 and Prss50 
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Figure 4. Gene expression analysis in Ctcflwt/del and Ctcfldel/del testis
RNA was isolated from testis of Ctcflwt/del and Ctcfldel/del mice of the indicated postnatal ages. Expression levels of 
Ctcfl (A, D), Prss50 (B, E) and Stra8 (C, F) were measured by qPCR. Expression levels were normalized to the 
housekeeping gene Ccna. In (D-F) expression is shown relative to wild type level. Data are shown ± SEM (N=2).
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mRNAs (and of GFP+ cells in FACS experiments) in Ctcfl knockout testes at certain periods 
of development. However, CTCFL is clearly not the only factor regulating expression of Stra8 
and Prss50. Our results support previous findings that revealed early CTCFL expression during 
spermatogenesis and down-regulation of Prss50 and Stra8 at day 23 in Ctcfldel/del mice (Sleutels 
et al., 2012). Overall, these results indicate that the regulation of Stra8 and Prss50 by CTCFL 
during development is complex.
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Figure 5. Gene expression analysis of testis specific factors in ES cells
(A) mRNA levels of testis specific factors Ctcfl, Stra8, Prss50 and Gal3st1 in ES cells expressing wild type CTCF (WT), 
GFP-CTCF, or the indicated GFP-tagged CTCF zinc finger mutants. Values are depicted in FPKM (Fragments Per 
Kilobase of transcripts per Million mapped reads).
(B) Ctcfl, Prss50, Stra8 mRNA levels in the indicated ES cell lines as determined by qPCR. Expression levels are 
relative to the housekeeping gene Cdk2 and were normalized to GFP-CTCF. All data are shown ± SEM (N=3).
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Figure 6. ChIP-Seq and ChIP-qPCR analysis in ES cells
(A) CTCF, CTCF zinc finger mutants and CTCFL ChIP-Seq profiles extracted from the UCSC genome browser for 
Kdelr1, Sec1, Stra8 and Prss50 genes.
(B) ChIP-qPCR validation experiment was performed with CTCF and Sox2 antibodies. Pre-immune serum was used 
as mock and amylase was used as non-CTCF binding site. CTCF enrichment was normalized to amylase. Data are 
shown ± SEM (N=3)
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Expression of Ctcfl and Ctcfl responsive genes
In order to study how CTCF utilizes its zinc fingers to recognize its DNA binding site 
we used CTCF zinc finger mutants. We have generated ES cells that, instead of endogenous 
CTCF, express GFP-tagged wild type CTCF, or mutant CTCF proteins with deletions of ZFs 
1, 8, 9, 10, or 11 (see chapter 3). RNA-Seq performed on these ES cells showed that the 
GFP-CTCF-∆8 mutant cells expressed Ctcfl, Prss50 and Stra8 (Figure 5A). Analysis of GFP-
CTCF-∆9 cells showed increased Stra8 expression. These unexpected observations were 
confirmed by qPCR (Figure 5B). 
We hypothesized that the increased expression of these genes could be caused by 
reduction of CTCF binding due to mutations in the ZF domain, and in the case of the ES cells 
expressing GFP-CTCF-∆8, to activation by CTCFL. We therefore examined CTCF and CTCFL 
genome-wide ChIP-Seq profiles in ES cells. Interestingly, focusing on the Prss50, and Stra8 
genes shows that GFP-CTCF-∆8 binding was reduced at the Stra8 promoter, as compared 
to wild type and GFP-CTCF binding (Figure 6A). Binding to the Prss50 promoter was less 
affected. Interestingly, CTCFL was also bound to the Stra8 and Prss50 promoters. As controls 
we examined binding at the Kdelr1 and Sec1 promoters, which were bound by CTCF and 
all the ZF mutants but not by CTCFL. These observations were confirmed by ChIP-qPCR, 
indicating that GFP-CTCF-∆8 is less stably bound than GFP-CTCF (Figure 6B). In addition to 
CTCF, endogenous SOX2 was also ChIPped, which is a CTCF-independent factor that should 
not change in binding profile upon expression of a ZF mutant. Indeed, SOX2 binding to a 
cognate site on chromosome 4 was unchanged irrespective of the ES cell line tested (Figure 
6B). Taken together these data suggest that CTCF acts as repressor of Stra8 and CTCFL as 
an activator. Relative loss of binding of the GFP-CTCF-∆8 and GFP-CTCF-∆9 mutants to the 
Stra8 promoter, in combination with a gain of binding of CTCFL in ES cells expressing GFP-
CTCF-∆8, explains the selective up-regulation of Stra8 in ES cells expressing the two mutant 
ZF proteins. Similarly, the induction of Prss50 in GFP-CTCF-∆8-expressing ES cells could be 
due to the expression of CTCFL in this cell line and the binding of the protein to the Prss50 
promoter.
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If CTCFL competes with CTCF on shared binding sites CTCFL should be able to 
compete with a CTCF mutant more efficiently than with wild type CTCF.  To test this CTCFL-RFP 
was transfected in GFP-CTCF- and GFP-CTCF-∆8-expressing ES cells and sorted for GFP 
and RFP double positive cells. We tested the expression level of Stra8, Prss50 and Gal3st1, 
using qPCR (Figure 7). As control we tested Ctcfl expression (Figure 7A). We found that 
Stra8 expression was higher in GFP-CTCF-∆8-expressing transfected ES cells than in GFP-
CTCF-expressing transfected cells (Figure 7B). Similar results were obtained with Gal3st1 
and Prss50 (Figure 7C, D), although for Prss50 only a ~1.5 fold increase was observed in 
GFP-CTCF-∆8-expressing transfected ES cells. However, GFP-CTCF-∆8-expressing non-
transfected ES cells already showed high levels of Prss50 (Figure 7C) and perhaps this gene 
cannot be further induced. Our data confirm that CTCFL competes more efficiently with less 
stably bound CTCF. 
Discussion
Spermatogenesis is a complex differentiation process that starts in the basal 
compartment of the seminiferous epithelium. In newborn mice the seminiferous epithelium 
contains gonocytes and Sertoli cells (for review see (Zhou and Griswold, 2008)). At day 6 of postnatal 
development germ cells are attached to the basement membrane and have differentiated to 
primitive type A spermatogonia, which form 16% of the total cell population in the seminiferous 
tubules (Bellve et al., 1977; Nebel et al., 1961). Type A and B spermatogonia are present at day 8 
after birth and primary spermatocytes at the preleptotene and leptotene stages of meiotic 
prophase are present at day 10 of development (Bellve et al., 1977; Nebel et al., 1961). Ctcfl and Stra8 
are expressed in type B spermatogonia and preleptotene spermatocytes and Prss50 is both 
expressed in CTCFL-positive cells and CTCFL-negative pachytene spermatocytes (Anderson et 
al., 2008; Baltus et al., 2006; Mark et al., 2008; Sleutels et al., 2012). 
Here we demonstrate that Ctcfl, Prss50 and Stra8 expression peak at 13 days of 
postnatal development. Initiation of Stra8 and Prss50 expression coincides with the presence 
of type B spermatogonia and the onset of preleptotene spermatocytes. Stra8 expression 
dropped at day 17 coinciding with the onset of pachytene spermatocytes and cells approaching 
the first meiotic metaphase. Unexpectedly, Prss50 expression showed similar dynamics and 
declined at day 17 with the onset of pachytene spermatocytes. This suggests that the PRSS50 
protein is present for a longer time period after transcription initiation during spermatogenesis. 
Ctcfl expression only started at day 13, which suggests that CTCFL is not involved in regulating 
the early expression of Stra8 and Prss50 but starts to regulate expression of these genes in 
a later phase. CTCFL clearly is not the only protein that regulates Stra8, since the Stra8-GFP 
transgene is expressed in a Ctcfl-negative background. Other factors, besides CTCFL, that 
could regulate Stra8 and Prss50 are, for example, DMRT1, WIN 18,466, P53 and SP1 (Krentz 
et al., 2011; Matson et al., 2010; Wang et al., 2010; Xu et al., 2007). The perfect co-localization of CTCFL 
and STRA8 in the adult testis that we observed in our earlier work (Sleutels et al., 2012), indicates 
that the timing of Stra8 and Ctcfl mRNA expression is different from that of protein expression. 
Ctcfldel/del mice contained more Stra8 and Prss50 mRNA at day 13 and 17 and more 
GFP+ (i.e. STRA8+) cells compared to wild type. This could be due to a developmental delay in 
the Ctcfldel/del mice caused by an accumulation of early stage spermatogenic cell types. Both, an 
arrest of CTCFL-negative cells during early stages of spermatogenesis or enhanced apoptosis 
Figure 7. Gene expression analysis in ES cells overexpressing CTCFL-V5-GFP
Ctcfl, Stra8, Prss50 and Gal3st1 expression levels were analyzed in ES cells expressing GFP-CTCF or GFP-
CTCF-∆8. Cells were either not transfected (NT) or transfected (T) with CTCFL-RFP. Expression levels are relative to 
the housekeeping gene Cdk2 and are normalized to not-transfected GFP-CTCF. Data are shown ± SEM (N=3)
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at later stages would result in an overrepresentation of GFP+ cells in the testis of Ctcfl knock out 
mice. To examine this further we have to discriminate the cell populations from each other during 
development by using cell surface markers at various time points of postnatal development. 
Our strategy to cross Ctcflwt/del mice with Stra8-Gfp transgenic mice and utilize FACS-
sorting on GFP in offspring from these mice was very efficient to obtain pure STRA8-positive 
cell populations with or without CTCFL. The RNA-Seq-based databases that we generated 
may serve as a valuable repository for other researchers in the field of spermatogenesis. RNA 
sequencing revealed that virtually all mis-regulated genes in the STRA8-positive fraction of 
Ctcfl knock out testis were down-regulated. This implies that CTCFL acts as transcriptional 
activator, which supports our previous findings (Sleutels et al., 2012). RNA-Seq showed reduced 
expression levels of many genes, including Stra8, Prss50 and Gal3st1, in Ctcfldel/del mice. Of 
these, Gal3st1 and Gm6525 were reduced more than 10-fold, suggesting that these two genes 
are completely dependent on CTCFL. The fact that Gal3st1 knock out mice show a much 
more severe phenotype in the testis than the Ctcfl knock outs (Honke et al., 2002; Sleutels et al., 2012; 
Suzuki et al., 2010) suggests that Gal3st1 is more widely expressed in the testis than Ctcfl, and is 
regulated by other factors in testicular cell types that do not express CTCFL.
Remarkably, a subset of deregulated genes was related to carcinogenesis and was 
down-regulated in the GFP+ testis fraction of Ctcfldel/del mice. CTCFL belongs to the group of 
cancer germline (CG) or cancer testis antigen (CTA) genes. CG genes are germ cell specific, 
but are reactivated and are aberrantly expressed in cancer (Cheng et al., 2011). Aberrant Ctcfl 
expression has indeed been observed in various cancer types (Hong et al., 2005; Looijenga et al., 2006; 
Renaud et al., 2005; Vatolin et al., 2005). CTCFL was proposed to induce expression of multiple genes 
within the MAGE-A family (Bhan et al., 2011; Smith et al., 2009). We indeed found a number of Mage-a 
genes down-regulated in Ctcfldel/del mice. In addition, multiple cancer-related genes, e.g. Brca1 
and Atm, were also down-regulated in the Ctcfldel/del mice. It has been proposed that aberrant 
Ctcfl and Mage-a expression could promote cell growth (Smith et al., 2009). Altogether these 
data suggest that CTCFL might promote carcinogenesis, since it positively regulates various 
cancer-related genes. So far only one study showed that patients with CTCFL expression in 
esophageal squamous cell cancer have a poor 5-years survival rate (Okabayashi et al., 2012). 
Additional research is required to understand the putative role of CTCFL in cancer. 
The analysis of the RNA-Seq data presented here revealed interesting candidate genes, 
which we can examine to understand how CTCFL regulates their transcription. However, the 
RNA-Seq data first requires further analysis before we are able to make solid conclusions. We 
need to pool the two datasets to examine significantly deregulated genes. In this way we are 
further able to perform additional downstream analysis, such as GO-analysis to reveal affected 
pathways in the Ctcfl knock out mice. Next, to CTCFL dependent transcriptional regulation it is 
interesting to examine were CTCFL and CTCF binds in the testis. ChIP-Seq on both proteins 
and histone modifications, e.g. H3K4me3, is suitable to address this question.
An unexpected observation was the expression of Ctcfl and the CTCFL-responsive 
genes Stra8 and Prss50 in GFP-CTCF-∆8-expressing ES cells. Stra8 was also expressed in 
GFP-CTCF-∆9-expressing ES cells. In both cell lines we observed a relative loss of binding of 
mutant proteins to the Stra8 promoter. This possible loss of function of mutant CTCF suggests 
that CTCF normally acts as repressor of this gene. Expression levels of CTCFL-responsive 
genes could be better stimulated by CTCFL when mutant CTCF was present instead of wild 
type protein. This suggests that on certain promoters there is a balance between the binding of 
the transcriptional repressor CTCF and the activator CTCFL.   
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Materials and Methods
Mouse models
Ctcflwt/del (Sleutels et al., 2012) and Stra8-Gfp transgenic (Nayernia et al., 2004) mice were 
crossed to generate Ctcflwt/wt-Stra8-Gfp, Ctcflwt/del-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice. In 
total 7 Ctcflwt/wt-Stra8-Gfp (2 mice: 33 days, 3 mice: 121 days and 2 mice: 133 days), and 10 
Ctcfldel/del-Stra8-Gfp mice (2 mice: 33 days, 4 mice 77 days and 4 mice: 121 days) were used 
in 4 independent FACS sorting experiments. Two independent RNA-seq experiments were 
performed using in each experiment 1 Ctcflwt/wt-Stra8-Gfp and 1 Ctcfldel/del-Stra8-Gfp mice. All 
mice used for RNA-seq were 33 days old. Whole testis extracts of Ctcflwt/del and Ctcfldel/del mice 
at various ages (day 10, 13, 17, 20, 29 and 48) were used to examine gene expression profiles 
by qPCR. 
Mice were maintained on a C57/Bl6 background at the Erasmus MC animal facility 
under specific pathogen–free conditions. Animal experiments were reviewed and approved by 
the Erasmus University committee of animal experiments.
Cell Culture and transfection
ES cells expressing CTCF zinc finger mutant  (see chapter 3) were grown on plastic 
dishes coated with 0.2% gelatin (Merck) in the presence of ES cell medium containing: 
Dulbecco’s Modified Eagle Medium (DMEM) (Lonza), 15% heat-inactivated fetal calf serum 
(FCS), Non Essential Amino Acids (Lonza), 100 U ml-1 penicillin and 100 mg ml-1 streptamycin, 
0.1 mM β-mercaptoethanol (Sigma) and 1000 U/ml leukaemia inhibitory factor (LIF). ES cells 
were cultured at 37°C with 5% CO2. Cells were passaged by trypsinization in 1xTE (trypsin/
EDTA) for 5 minutes at 37°C and subsequently diluted and resuspended in ES medium. 
Transient transfection of CTCFL-RFP in ES cells was performed with Lipofectamine 2000 
(invitrogen). Cells were harvested after 24 hours of transfection. 
RNA-isolation whole testis and ES cells for qPCR analysis
Total RNA of whole testis of Ctcflwt/wt and Ctcfldel/del mice (age: 10, 13, 17, 20, 29 and 
48 days), CTCF zinc finger mutant ES cells and CTCF zinc finger mutant ES cells expressing 
CTCFL-RFP was isolated using Trizol-BCP (1-bromo-3-chloro propane). RNA in aqueous 
phase was precipitated with isopropanol and washed with 70% ethanol. RNA was resuspended 
in water and reverse transcribed (RT) with a combination of random and oligo-dT primers by 
Superscript reverse transcriptase (Invitrogen). qPCR was performed with a Sybrgreen platform 
on a Bio-Rad CFX Cycler. The relative quantification method was used to calculate ∆Ct and 
∆∆Ct values (Livak and Schmittgen, 2001). Housekeeping genes Ccna and Cdk2 were used to 
normalize the qPCR data generated from the testes and ES cells, respectively. For primer 
sequences see supplemental table 2.
   
Generation of germ cell enriched populations
4 testes were incubated in 20 ml DPBS (Lonza) (volume was adjusted according to 
the amount of testes, 2 testes per 5 ml) with 1.1 mM Ca2+ and 0.52 mM Mg2+. 20 mg / 200 µl 
Collagenase (Boehringer), 10 mg / 200 µl Hyaluronidase and 20 mg / 200 µl Trypsin were 
added, followed by 20 minutes incubation at 32-34°C at 90 rpm. Samples were centrifuged for 
3 minutes at 1800 rpm at room temperature. Extracts were resuspended in 20 ml DPBS without 
Ca2+ and Mg2+ and incubated for 10 minutes at 32-34°C at 90 rpm. Clumps were removed and 
samples went through a 0.45 µm cell strainer. 
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Flow cytometric analysis
Testis extracts were sorted on GFP expression. In total 7 Ctcflwt/wt-Stra8-Gfp (2 mice: 
33 days, 3 mice: 121 days and 2 mice: 133 days), and 10 Ctcfldel/del-Stra8-Gfp mice (2 mice: 
33 days, 4 mice 77 days and 4 mice: 121 days) were used in 4 independent FACS sorting 
experiments. GFP cell lines with CTCFL-RFP expression were sorted on GFP and RFP 
expression by BD FACS Aria Cell sorter. Data was analyzed with FlowJo software.
RNA-sequencing of testis and ES cells
Two independent RNA-seq experiments were performed using in each experiment 1 
Ctcflwt/wt-Stra8-Gfp and 1 Ctcfldel/del-Stra8-Gfp mice. Testes were enriched for germ cells and 
subsequently FACS sorted for GFP. Two independent RNA-Seq experiments were performed on 
ES cells expressing a CTCF mutant. Total RNA isolation was performed with Trizol-chloroform 
extraction. After Trizol addition samples were incubated for 5 minutes at 30°C. Chloroform was 
added and aquaeous phase was transferred after centrifugation. 100% ethanol was added and 
an RNeasy Mini Kit was subsequently used (Cat. no. 74104, Qiagen).
Purity and quality of the isolated RNA was assessed by RNA 6000 Nano assay on a 
2100 Bioanalyzer (Agilent Technologies). 1 µg total RNA of each sample was used as starting 
material for Illumina Truseq sequencing. Samples were sequenced on a HiSeq 2000 generating 
36 bp single reads and a 7 bp index read. Samples were de-multiplexed and aligned to the 
mouse reference genome (build mm9) using Tophat alignment software. 
Aligned reads of testis RNA-Seq were visualized using the IGV viewer. Aligned reads 
of testis and CTCF zinc finger mutant ES cells were used to identify differentially expressed 
genes and to calculate FPKM values by Cufflinks (Trapnell et al., 2013). Expression levels were 
normalized according to gene length and sequencing dept. Ctcflwt/wt GFP+ samples were 
compared to the corresponding Ctcfdel/del GFP+ samples. The false discovery rate was set to 0.1 
and an internal t-test (p-value <0.05) was used. Comparisons with p>0.05 were excluded from 
further analysis. Manual analysis was performed to identify overlapping deregulated genes.
Chromatin immunoprecipitation ES cells
ChIP was performed as described (van de Nobelen et al., 2010). Briefly, 40-80*106 cells were 
harvested and cross-linked with 1% formaldehyde (Sigma) for 10 minutes at room temperature 
and quenched with Glycine (Sigma). Cell lysates were prepared with cell lysis buffer (10 mM Tris 
pH 8.0, 10 mM NaCl, 0.2% NP-40 (Sigma), Protease Inhibitor) followed by nuclei lysis buffer (50 
mM Tris pH 8.0, 10 mM EDTA, 1% SDS, Protease Inhibitor). Sonication was performed with the 
bioruptor (Diagnode) to yield fragments up to 800 bp. Immunoprecipitation with CTCF antibody 
(N2.2, home made), SOX2 (goat, Santa cruz) or pre-immune serum rabbit (home made) was 
performed. ChIP-Seq was validated by three independent ChIP-qPCR experiments. Ct values 
from qPCR were normalized to input measurements, and enrichment was calculated relative to 
CTCF negative binding site amylase. For primer sequences see supplemental table 3.
ChIP-Sequencing
A ChIP DNA library was prepared according to the Illumina protocol (www.illumina.
com). Briefly, 10 ng of end-repaired ChIPped DNA was ligated to adapters, size selected on gel 
(200±25 bp range), and PCR amplified using Phusion polymerase as follow: 30 sec at 98ºC, 18 
cycles of (10 sec at 98ºC, 30 sec at 65ºC, 30 sec at 72ºC), 5 min at 72ºC final extension. Cluster 
generation was performed using the Illumina Cluster Reagents preparation. The library was 
sequenced on the Illumina HiSeq2000 systems to generate 36 bp reads and a 7 bp index read. 
Images were recorded and analyzed by the Illumina Genome Analyzer Pipeline (GAP) and 
processed using the IPAR (Integrated Primary Analysis Reporting Software). Samples were 
de-multiplexed and mapped against mouse build mm9 reference genome. ChIP-Seq reads 
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were aligned to mm9 reference genome using Bowtie2 (Langmead and Salzberg, 2012). Datasets 
were uploaded into the UCSC genome browser.
158
5
References
Anderson, E.L., Baltus, A.E., Roepers-Gajadien, H.L., Hassold, T.J., de Rooij, D.G., van Pelt, A.M., and Page, D.C. 
(2008). Stra8 and its inducer, retinoic acid, regulate meiotic initiation in both spermatogenesis and oogenesis in mice. 
Proc Natl Acad Sci U S A 105, 14976-14980.
Baltus, A.E., Menke, D.B., Hu, Y.C., Goodheart, M.L., Carpenter, A.E., de Rooij, D.G., and Page, D.C. (2006). In germ 
cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication. Nat Genet 38, 
1430-1434.
Bellve, A.R., Cavicchia, J.C., Millette, C.F., O’Brien, D.A., Bhatnagar, Y.M., and Dym, M. (1977). Spermatogenic cells 
of the prepuberal mouse. Isolation and morphological characterization. J Cell Biol 74, 68-85.
Bhan, S., Negi, S.S., Shao, C., Glazer, C.A., Chuang, A., Gaykalova, D.A., Sun, W., Sidransky, D., Ha, P.K., and 
Califano, J.A. (2011). BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is 
associated with their transcriptional activation in lung cancer. Clin Cancer Res 17, 4267-4276.
Brannan, C.I., Bedell, M.A., Resnick, J.L., Eppig, J.J., Handel, M.A., Williams, D.E., Lyman, S.D., Donovan, P.J., 
Jenkins, N.A., and Copeland, N.G. (1992). Developmental abnormalities in Steel17H mice result from a splicing defect 
in the steel factor cytoplasmic tail. Genes Dev 6, 1832-1842.
Cheng, Y.H., Wong, E.W., and Cheng, C.Y. (2011). Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. 
Spermatogenesis 1, 209-220.
Giuili, G., Tomljenovic, A., Labrecque, N., Oulad-Abdelghani, M., Rassoulzadegan, M., and Cuzin, F. (2002). Murine 
spermatogonial stem cells: targeted transgene expression and purification in an active state. EMBO Rep 3, 753-759.
Hong, J.A., Kang, Y., Abdullaev, Z., Flanagan, P.T., Pack, S.D., Fischette, M.R., Adnani, M.T., Loukinov, D.I., Vatolin, 
S., Risinger, J.I., et al. (2005). Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with 
derepression of this cancer-testis gene in lung cancer cells. Cancer Res 65, 7763-7774.
Honke, K., Hirahara, Y., Dupree, J., Suzuki, K., Popko, B., Fukushima, K., Fukushima, J., Nagasawa, T., Yoshida, N., 
Wada, Y., et al. (2002). Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci 
U S A 99, 4227-4232.
Hore, T.A., Deakin, J.E., and Marshall Graves, J.A. (2008). The evolution of epigenetic regulators CTCF and BORIS/
CTCFL in amniotes. PLoS Genet 4, e1000169.
Kosaka-Suzuki, N., Suzuki, T., Pugacheva, E.M., Vostrov, A.A., Morse, H.C., 3rd, Loukinov, D., and Lobanenkov, 
V. (2011). Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a 
cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter. J Biol Chem 286, 27378-27388.
Krentz, A.D., Murphy, M.W., Sarver, A.L., Griswold, M.D., Bardwell, V.J., and Zarkower, D. (2011). DMRT1 promotes 
oogenesis by transcriptional activation of Stra8 in the mammalian fetal ovary. Dev Biol 356, 63-70.
Langmead, B., and Salzberg, S.L. (2012). Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357-359.
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR 
and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
Looijenga, L.H., Hersmus, R., Gillis, A.J., Pfundt, R., Stoop, H.J., van Gurp, R.J., Veltman, J., Beverloo, H.B., van 
Drunen, E., van Kessel, A.G., et al. (2006). Genomic and expression profiling of human spermatocytic seminomas: 
primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 66, 290-
302.
Loukinov, D.I., Pugacheva, E., Vatolin, S., Pack, S.D., Moon, H., Chernukhin, I., Mannan, P., Larsson, E., Kanduri, C., 
Vostrov, A.A., et al. (2002). BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming 
events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in 
the soma. Proc Natl Acad Sci U S A 99, 6806-6811.
159
5
Mark, M., Jacobs, H., Oulad-Abdelghani, M., Dennefeld, C., Feret, B., Vernet, N., Codreanu, C.A., Chambon, P., and 
Ghyselinck, N.B. (2008). STRA8-deficient spermatocytes initiate, but fail to complete, meiosis and undergo premature 
chromosome condensation. J Cell Sci 121, 3233-3242.
Matson, C.K., Murphy, M.W., Griswold, M.D., Yoshida, S., Bardwell, V.J., and Zarkower, D. (2010). The mammalian 
doublesex homolog DMRT1 is a transcriptional gatekeeper that controls the mitosis versus meiosis decision in male 
germ cells. Dev Cell 19, 612-624.
Nayernia, K., Li, M., Jaroszynski, L., Khusainov, R., Wulf, G., Schwandt, I., Korabiowska, M., Michelmann, H.W., 
Meinhardt, A., and Engel, W. (2004). Stem cell based therapeutical approach of male infertility by teratocarcinoma 
derived germ cells. Hum Mol Genet 13, 1451-1460.
Nebel, B.R., Amarose, A.P., and Hacket, E.M. (1961). Calendar of gametogenic development in the prepuberal male 
mouse. Science 134, 832-833.
Okabayashi, K., Fujita, T., Miyazaki, J., Okada, T., Iwata, T., Hirao, N., Noji, S., Tsukamoto, N., Goshima, N., Hasegawa, 
H., et al. (2012). Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. 
Cancer Sci 103, 1617-1624.
Phillips, J.E., and Corces, V.G. (2009). CTCF: master weaver of the genome. Cell 137, 1194-1211.
Renaud, S., Loukinov, D., Bosman, F.T., Lobanenkov, V., and Benhattar, J. (2005). CTCF binds the proximal exonic 
region of hTERT and inhibits its transcription. Nucleic Acids Res 33, 6850-6860.
Schrans-Stassen, B.H., van de Kant, H.J., de Rooij, D.G., and van Pelt, A.M. (1999). Differential expression of c-kit in 
mouse undifferentiated and differentiating type A spermatogonia. Endocrinology 140, 5894-5900.
Sleutels, F., Soochit, W., Bartkuhn, M., Heath, H., Dienstbach, S., Bergmaier, P., Franke, V., Rosa-Garrido, M., van de 
Nobelen, S., Caesar, L., et al. (2012). The male germ cell gene regulator CTCFL is functionally different from CTCF 
and binds CTCF-like consensus sites in a nucleosome composition-dependent manner. Epigenetics Chromatin 5, 8.
Smith, I.M., Glazer, C.A., Mithani, S.K., Ochs, M.F., Sun, W., Bhan, S., Vostrov, A., Abdullaev, Z., Lobanenkov, V., 
Gray, A., et al. (2009). Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter 
demethylation in head and neck cancer and lung cancer. PLoS One 4, e4961.
Suzuki, T., Kosaka-Suzuki, N., Pack, S., Shin, D.M., Yoon, J., Abdullaev, Z., Pugacheva, E., Morse, H.C., 3rd, 
Loukinov, D., and Lobanenkov, V. (2010). Expression of a testis-specific form of Gal3st1 (CST), a gene essential for 
spermatogenesis, is regulated by the CTCF paralogous gene BORIS. Mol Cell Biol 30, 2473-2484.
Trapnell, C., Hendrickson, D.G., Sauvageau, M., Goff, L., Rinn, J.L., and Pachter, L. (2013). Differential analysis of 
gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31, 46-53.
van de Nobelen, S., Rosa-Garrido, M., Leers, J., Heath, H., Soochit, W., Joosen, L., Jonkers, I., Demmers, J., van der 
Reijden, M., Torrano, V., et al. (2010). CTCF regulates the local epigenetic state of ribosomal DNA repeats. Epigenetics 
Chromatin 3, 19.
Vatolin, S., Abdullaev, Z., Pack, S.D., Flanagan, P.T., Custer, M., Loukinov, D.I., Pugacheva, E., Hong, J.A., Morse, 
H., 3rd, Schrump, D.S., et al. (2005). Conditional expression of the CTCF-paralogous transcriptional factor BORIS in 
normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. 
Cancer Res 65, 7751-7762.
Wang, M., Bao, Y.L., Wu, Y., Yu, C.L., Meng, X.Y., Huang, Y.X., Sun, Y., Zheng, L.H., and Li, Y.X. (2010). Basic FGF 
downregulates TSP50 expression via the ERK/Sp1 pathway. J Cell Biochem 111, 75-81.
Xu, H., Shan, J., Jurukovski, V., Yuan, L., Li, J., and Tian, K. (2007). TSP50 encodes a testis-specific protease and is 
negatively regulated by p53. Cancer Res 67, 1239-1245.
Zhou, Q., and Griswold, M.D. (2008). Regulation of spermatogonia.
160
5
gene wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value
Ctcfl 2.51 0.19 -3.70 2.33E-06 3.09 0.03 -6.52 1.57E-05
Gal3st1 4.73 0.26 -4.18 5.84E-05 4.05 0.38 -3.41 2.40E-04
Prss50 47.73 12.89 -1.89 6.24E-08 47.17 15.57 -1.60 7.03E-05
Stra8 33.19 12.60 -1.40 1.00E-04 42.10 23.00 -0.87 2.32E-02
Gm6525 7.88 0.53 -3.88 1.15E-02 15.46 0.93 -4.05 3.05E-03
Mid1 3.03 0.29 -3.40 5.44E-05 3.12 1.37 -1.19 3.43E-02
Tubb6 7.28 0.87 -3.06 1.24E-06 7.43 2.88 -1.37 1.51E-02
Tcf7l1 1.94 0.65 -1.59 2.06E-02 2.43 0.97 -1.32 3.89E-02
Magea10 1.54 0.53 -1.55 4.78E-02 2.56 0.79 -1.70 1.78E-02
Greb1l 1.31 0.45 -1.53 3.30E-03 1.24 0.37 -1.74 2.92E-03
Amot 0.85 0.31 -1.44 2.14E-02 1.22 0.48 -1.34 2.61E-02
1600021P15Rik 1.09 0.40 -1.43 4.48E-02 2.24 0.96 -1.23 4.71E-02
Casp7 2.68 1.00 -1.43 2.02E-02 5.04 2.27 -1.15 3.88E-02
Mycn 3.12 1.18 -1.40 1.43E-02 4.17 1.85 -1.17 3.83E-02
Cyp17a1 7.48 2.89 -1.37 6.55E-03 5.26 2.27 -1.21 3.92E-02
Art1 3.73 1.45 -1.36 3.85E-02 6.39 1.72 -1.89 3.08E-03
Snhg11 1.73 0.68 -1.35 1.03E-02 2.00 0.88 -1.19 3.05E-02
Glt25d1 11.71 4.61 -1.35 2.44E-04 15.37 8.51 -0.85 2.84E-02
Vgll3 1.32 0.52 -1.34 4.18E-02 1.20 0.32 -1.88 1.14E-02
Serpine2 3.50 1.43 -1.30 2.84E-02 8.60 3.91 -1.14 2.69E-02
Zmynd8 1.86 0.76 -1.29 1.47E-02 3.09 1.34 -1.21 1.86E-02
4933427D06Rik 6.96 2.87 -1.28 4.68E-03 10.45 5.49 -0.93 3.95E-02
Ctnnd2 1.47 0.61 -1.26 1.96E-02 1.91 0.90 -1.09 4.67E-02
Xlr4b 5.49 2.32 -1.24 4.19E-02 8.17 3.21 -1.35 2.39E-02
Pxdn 3.29 1.41 -1.22 3.20E-03 4.23 2.04 -1.05 1.78E-02
Fam199x 1.17 0.53 -1.14 2.72E-02 2.45 1.10 -1.16 1.62E-02
Col5a1 2.60 1.25 -1.06 8.72E-03 3.96 2.09 -0.92 2.82E-02
Dck 5.94 2.86 -1.06 1.56E-02 9.52 5.04 -0.92 3.75E-02
Sema6d 1.42 0.69 -1.04 4.59E-02 2.56 1.11 -1.21 3.21E-02
Atm 8.05 3.97 -1.02 3.39E-04 9.61 5.26 -0.87 8.20E-03
Dataset 1 Dataset 2
Supplemental Table S1
Supplemental Table S1. RNA-Seq expression profiles of Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice
Gene expression levels of common down-regulated genes by RNA-sequencing in Ctcflwt/wt-Stra8-Gfp and Ctcfldel/
del-Stra8-Gfp mice from two independent experiments. Values are depicted in FPKM (Fragments per Kilobase of 
transcripts per Million mapped reads). Fold change (log2) between wild type and knock out mice are depicted together 
with the p-value.
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gene wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value
Mll1 5.19 2.56 -1.02 4.25E-04 5.84 3.10 -0.91 6.89E-03
Ppp1ca 47.61 23.59 -1.01 3.79E-03 75.24 43.41 -0.79 3.08E-02
Trim26 6.95 3.45 -1.01 1.30E-02 9.89 5.32 -0.89 3.81E-02
Usp22 8.93 4.43 -1.01 3.17E-03 13.15 7.94 -0.73 4.82E-02
Gm98 3.96 2.00 -0.98 1.40E-02 5.07 2.16 -1.23 6.39E-03
Nkain1 6.00 3.06 -0.97 3.43E-02 10.96 5.18 -1.08 1.76E-02
Tex15 27.22 13.94 -0.97 5.47E-04 28.95 16.31 -0.83 7.37E-03
Wdhd1 16.75 8.76 -0.94 1.79E-03 26.24 15.12 -0.80 1.65E-02
Mex3a 4.24 2.24 -0.92 1.74E-02 6.25 3.46 -0.85 3.84E-02
Kdm1b 3.18 1.69 -0.91 4.85E-02 5.83 2.80 -1.06 2.17E-02
Tex13 12.80 6.88 -0.89 2.05E-02 19.90 10.40 -0.94 2.30E-02
Tet3 3.54 1.91 -0.89 7.86E-03 5.06 2.93 -0.79 3.37E-02
Igf1r 3.09 1.66 -0.89 8.68E-03 4.24 2.32 -0.87 2.19E-02
Prep 11.20 6.11 -0.87 1.76E-02 18.66 10.29 -0.86 2.68E-02
Apaf1 2.41 1.32 -0.87 4.76E-02 3.43 1.71 -1.00 3.37E-02
Prr12 4.39 2.40 -0.87 1.59E-02 6.85 3.82 -0.84 2.94E-02
Zdhhc18 6.13 3.36 -0.87 4.54E-02 9.06 4.22 -1.10 1.75E-02
4930529F22Rik 6.65 3.65 -0.86 4.79E-02 7.10 2.71 -1.39 7.12E-03
Klf11 4.70 2.59 -0.86 3.93E-02 7.85 4.26 -0.88 4.00E-02
Dhcr24 8.79 4.87 -0.85 1.41E-02 13.43 7.65 -0.81 3.14E-02
Spnb3 4.52 2.51 -0.85 1.23E-02 6.31 3.48 -0.86 2.36E-02
Dmrt1 30.90 17.21 -0.84 5.16E-03 55.34 30.11 -0.88 8.01E-03
Gsr 15.21 8.47 -0.84 1.28E-02 26.89 15.70 -0.78 3.05E-02
Ptma 245.09 137.82 -0.83 2.83E-03 386.98 222.22 -0.80 9.43E-03
Abca2 10.59 5.98 -0.82 3.91E-03 13.86 6.87 -1.01 2.43E-03
Ubtf 10.96 6.20 -0.82 3.19E-02 16.22 9.10 -0.83 3.15E-02
Cdca7 10.47 5.94 -0.82 3.61E-02 19.20 9.71 -0.98 1.51E-02
Ctps 17.88 10.14 -0.82 1.14E-02 27.99 16.92 -0.73 4.01E-02
Taf1 7.92 4.50 -0.81 6.49E-03 11.39 6.35 -0.84 1.30E-02
Nmt2 45.01 25.62 -0.81 5.49E-03 67.62 41.34 -0.71 3.07E-02
Dataset 1 Dataset 2
  
Supplemental Table S1-Part 2
Supplemental Table S1. RNA-Seq expression profiles of Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice
Gene expression levels of common down-regulated genes by RNA-sequencing in Ctcflwt/wt-Stra8-Gfp and Ctcfldel/
del-Stra8-Gfp mice from two independent experiments. Values are depicted in FPKM (Fragments per Kilobase of 
transcripts per Million mapped reads). Fold change (log2) between wild type and knock out mice are depicted together 
with the p-value.
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gene wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value wt/wt 
Expression 
(FPKM)
del/del 
Expression 
(FPKM)
fold change 
(log2)
p-value
Rlim 4.48 2.56 -0.81 2.01E-02 5.15 2.92 -0.82 4.28E-02
Msh2 9.17 5.27 -0.80 3.14E-02 16.68 9.68 -0.78 4.10E-02
Lrba 4.79 2.76 -0.80 1.48E-02 6.99 4.14 -0.76 3.63E-02
Marcksl1 53.06 30.71 -0.79 7.30E-03 83.30 49.13 -0.76 2.06E-02
Sgpl1 11.24 6.50 -0.79 1.44E-02 16.45 9.05 -0.86 1.72E-02
Esx1 28.15 16.35 -0.78 2.00E-02 37.55 20.03 -0.91 1.84E-02
Srp54a 11.39 6.63 -0.78 1.42E-02 11.23 6.28 -0.84 3.05E-02
Itpr3 3.47 2.02 -0.78 2.68E-02 6.36 3.10 -1.04 5.96E-03
Tubb5 14.68 8.56 -0.78 2.24E-02 26.03 15.20 -0.78 3.20E-02
Mageb4 13.79 8.08 -0.77 3.06E-02 24.38 13.39 -0.86 2.22E-02
Zfp36l2 7.59 4.52 -0.75 4.41E-02 10.92 5.77 -0.92 2.57E-02
Plod1 10.21 6.13 -0.74 3.61E-02 14.04 8.10 -0.79 4.32E-02
Hdac6 19.19 11.92 -0.69 3.77E-02 33.21 18.87 -0.82 3.32E-02
Huwe1 24.78 15.40 -0.69 2.15E-02 32.14 18.82 -0.77 1.35E-02
Mcm4 9.83 6.11 -0.69 4.50E-02 16.10 9.23 -0.80 3.11E-02
Hcfc1 10.37 6.47 -0.68 1.63E-02 14.46 8.46 -0.77 1.77E-02
Mcm2 16.78 10.46 -0.68 2.63E-02 30.05 16.36 -0.88 9.59E-03
Ccnd1 8.89 5.55 -0.68 4.93E-02 16.76 10.16 -0.72 4.64E-02
Fat1 5.73 3.58 -0.68 1.65E-02 7.86 4.36 -0.85 9.42E-03
Ncl 27.64 17.59 -0.65 2.03E-02 43.82 28.59 -0.62 4.63E-02
Bahcc1 4.32 2.75 -0.65 3.82E-02 8.63 4.38 -0.98 4.22E-03
Nxf2 20.22 12.90 -0.65 4.28E-02 29.62 15.97 -0.89 1.47E-02
Spnb2 8.59 5.48 -0.65 2.29E-02 11.45 6.05 -0.92 7.15E-03
Smc3 21.05 13.58 -0.63 2.30E-02 25.35 16.20 -0.65 4.56E-02
Brca1 6.87 4.44 -0.63 4.59E-02 10.52 6.14 -0.78 2.89E-02
Hspg2 4.92 3.22 -0.61 3.45E-02 6.81 3.60 -0.92 6.54E-03
Akap9 6.54 4.44 -0.56 4.87E-02 8.37 5.19 -0.69 3.69E-02
Lphn1 13.12 9.01 -0.54 4.87E-02 15.13 9.69 -0.64 4.54E-02
Dataset 1 Dataset 2
Supplemental Table S1-Part 3
Supplemental Table S1. RNA-Seq expression profiles of Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice
Gene expression levels of common down-regulated genes by RNA-sequencing in Ctcflwt/wt-Stra8-Gfp and Ctcfldel/
del-Stra8-Gfp mice from two independent experiments. Values are depicted in FPKM (Fragments per Kilobase of 
transcripts per Million mapped reads). Fold change (log2) between wild type and knock out mice are depicted together 
with the p-value.
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q-PCR primer 
name Primer sequence
Ctcfl_F GCTCTGGCTGTGCACCTTACG
Ctcfl_R CCCACTGTGCCACCATCATC
Stra8_F GGCAGTTTACTCCCAGTCTGATA
Stra8_R CAACTTATCCAGGCTTTCTTCCT
Prss50_F GACAGTTCTCTCTGCACTGTGAC
Prss50_R CACATTTCTTGCTGTTCAGGATA
Gal3st1_F ACTGTATCCCAACATGGCCTTC
Gal3st1_R ATATCTCGCCGAGGTTGACAC
Ccna1_F GAGTATGCAGAGGAGATTCATCG
Ccna1_R TCATGTAGTGAGCCTTGGGTCTG
Cdk2_F ACAGCCGTGGATATCTGGAG
Cdk2_R TTAGCATGGTGCTGGGTACA
Gal3st1 testis 
specific form_F GCTACTCGGAGTTCCGGAAA
Gal3st1 testis 
specific form_R GACTTGCAGGGCTTCTTTGG
ChIP primer name Primer sequence
Amylase_ChIP_F AATTCTCCTTGTACGGCTTCGTG
Amylase_ChIP_R TAGCAATGATGTGCACAGCTGAA
Stra8_ChIP_F TCCTAGAGAAGGGGGTGTTACC
Stra8_ChIP_R AGCTGACCACCACACGTTTTC
Prss50_ChIP_F AGAGGAGGGTAGGGGTATCGAC
Prss50_ChIP_R TCGCCTCAGCTAATTTCTAAGC
Kdelr1_ChIP_F CCCTAAAGACCCTTCCATCAG
Kdelr1_ChIP_R TAAAGCTGGCTGGGAGAAAAG
Sec1_ChIP_F ACCTGGGCAGAGAAGAGAAAG
Sec_ChIP_R AGCCTCTCCACTGAGTCTTCC
Sox2_Ch4_ ChIP_F TCGGGATAGAAAGAGGGTAAGG
Sox2_Ch4_ChIP_R AGCATCTGGGGAGTAACTGTTG
Supplemental Table S2
Supplemental Table S3
Supplemental Table S2. Primers used for gene expression analysis by qPCR
Supplemental Table S3. Primers used ChIP-qPCR
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General Discussion 
Chromatin is hierarchically organized in order to compact DNA on the one hand and 
on the other hand to allow regulation of various cellular processes (Misteli, 2007). CTCF is an 
important factor that regulates chromatin and spatial organization (Phillips and Corces, 2009). It is 
important to understand how CTCF binds to DNA and interacts with other proteins in order to 
gain insight into the functionality of CTCF. It has only one homologous protein called CTCFL, 
which normally is only expressed in the testis but is also found in various cancer types. In order 
to understand the role of CTCFL in cancer pathology, it is important to gain an understanding 
about its basic function during spermatogenesis. In this thesis we investigated the role of 
CTCF and CTCFL in mice, by identifying interacting proteins, examining CTCF- and CTCFL-
dependent gene regulation, and by analyzing the genome-wide distribution and intracellular 
localization of these proteins. 
We used a mass-spectrometry based proteomics analysis of biotinylated CTCF to 
identify novel interacting partners. We showed that CTCF interacts with the rDNA factor UBF 
and that it regulates the local chromatin state at the rDNA spacer promoter (Chapter 2). 
CTCF mutants with individual ZF deletions were used to elucidate which specific 
nucleotides within the CTCF binding motif are recognized by a given ZF. We found that ZFs 
2-7 are essential for the function of CTCF. By contrast, deletion of ZFs 1 and 8-11 did not 
affect ES cell viability and these ZFs are therefore less essential. Furthermore, we identified 
the full length CTCF binding motif and showed that ZFs 8-11 are important to bind a CTCF 
bipartite motif. This particular motif is excluded from transcription start sites and exons and is 
associated with the repressive chromatin mark H3K9me3 (Chapter 3).
Finally, we used genome-wide approaches to identify CTCFL function. We identified 
a CTCFL consensus sequence, which is highly similar to the 20 bp consensus sequence of 
CTCF. In addition we found that CTCFL binds to sites that are also occupied by CTCF as 
well as to CTCFL only-sites. CTCFL competes with CTCF on specific sites to maintain the 
expression of male germ cell genes and is often located to promoters associated with loosely 
assembled histones (Chapters 4 and 5). 
Regulation of rDNA transcription by CTCF
The higher-order organization of chromatin is dynamic and specific chromatin regions 
can localize to various subnuclear compartments to influence genome configuration and 
transcription (Brown et al., 2008; Capelson et al., 2010; Guelen et al., 2008; Nemeth et al., 2010; Peric-Hupkes 
et al., 2010; van Koningsbruggen et al., 2010). The nucleolus is a subnuclear compartment where 
rDNA is actively transcribed and ribosomal RNA is synthesized, processed and assembled 
with ribosomal proteins (Andersen et al., 2002; Grandori et al., 2005; Hernandez-Verdun and Roussel, 2003). 
CTCF localizes throughout the nucleus, but seems to be excluded from the nucleolus (Chapter 
3), yet appears to associate with the borders of lamina associated domains (LADs) and the 
nucleolus (Guelen et al., 2008; Yusufzai et al., 2004). rDNA is shifted according to its transcriptional 
activity between two subnucleolar compartments (Nemeth et al., 2010; van Koningsbruggen et al., 2010). 
Within the nucleolus CTCF interacts at the borders with nucleophosmin (Yusufzai et al., 2004) 
and, as described in chapter 2, with UBF on the rDNA repeat. We found a specific CTCF 
binding site on the rDNA, at the spacer promoter, where it regulates the local epigenetic state 
of rDNA by stimulating the binding of UBF, H3K4me2 and H2A.Z. Additionally, CTCF enhances 
RNA polymerase I dependent transcription of non-coding RNA from the spacer promoter. All 
together, CTCF binding results in an open chromatin state near the spacer promoter, which 
indicates that CTCF binding maintains rDNA repeats poised for transcription. Our findings in 
mouse have been supported by a genome-wide analysis of human rDNA repeats that also 
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identified CTCF binding to the spacer promoter (Zentner et al., 2011). Another proteomic approach 
identified CTCF interaction with RNA polymerase I and its binding to the spacer promoter. 
Here, CTCF positively regulates rRNA transcription in an RNA polymerase I-dependent fashion. 
Additionally, CTCF binding enhances histone acetylation across the rDNA locus to establish an 
open chromatin state (Huang et al., 2013). This implies that CTCF acts as transcriptional activator 
on rDNA repeats by interacting with the RNA polymerase I transcription initiation complex at the 
spacer promoter. However, we could not show an effect on total rRNA levels when we deleted 
Ctcf in mouse embryonic fibroblasts (Chapter 2).
 The importance of CTCF’s function with regard to the regulation of rDNA repeats was 
emphasized by the identification of a putative nucleolar localization sequence, RRGR motif, 
in the C-terminus of the protein (Huang et al., 2013). However, in chapter 3 we show that CTCF 
localizes throughout the nucleus but does not accumulate extensively inside the nucleolus. 
Beside UBF and RNA polymerase I, two subunits of the condensin complex, SMC2 and SMC4, 
were shown to interact with CTCF and to negatively regulate CTCF-mediated rRNA gene 
transcription (Huang et al., 2013). Thus CTCF interacts with transcriptional activators to promote 
transcription but is also competed from the active rDNA repeats by transcriptional repressors. 
This suggests that there is a balance between activation and repression of CTCF-mediated 
transcription of rDNA repeats. Identification of other repressors and activators is required to 
gain better understanding on the regulation of the rDNA repeats. 
CTCF co-localizes with cohesin on a subset of CTCF binding sites. Both factors 
mediate long-range interactions on a genome-wide scale. CTCF binding is related to the 
transcriptional activity of rDNA repeats and cohesin facilitates production of rRNA and thus 
enhances protein translation (Bose et al., 2012). To gain insight how CTCF and/or cohesin organize 
the spatial organization of active and inactive rDNA repeats one should first determine whether 
both proteins are localized on either all rDNA repeats or only a subset (active or inactive). 
This could be analyzed by including rDNA repeats in the bioinformatic analysis of ChIP-Seq 
profiles of both proteins. DNA FISH experiment incombination with RNA FISH can be used to 
gain understanding into the spatial organization of the inactive and active rDNA locus. Both 
experiments can be done in a conditional Ctcf knock out mice background and/or in cells with a 
depletion of cohesin to examine whether the 3D configuration of rDNA repeats changes.
CTCF binding recognition and motif distribution
CTCF’s binding to DNA is established by its ZF domain. All ZFs are highly conserved 
across species and must therefore be important for the functionality of the protein (Moon et al., 
2005; Pugacheva et al., 2006). ZFs 4-7 bind to the 20 bp core motif present in 80-99.5% of all CTCF 
binding sites, and therefore these ZFs are essential to establish CTCF binding (Nakahashi et al., 
2013; Renda et al., 2007; Rhee and Pugh, 2011). The remaining ZFs were proposed to be required for 
stabilizing CTCF binding to its target sites (Nakahashi et al., 2013; Renda et al., 2007). 
In order to understand the functional relevance of each ZF with regard to CTCF binding 
recognition we generated ES cells expressing CTCF ZF mutants in a Ctcf knockout background 
(Chapter 3). Deletion of endogenous CTCF results in cellular lethality (Heath et al., 2008). This 
can be prevented by substitution of endogenous CTCF with wild type GFP-CTCF (Sleutels et 
al., 2012). In chapter 3 we describe that mutant CTCF with distinct individual ZF deletions can 
also substitute for endogenous CTCF, allowing us to study ZF specific effects on DNA binding. 
However, because we delete ZFs our method results in shifted position of the remaining ZFs 
within the complete domain. This might influence CTCF binding to DNA. Indeed, we speculate 
that the major reason why GFP-CTCF-∆8 fails to bind the bipartite CTCF consensus motif is 
because ZFs 9-11 are shifted and can not bind essential nucleotides. This is also the case for 
GFP-CTCF-∆9 and GFP-CTCF-∆10. Recently, an alternative approach was published, where 
ZF mutants were created with mutated key histidine residues that coordinate zinc binding 
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(Nakahashi et al., 2013). This method maintains the position of each ZF although, however, folding 
of the finger might be affected. 
About 80% of the CTCF binding sites contain the 20 bp consensus core motif and 
15-30% the bipartite motif (Boyle et al., 2011; Chen et al., 2008; Kim et al., 2007; Nakahashi et al., 2013; Rhee 
and Pugh, 2011; Schmidt et al., 2012; Xie et al., 2007). It is therefore remarkable that CTCF zinc finger 
mutants are reduced in DNA binding on bipartite motif sites, since the core motif is present and 
ZF4-7 are not affected in these mutants. Thus, in addition to the shifted position of the ZFs, 
another environmental factor could be present that affect CTCF binding to core motif sites. It 
might be possible that CTCF protects bipartite motifs from binding of other factors. Reduction of 
CTCF binding in the zinc finger mutants might allow competition between CTCF and additional 
factors resulting in a reduction in DNA binding of CTCF zinc finger mutants to bipartite motifs.
In support of current understanding our rescue experiment suggested that ZFs 
4-7 are essential for the functionality of CTCF. We were also not able to generate ES cells 
expressing GFP-CTCF-∆2, or -3, suggesting that these fingers are also highly important for 
CTCF’s function. It is possible that these two ZFs are required for binding to the core motif 
by recognizing sequences adjacent to it and/or are essential for protein-protein interactions 
involving important cellular processes. These hypotheses could be tested in ES cells with one 
remaining endogenous allele or through in vitro assays e.g. EMSA and immunoprecipitation 
experiments. 
   Although all ZFs of CTCF are highly conserved we were able to delete fingers 1 and 
8-11 and demonstrated that these fingers are required for binding the bipartite CTCF recognition 
sequence. By establishing binding deficiencies of ES cells expressing CTCF mutants in these 
peripheral ZFs we identified the complete CTCF binding motif. Our data result in a model where 
ZFs 1-7 bind adjacent to each other, with finger 1 mainly binding to a nucleotide on ‘position 
44’, 10 nucleotides downstream of the core sequence (Chapter 3), indicating the 3’end of the 
binding sequence. The region bound by ZF1-7 is followed by an approximately 10 bp helical 
turn, which might be bridged by ZF8. After this ZFs 9-11 are able to bind to the upstream motif 
of the bipartite sequence. It is still unknown what the exact role of ZFs 8-11 is when CTCF is 
bound to sites containing only the core motif. 
 In chapter 3 we show that CTCF sites containing the bipartite motif are excluded 
from transcription start sites and exons and preferentially located in intergenic and intronic 
regions. These sites are associated with the repressive chromatin mark H3K9me3 whereas 
CTCF is often located to open chromatin environments. As CTCF is one of the key players in 
the regulation of long-range interactions the question remains if these CTCF bipartite motif-
containing sites are involved in 3D looping.
Functional analysis of CTCFL 
Initial studies on the localization of CTCFL and CTCF in testis yielded contradictory 
results. First, both proteins were detected in a mutually exclusive pattern, with CTCFL being 
localized in primary spermatocytes, preceding CTCF expression in round spermatids (Loukinov 
et al., 2002). Later reports identified CTCFL in gonocytes during embryonic development and in 
spermatogonia after birth (Jelinic et al., 2006). Ctcfl expression was later also detected in round 
spermatids (Kosaka-Suzuki et al., 2011; Suzuki et al., 2010). 
In order to elucidate where CTCFL and CTCF are localized in the testis we used various 
mouse models and technologies (Chapter 4). Ctcfl knock out, as well as Ctcfgfp and Ctcflgfp 
knock-in mice were examined using immunohistochemistry, immunofluorescence staining and 
ex-vivo imaging with multiphoton confocal laser scanning microscopy. This analysis revealed 
that CTCF is expressed in all cell types of the seminiferous tubule, but that the amount of CTCF 
decreases drastically in spermiogenesis. CTCFL expression could only be detected in late 
spermatogonia and pre-leptotene spermatocytes. Our results oppose the theory that CTCF 
170
6
and CTCFL are expressed in a mutually exclusive pattern (Loukinov et al., 2002), since we showed 
that these proteins are expressed in the same cells during early spermatogenesis.
It has been hypothesized that CTCFL is involved in establishing DNA imprints 
during reprogramming (Loukinov et al., 2002). Establishment of sex-specific imprints takes place 
at prospermatogonia stage (E15-16) (Reik et al., 2001). This process is initiated prior to the 
expression of CTCFL, which indicates that CTCFL is most likely not involved in reprogramming. 
Furthermore, as described in chapter 4, Ctcfl knock out mice do not exhibit DNA methylation 
defects and do not show imprinted-related developmental defects. 
In chapter 4 we hypothesized that CTCFL acts as transcriptional activator, since many 
genes are down-regulated genes in Ctcfl knock out mice. Surprisingly, microarray experiments 
revealed only very few testis-related genes, including Prss50 and Gal3st1. The absence of 
more deregulated testis-associated genes in these microarray experiments can be explained. 
CTCFL is only expressed in a small population of cells in the testis and the use of whole 
testis extracts will ‘dilute’ CTCFL-specific responses, which are subsequently not detected by 
microarray. The fact that Prss50 and Gal3st1 were found in this experimental set-up indicates 
that these genes are regulated by CTCFL. This was confirmed in Chapter 5.
To study CTCFL-dependent transcription regulation we isolated a pure CTCFL-
expressing population by crossing Ctcfl mutant mice with Stra8-gfp transgenic mice as presented 
in chapter 5. STRA8 and CTCFL are expressed in the same cells during spermatogenesis 
(Sleutels et al., 2012); therefore GFP driven by the Stra8 promoter can be used as a marker 
to isolate CTCFL-expressing cells via FACS. An RNA-Seq-based analysis confirmed our 
statement that CTCFL is a transcriptional activator, since the majority of mis-regulated genes 
are negatively affected. Next to Stra8, Prss50 and Gal3st1 we found additional testis-related 
genes such as Dmrt1 and, surprisingly, a subset of genes involved in carcinogenesis. CTCFL 
is aberrantly expressed in cancer cell lines and different types of cancer. It belongs to the group 
of cancer germline genes (CG genes), which are germ cell-specific genes that are reactivated 
and aberrantly expressed in various cancer types (Cheng et al., 2011). CTCFL stimulates the 
expression of CG genes NY-ESO-1 and several MAGE-A genes in cancer cell lines (Bhan et 
al., 2011; Hong et al., 2005; Kang et al., 2007; Smith et al., 2009; Vatolin et al., 2005). Our RNA-Seq data from 
testis revealed new candidate genes that could enhance our understanding regarding CTCFL’s 
function during cancer development. 
Genome-wide analysis revealed that CTCFL binding sites are mainly located at 
promoters with loosely assembled histones (Chapter 4). CTCFL enhances expression of 
several CG genes by binding to their promoters. A subset of CTCFL binding sites is also bound 
by CTCF and CTCFL is able to compete with CTCF on some of the ‘shared’ sites. CTCFL binds 
a similar 20 bp consensus sequence as CTCF, which is not so surprising given 71% identity 
of the ZF domains of these proteins. This begs the question how it is possible that there are 
both CTCF-only and CTCFL-only sites. For one, CTCFL ZFs 10 and 11 are less homologous 
to corresponding fingers of CTCF (Loukinov et al., 2002), which suggests that CTCFL is not able to 
bind to CTCF’s upstream motif described in chapter 3. Secondly, in chapter 4 we also propose 
that nucleosome composition containing loosely assembled histones, e.g. H3.3 and H2A.Z, 
determines binding of CTCF and CTCFL.
It is unknown whether a subset of CTCFL-CTCF binding sites is involved in long-
range interactions. If CTCFL is able to compete with CTCF on shared binding sites it would 
be interesting to examine whether CTCFL can interfere with CTCF-mediated loops to affect 
transcription. Can CTCFL mediate loops at all? The fact that in ES cells CTCFL binds to ~2000 
sites to which CTCF does not bind but cohesin does (Sleutels et al., 2012), indicates that CTCFL 
might also act in conjunction with cohesin. Whether CTCFL is involved in chromatin interactions 
in vivo can be tested using the Ctcflwt/wt-Stra8-Gfp and Ctcfldel/del-Stra8-Gfp mice described in 
chapter 5. Purified cell populations from Ctcfl wild type and knock out mice can be used to 
perform chromatin conformation capture techniques such as 3C or 4C to examine whether the 
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presence or absence of CTCFL cause changes in chromatin structure.
 In conclusion, the data presented in this thesis have enhanced our understanding of 
the biological functions of CTCF and CTCFL, and the interplay between these factors. The 
genome-wide approaches applied in our research have contributed enormously to this and 
provide future prospective and clues for research.   
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Summary
DNA is a long molecule that is stored inside the small volume of the nucleus by 
hierarchical wrapping and folding. DNA and the proteins that associate with it, which together 
are called chromatin, are organized to enable compaction on the one hand and to allow 
transcription, DNA repair and all kinds of other processes on the other. One of the key players 
in chromatin structure and spatial organization of the genome is CTCF (CCCTCF binding 
factor). CTCF is a multifunctional and highly conserved nuclear protein that is characterized 
by an eleven zinc finger (ZF) domain that is surrounded by N- and C-terminal regions. CTCFL 
(CCCTC binding factor like), whose function has been characterized to a lesser extent, is a 
less well conserved testis-specific paralogue of CTCF. In this thesis we examined the biological 
roles of CTCF and CTCFL using various techniques and approaches. We identified interacting 
proteins of CTCF(L), examined CTCF- and CTCFL dependent gene regulation, and analyzed 
the genome-wide distribution and intracellular localization of these proteins.
One of the CTCF- and CTCFL-interacting proteins that we identified is UBF (upstream 
binding factor). UBF is localized in the nucleolus and binds to the ribosomal DNA (rDNA) repeat 
to regulate the transcription of ribosomal RNAs (rRNAs), which are major components of 
ribosomes. CTCF is bound upstream of the unmethylated spacer promoter of the rDNA repeat. 
Its binding stimulates binding of RNA polymerase I and H2A.Z near the spacer promoter. This 
leads to enhanced transcription of non-coding RNA from the spacer promoter. Thus, CTCF 
affects RNA polymerase I-mediated events by regulating chromatin at the rDNA spacer 
promoter. CTCF may load UBF onto rDNA, thereby forming part of a network that maintains 
rDNA genes poised for transcription (chapter 2).
In addition to binding to rDNA, CTCF binds to 25,000-50,000 sites in mouse and 
human genomes using its eleven ZF domain. It recognizes a 20 bp conserved consensus 
sequence (core motif). Additionally, it binds sites containing both the core motif and a 9 bp 
sequence upstream of the core motif (upstream motif). To determine how the different ZFs of 
CTCF contribute to binding specificity and how this relates to cellular function, we replaced the 
endogenous Ctcf gene in mouse embryonic stem (ES) cells with either wild type GFP-CTCF 
or with mutants in which individual ZF domains were deleted. ES cell lines with deletion of 
individual ZFs 2-7 could not be established suggesting that these ZFs are required for ES cell 
viability. By contrast, ZF1 and ZF 8-11 were dispensable. Based on ChIP-Sequencing analysis 
of GFP-CTCF- and GFP-CTCF-ZF-mutant-expressing ES cells we propose that ZF1-3 bind 
nine contiguous nucleotides immediately downstream of the CTCF core motif, which is bound 
by ZF4-7, and that ZF8-11 are required for binding a spacer sequence and the upstream motif. 
CTCF binding sites containing the core with upstream motif are specifically depleted from 
transcription start sites and exons, and are associated with the repressive chromatin mark 
H3K9me3. These sites are less well bound by GFP-CTCF-∆8-11 mutants. Some of the genes 
with such CTCF binding sites show an altered expression. Combined, our data suggest that 
CTCF binds DNA throughout the genome to regulate essential nuclear processes, and that it 
binds near genes to regulate transcription locally (chapter 3).
We also examined the function of CTCFL using mouse models and ES cells. Our data 
show that in the testis of adult male mice CTCFL is expressed in type B spermatogonia and pre-
leptotene spermatocytes. Absence of CTCFL causes subfertility because of partially penetrant 
testis atrophy. Furthermore, CTCFL positively regulates expression of the germ cell-specific 
factors Prss50, Stra8 and Gal3st1, suggesting that it acts as transcriptional activator. Genome-
wide analysis of ES cells expressing CTCFL showed that the protein binds a 20 bp consensus 
sequence similar to that of CTCF and is able to compete with CTCF. However, only ~3,700 out 
of the ~ 5,700 CTCFL- and ~31,000 CTCF-binding sites overlap. Strikingly, CTCFL is mainly 
located on promoters with loosely assembled nucleosomes whereas CTCF binds to sites 
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surrounded by phased nucleosomes. This suggests that nucleosome composition specifies 
the genome-wide binding of CTCFL and CTCF. We propose that the transient expression 
of CTCFL in spermatogonia and pre-leptotene spermatocytes serves to occupy a subset of 
promoters and maintain the expression of male germ cell genes (chapter 4). 
The function of CTCFL in transcription regulation in the testis was further analyzed. The 
cellular expression pattern of CTCFL in the testis completely overlaps with that of STRA8. To 
examine the transcriptional function of CTCFL in more detail, we used a FACS-based approach 
to separate CTCFL-expressing from non-expressing testicular cells. We sorted GFP+ (i.e. 
CTCFL-expressing) and GFP- (i.e. not containing CTCFL) cell populations from a Stra8-Gfp 
transgenic mouse maintained in wild type or Ctcfl knock out backgrounds. RNA-Sequencing 
revealed highly specific enrichment of the Stra8 mRNA in the GFP+ fractions, validating our 
separation method. Many more genes were down-regulated than up-regulated genes in 
the GFP+ Ctcfl knock out fraction, confirming the hypothesis that CTCFL is a transcriptional 
activator. Combined our data suggest that CTCFL activates transcription of a limited number of 
genes in the testis and that CTCF acts as repressor of these genes. This suggests that CTCFL 
competes with CTCF to maintain proper gene expression in the testis (chapter 5).  
In conclusion, this thesis contains studies that provide further insight into the biological 
functions of CTCF and CTCFL in terms of protein interaction, chromatin organization and 
transcriptional regulation. 
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Samenvatting
Het DNA is een lang molecuul, dat opgeslagen is in het kleine volume van de celkern 
doormiddel van hiërarchisch wikkelen en vouwen. Het DNA en de eiwitten die geassocieerd zijn 
met het DNA worden samen chromatine genoemd en zijn op zodanige manier georganiseerd 
om aan de ene kant compressie toe te staan en aan de andere kant transcriptie, DNA reparatie 
en overige cellulaire processen. Een van de belangrijkste factoren in het structureren van 
chromatine en de ruimtelijke organisatie van het genoom is CTCF (CCCTC-binding factor). 
CTCF is een multifunctioneel en zeer geconserveerd nucleair eiwit dat gekarakteriseerd wordt 
door een elf zink vinger (ZV) domein, die omgeven is door de N- en C-terminale regio’s. CTCFL 
(CCCTCF-binding factor-like), van wie de functie op mindere mate gekarakteriseerd is, is een 
minder goed geconserveerd testis-specifiek paraloog van CTCF. In dit proefschrift bestuderen 
wij de biologische rollen van CTCF en CTCFL door gebruik te maken van verschillende 
technieken en benaderingen. We identificeren de interacterende eiwitten van CTCF(L), 
bestuderen CTCF- en CTCFL-afhankelijke gen regulatie, en analyseren de distributie over het 
gehele genoom en de intracellulaire lokalisatie van deze eiwitten. 
Een van de CTCF- en CTCFL-interacterende eiwitten die wij geïdentificeerd hebben is 
UBF (upstream binding factor). UBF is gelokaliseerd in de nucleolus en bindt aan het ribosomaal 
DNA (rDNA) repeat om de transcriptie van ribosomaal RNAs (rRNAs), die de grootste 
component van de ribosomen zijn, te reguleren. CTCF bindt voor de ongemethyleerde spacer 
promoter van het rDNA repeat. Deze binding stimuleert de bindingen van RNA polymerase I en 
H2A.Z nabij de spacer promoter. Dit leidt tot verhoogde transcriptie van het niet-gecodeerde 
RNA van de spacer promoter. Dus, CTCF heeft een effect op RNA polymerase I gemedieerde 
gebeurtenissen door de regulatie van chromatine op de rDNA spacer promoter. CTCF kan UBF 
op het DNA zetten, waardoor het onderdeel wordt van een netwerk dat het rDNA toegankelijk 
houdt voor transcriptie (hoofdstuk 2).
Naast het binden aan rDNA, bindt CTCF aan 25.000-50.000 plekken in het genoom van 
muis en mens gebruikmakend van het elf ZV domein. Het herkent een 20 bp geconserveerd 
consensus sequentie (kern motief/core motif). Bovendien bindt het ook plekken die het kern 
motief en een 9 bp sequentie voor het kern motief bevatten (voorop gelegen motief/upstream 
motif). Om te bepalen hoe de verschillenden ZVs van CTCF bijdragen aan de bindingscapaciteit 
en hoe dit relateert naar cellulaire functies, hebben wij het endogene Ctcf gen in muis embryonale 
stam (ES) cellen vervangen met wild type GFP-CTCF of met mutanten waarvan individuele 
zink vinger domeinen waren verwijderd. ES cellijnen met een deletie van individuele ZVs 2-7 
kunnen niet bewerkstelligd worden, wat suggereert dat deze ZVs nodig zijn voor de vitaliteit 
van ES cellen. In tegenstelling tot ZV1 en ZV 8-11 die overbodig waren. Gebaseerd op ChIP-
Seq analyses van GFP-CTCF en GFP-CTCF-ZV-mutant expresserende ES cellen stellen wij 
voor dat ZV 1-3 aan negen opeenvolgende nucleotide aan het einde van de kern motief binden. 
Het kern motief wordt gebonden door ZV 4-7, en ZV 8-11 zijn nodig voor de binding aan de 
tussenliggende sequentie en het voorop gelegen motief. CTCF bindingsplekken bevattende de 
kern en voorop gelegen motief zijn specifiek afwezig op transcriptie start plekken en exonen, 
en zijn geassocieerd met de repressieve chromatine marker H3K9me3. Deze plekken zijn 
minder goed gebonden door GFP-CTCF-Δ8-11 mutanten. Sommige genen met deze CTCF 
bindingsplek vertonen een andere expressie. Al met al suggereren onze data dat CTCF over 
het hele genoom bindt om essentiële nucleaire processen te reguleren, en dat het nabij genen 
bindt om lokaal transcriptie te reguleren (hoofdstuk 3).
Wij hebben ook de functie van CTCFL bestudeerd met muis modellen en ES cellen. 
Onze data laten zien dat CTCFL in de testis van volwassen muizen in type B spermatogonia 
en pre-leptotene spermatocyten tot expressie komt. Afwezigheid van CTCFL zorgt voor 
subfertiliteit door een partiële penetrerende testis atrofie. Bovendien heeft CTCFL een positief 
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regulerend effect op de expressie van geslachtscel specifieke factoren Prss50, Stra8 en 
Gal3st1 wat suggereert dat het een transcriptionele activator is. Analyses van het hele genoom 
van CTCFL expresserende ES cellen laten zien dat het eiwit een 20 bp consensus sequentie 
bindt vergelijkbaar met dat van CTCF en dat is met CTCF kan competeren. Echter, alleen 
~3.700 van de ~5700 CTCFL- en ~31.000 CTCF-bindingsplekken overlappen. Opvallend is 
dat CTCFL voornamelijk op promoters met los bindende nucleosomen bindt, terwijl CTCF op 
plekken bindt met gefaseerde nucleosomen. Dit suggereert dat nucleosoom compositie de 
bindingsplekken van CTCF en CTCFL specificeert. Wij stellen voor dat de tijdelijke expressie 
van CTCFL in spermatogonia en pre-leptotene spermatocyten als doel heeft om een aantal 
promoters te binden en de expressie van mannelijke geslachtscel genen te behouden.
De functie van CTCFL in de transcriptionele regulatie in de testis is verder geanalyseerd. 
Het cellulaire expressie patroon van CTCFL in de testis overlapt compleet met dat van STRA8. 
Om de transcriptionele functie van CTCFL in meer detail te bestuderen, maken wij gebruik van 
een FACS methode om de CTCFL-expresserende van de niet-expresserende testiculaire cellen 
te scheiden. We hebben GFP+ (CTCFL-expresserend) en GFP- (niet CTCFL-expresserend) cel 
populaties gesorteerd van een Stra8-Gfp transgene muis in een wild type of Ctcfl gedeleteerde 
muis. RNA-Sequencing laat zien dat er een hoge verrijking is van het Stra8 mRNA in de GFP+ 
fractie, wat onze methode valideerde. Meer genen waren omlaag dan omhoog gereguleerd in 
de GFP+ Ctcfl gedeleteerde muis, wat de hypothesis dat CTCFL een transcriptionele activator 
is verder bevestigd. Al met al suggereren onze data dat CTCFL transcriptie van een aantal 
genen in de testis activeert en dat CTCF een repressor is van deze genen. Dit suggereert 
dat CTCFL met CTCF competeert om een juiste gen expressie in de testis te bewerkstelligen 
(hoofdstuk 4).
Concluderend, dit proefschrift bevat studies die meer inzicht in de biologische functies 
van CTCF en CTCFL geven omtrent eiwit interacties, chromatine organisatie en transcriptie 
regulatie. 
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List of abbreviations
bp  base pairs
cDNA  Complementary desoxyribonucleic acid
CG gene  Cancer germ cell gene
ChIP  Chromatin immunoprecipitation
ChIP-Seq  ChIP-Sequencing
CT  Chromosome territory
CTCF  CCCTC-binding factor
CTCFL  CCCTC-binding factor like
DNA  Deoxyribonucleic acid
EM  Electron microscopic
ES  Embryonic stem cells
FACS  Fluorescence-activated cekk sorting
FDR  False discovery rate
FISH  Fluorescent in situ hybridization
FPKM  Fragments per kilobase of transcripts per Million mapped reads
FRAP  Fluorescence recovery after photobleaching
GFP  Green Fluorescence Protein
GST  Glutatione-S-transferase
H2A.Z  Histone H2A.Z
HAT  Histone acetyl transferase
HDAC  Histone deacetylase
HMG  High mobility group
HS  Hypersensitivity site
ICR  Imprinting control region
IGS  Intergenic spacer
Kb  Kilo base pairs
kDa  Kilo Dalton
LAD  Lamina associated domain
LCR  Locus control region
Mb  Mega base pairs
MEF  Mouse embryonic fibroblast
NAD  Nucleolus associated domain
PCR  Polymerase chain reaction
PGC  Primordial germ cell
qPCR  Quantitative PCR
rDNA  ribosomal DNA
RFP  Red fluorescence protein
RNA  Ribonucleic acid
RNAi  RNA interference
RNA-Seq  RNA-Sequencing
RPA194  RNA polymerase I large subunit of 194 kD
rRNA  ribosomal RNA
TAD  Topologically associated domain
TES  Transcription elongation site
TSS  Transcription start site
UC motif  Upstream core motif
WT  Wild type
ZF  Zinc Finger
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